trait_uri	efoId	trait	N_study	traitNgene
http://www.ebi.ac.uk/efo/EFO_0008009	EFO_0008009	1,5 anhydroglucitol measurement	2	29
http://www.ebi.ac.uk/efo/EFO_0010220	EFO_0010220	17-hydroxyprogesterone measurement	5	7
http://www.ebi.ac.uk/efo/EFO_0010980	EFO_0010980	3-aminoisobutyrate measurement	4	7
http://www.ebi.ac.uk/efo/EFO_0010982	EFO_0010982	3-hydroxybutyrate measurement	3	81
http://www.ebi.ac.uk/efo/EFO_0010983	EFO_0010983	3-hydroxyisobutyrate measurement	3	7
http://www.ebi.ac.uk/efo/EFO_0005132	EFO_0005132	5-HIAA measurement	4	2
http://www.ebi.ac.uk/efo/EFO_0020013	EFO_0020013	5-methyluridine (ribothymidine) measurement	2	14
http://www.ebi.ac.uk/efo/EFO_0009459	EFO_0009459	ACPA-positive rheumatoid arthritis	2	75
http://www.ebi.ac.uk/efo/EFO_0006955	EFO_0006955	ADAMTS13 activity measurement	1	27
http://www.ebi.ac.uk/efo/EFO_0000765	EFO_0000765	AIDS	4	26
http://purl.obolibrary.org/obo/MONDO_0019438	MONDO_0019438	AL amyloidosis	10	15
http://www.ebi.ac.uk/efo/EFO_0020861	EFO_0020861	ANGPTL8 measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0007659	EFO_0007659	APOE carrier status	5	4
http://www.ebi.ac.uk/efo/EFO_0009324	EFO_0009324	APOL1 risk genotype carrier status	2	2
http://www.ebi.ac.uk/efo/EFO_0009584	EFO_0009584	AQP4-IgG-positive neuromyelitis optica	1	77
http://www.ebi.ac.uk/efo/EFO_0007020	EFO_0007020	AR-C124910XX measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004214	EFO_0004214	Abdominal Aortic Aneurysm	12	95
http://purl.obolibrary.org/obo/HP_0011458	HP_0011458	Abdominal symptom	14	3
http://www.ebi.ac.uk/efo/EFO_0008012	EFO_0008012	Abelson tyrosine-protein kinase 2 measurement	1	9
http://purl.obolibrary.org/obo/HP_0003119	HP_0003119	Abnormal circulating lipid concentration	1	4
http://purl.obolibrary.org/obo/HP_0000539	HP_0000539	Abnormality of refraction	8	46
http://purl.obolibrary.org/obo/HP_0004408	HP_0004408	Abnormality of the sense of smell	6	4
http://purl.obolibrary.org/obo/HP_0000079	HP_0000079	Abnormality of the urinary system	3	2
http://purl.obolibrary.org/obo/HP_0002571	HP_0002571	Achalasia	2	25
http://purl.obolibrary.org/obo/HP_0011142	HP_0011142	Age-related nuclear cataract	4	17
http://www.ebi.ac.uk/efo/EFO_0009931	EFO_0009931	Agents acting on the renin-angiotensin system use measurement	3	746
http://www.ebi.ac.uk/efo/EFO_0008016	EFO_0008016	Agouti-related protein measurement	2	13
http://www.orpha.net/ORDO/Orphanet_79364	Orphanet_79364	Alopecia	7	260
http://purl.obolibrary.org/obo/MONDO_0004975	MONDO_0004975	Alzheimer disease	127	725
http://www.ebi.ac.uk/efo/EFO_0006514	EFO_0006514	Alzheimer's disease biomarker measurement	130	21
http://www.ebi.ac.uk/efo/EFO_0009938	EFO_0009938	Anilide use measurement	3	185
http://www.ebi.ac.uk/efo/EFO_0009352	EFO_0009352	Anti-Helicobacter pylori IgG measurement	6	19
http://www.ebi.ac.uk/efo/EFO_0009353	EFO_0009353	Anti-Toxoplasma gondii IgG measurement	3	7
http://www.ebi.ac.uk/efo/EFO_0009347	EFO_0009347	Anti-cytomegalovirus IgG measurement	4	2
http://www.ebi.ac.uk/efo/EFO_0009358	EFO_0009358	Anti-hepatitis B virus surface antigen IgG measurement	2	25
http://www.ebi.ac.uk/efo/EFO_0009350	EFO_0009350	Anti-herpes simplex virus 2 IgG measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0009357	EFO_0009357	Anti-rubella virus IgG measurement	1	25
http://www.ebi.ac.uk/efo/EFO_0009351	EFO_0009351	Anti-varicella zoster virus IgG measurement	2	46
http://www.ebi.ac.uk/efo/EFO_0009940	EFO_0009940	Antidepressant use measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0009944	EFO_0009944	Antiglaucoma preparations and miotics use measurement	3	35
http://www.ebi.ac.uk/efo/EFO_0009943	EFO_0009943	Antihistamine use measurement	3	46
http://www.ebi.ac.uk/efo/EFO_0009927	EFO_0009927	Antihypertensive use measurement	3	25
http://www.ebi.ac.uk/efo/EFO_0009939	EFO_0009939	Antimigraine preparation use measurement	3	31
http://www.ebi.ac.uk/efo/EFO_0009925	EFO_0009925	Antithrombotic agent use measurement	3	162
http://purl.obolibrary.org/obo/HP_0001915	HP_0001915	Aplastic anemia	4	6
http://purl.obolibrary.org/obo/HP_0000483	HP_0000483	Astigmatism	27	13
http://www.ebi.ac.uk/efo/EFO_0005676	EFO_0005676	Autoimmune Hepatitis	5	39
http://www.ebi.ac.uk/efo/EFO_0000094	EFO_0000094	B-cell acute lymphoblastic leukemia	14	29
http://purl.obolibrary.org/obo/MONDO_0600030	MONDO_0600030	B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)	2	1
http://www.ebi.ac.uk/efo/EFO_0007737	EFO_0007737	BMI-adjusted adiponectin measurement	3	12
http://www.ebi.ac.uk/efo/EFO_0008036	EFO_0008036	BMI-adjusted fasting blood glucose measurement	10	58
http://www.ebi.ac.uk/efo/EFO_0008037	EFO_0008037	BMI-adjusted fasting blood insulin measurement	9	26
http://www.ebi.ac.uk/efo/EFO_0008039	EFO_0008039	BMI-adjusted hip circumference	11	3286
http://www.ebi.ac.uk/efo/EFO_0007793	EFO_0007793	BMI-adjusted leptin measurement	13	19
http://www.ebi.ac.uk/efo/EFO_0011044	EFO_0011044	BMI-adjusted neck circumference	3	2
http://www.ebi.ac.uk/efo/EFO_0007789	EFO_0007789	BMI-adjusted waist circumference	26	2794
http://www.ebi.ac.uk/efo/EFO_0007788	EFO_0007788	BMI-adjusted waist-hip ratio	68	2757
http://www.ebi.ac.uk/efo/EFO_0006920	EFO_0006920	BNP measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0009443	EFO_0009443	BRCAX breast cancer	1	4
http://purl.obolibrary.org/obo/HP_0003418	HP_0003418	Back pain	26	10
http://www.ebi.ac.uk/efo/EFO_0000280	EFO_0000280	Barrett's esophagus	22	76
http://www.ebi.ac.uk/efo/EFO_0003780	EFO_0003780	Behcet's syndrome	14	87
http://www.ebi.ac.uk/efo/EFO_0007167	EFO_0007167	Bell's palsy	7	3
http://www.ebi.ac.uk/efo/EFO_0009929	EFO_0009929	Beta blocking agent use measurement	3	295
http://www.orpha.net/ORDO/Orphanet_30391	Orphanet_30391	Biliary atresia	2	3
http://www.orpha.net/ORDO/Orphanet_179	Orphanet_179	Birdshot chorioretinopathy	1	3
http://www.orpha.net/ORDO/Orphanet_93930	Orphanet_93930	Bladder exstrophy	1	1
http://www.ebi.ac.uk/efo/EFO_0004955	EFO_0004955	Breslow thickness	2	1
http://purl.obolibrary.org/obo/MONDO_0015263	MONDO_0015263	Brugada syndrome	3	28
http://www.ebi.ac.uk/efo/EFO_0008041	EFO_0008041	C-C motif chemokine 1 measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008045	EFO_0008045	C-C motif chemokine 17 measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0008046	EFO_0008046	C-C motif chemokine 18 measurement	1	18
http://www.ebi.ac.uk/efo/EFO_0010910	EFO_0010910	C-C motif chemokine 20 measurement	2	12
http://www.ebi.ac.uk/efo/EFO_0008048	EFO_0008048	C-C motif chemokine 21 measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008049	EFO_0008049	C-C motif chemokine 23 measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0008050	EFO_0008050	C-C motif chemokine 25 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008051	EFO_0008051	C-C motif chemokine 3 measurement	2	46
http://www.ebi.ac.uk/efo/EFO_0008052	EFO_0008052	C-C motif chemokine 3-like 1 measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0008053	EFO_0008053	C-C motif chemokine 5 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0008054	EFO_0008054	C-C motif chemokine 7 measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0008055	EFO_0008055	C-C motif chemokine 8 measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0008056	EFO_0008056	C-X-C motif chemokine 10 measurement	4	8
http://www.ebi.ac.uk/efo/EFO_0008057	EFO_0008057	C-X-C motif chemokine 11 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0010911	EFO_0010911	C-X-C motif chemokine 16 measurement	3	66
http://www.ebi.ac.uk/efo/EFO_0008059	EFO_0008059	C-X-C motif chemokine 6 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0005187	EFO_0005187	C-peptide measurement	7	22
http://www.ebi.ac.uk/efo/EFO_0004458	EFO_0004458	C-reactive protein measurement	67	2155
http://www.ebi.ac.uk/efo/EFO_0020206	EFO_0020206	C3a anaphylatoxin des arginine measurement	2	66
http://www.ebi.ac.uk/efo/EFO_0005080	EFO_0005080	CC16 measurement	2	30
http://www.ebi.ac.uk/efo/EFO_0005188	EFO_0005188	CCL11 measurement	3	14
http://www.ebi.ac.uk/efo/EFO_0009411	EFO_0009411	CCL13 measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0009413	EFO_0009413	CCL15 measurement	2	14
http://www.ebi.ac.uk/efo/EFO_0009414	EFO_0009414	CCL17 measurement	3	24
http://www.ebi.ac.uk/efo/EFO_0009415	EFO_0009415	CCL19 measurement	3	132
http://www.ebi.ac.uk/efo/EFO_0004749	EFO_0004749	CCL2 measurement	10	170
http://www.ebi.ac.uk/efo/EFO_0009416	EFO_0009416	CCL21 measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0009417	EFO_0009417	CCL23 measurement	4	20
http://www.ebi.ac.uk/efo/EFO_0009418	EFO_0009418	CCL24 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0010768	EFO_0010768	CCL25 measurement	4	34
http://www.ebi.ac.uk/efo/EFO_0010769	EFO_0010769	CCL28 measurement	2	32
http://www.ebi.ac.uk/efo/EFO_0010770	EFO_0010770	CCL3 measurement	3	14
http://www.ebi.ac.uk/efo/EFO_0004751	EFO_0004751	CCL4 measurement	4	40
http://www.ebi.ac.uk/efo/EFO_0005117	EFO_0005117	CCL5 measurement	5	150
http://www.ebi.ac.uk/efo/EFO_0008076	EFO_0008076	CD109 antigen measurement	2	18
http://www.ebi.ac.uk/efo/EFO_0008077	EFO_0008077	CD209 antigen measurement	2	26
http://www.ebi.ac.uk/efo/EFO_0010772	EFO_0010772	CD244 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0008078	EFO_0008078	CD27 antigen measurement	2	18
http://www.ebi.ac.uk/efo/EFO_0004790	EFO_0004790	CD40 ligand measurement	5	3
http://www.ebi.ac.uk/efo/EFO_0010586	EFO_0010586	CD40 measurement	4	17
http://www.ebi.ac.uk/efo/EFO_0004839	EFO_0004839	CD4:CD8 lymphocyte ratio	1	10
http://www.ebi.ac.uk/efo/EFO_0010773	EFO_0010773	CD5 measurement	3	14
http://www.ebi.ac.uk/efo/EFO_0010774	EFO_0010774	CD6 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0010107	EFO_0010107	CD8-positive T-lymphocyte count	1	10
http://www.ebi.ac.uk/efo/EFO_0007909	EFO_0007909	CHGA cleavage product measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0007910	EFO_0007910	CHGB cleavage product measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0008086	EFO_0008086	CMRF35-like molecule 6 measurement	1	4
http://purl.obolibrary.org/obo/MONDO_0100096	MONDO_0100096	COVID-19	117	200
http://www.ebi.ac.uk/efo/EFO_0600019	EFO_0600019	COVID-19 symptoms measurement	12	4
http://www.ebi.ac.uk/efo/EFO_0009419	EFO_0009419	CX3CL1 measurement	3	42
http://www.ebi.ac.uk/efo/EFO_0010777	EFO_0010777	CXCL1 measurement	2	16
http://www.ebi.ac.uk/efo/EFO_0010779	EFO_0010779	CXCL11 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0009420	EFO_0009420	CXCL12 measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0009422	EFO_0009422	CXCL5 measurement	4	15
http://www.ebi.ac.uk/efo/EFO_0009423	EFO_0009423	CXCL6 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010780	EFO_0010780	CXCL9 measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0009930	EFO_0009930	Calcium channel blocker use measurement	3	550
http://www.ebi.ac.uk/efo/EFO_0007585	EFO_0007585	Cannabis use	14	39
http://www.ebi.ac.uk/efo/EFO_0009029	EFO_0009029	Central precocious puberty	1	10
http://www.ebi.ac.uk/efo/EFO_1000166	EFO_1000166	Cervical Intraepithelial Neoplasia Grade 2/3	2	11
http://www.orpha.net/ORDO/Orphanet_64280	Orphanet_64280	Childhood absence epilepsy	1	1
http://www.ebi.ac.uk/efo/EFO_0009330	EFO_0009330	Chlamydia trachomatis seropositivity	4	1
http://purl.obolibrary.org/obo/HP_0001082	HP_0001082	Cholecystitis	9	51
http://www.ebi.ac.uk/efo/EFO_0007208	EFO_0007208	Churg-Strauss syndrome	3	25
http://www.ebi.ac.uk/efo/EFO_0008085	EFO_0008085	Ck-beta-8-1 measurement	1	18
http://purl.obolibrary.org/obo/HP_0000175	HP_0000175	Cleft palate	31	125
http://purl.obolibrary.org/obo/HP_0012199	HP_0012199	Cluster headache	2	5
http://purl.obolibrary.org/obo/HP_0100543	HP_0100543	Cognitive impairment	23	10
http://www.ebi.ac.uk/efo/EFO_1002040	EFO_1002040	Corneal astigmatism	23	14
http://www.orpha.net/ORDO/Orphanet_278	Orphanet_278	Corticobasal degeneration	3	7
http://purl.obolibrary.org/obo/HP_0012735	HP_0012735	Cough	7	6
http://www.ebi.ac.uk/efo/EFO_0004226	EFO_0004226	Creutzfeldt Jacob Disease	2	3
http://www.ebi.ac.uk/efo/EFO_0000384	EFO_0000384	Crohn's disease	60	771
http://www.orpha.net/ORDO/Orphanet_586	Orphanet_586	Cystic fibrosis	3	4
http://www.ebi.ac.uk/efo/EFO_0007886	EFO_0007886	DDT metabolite measurement	2	3
http://purl.obolibrary.org/obo/GO_0006306	GO_0006306	DNA methylation	4	24
http://www.ebi.ac.uk/efo/EFO_0020330	EFO_0020330	DNA repair protein rad51 homolog 1 measurement	2	75
http://www.ebi.ac.uk/efo/EFO_0004227	EFO_0004227	Dengue Hemorrhagic Fever	1	55
http://purl.obolibrary.org/obo/HP_0002014	HP_0002014	Diarrhea	17	41
http://www.ebi.ac.uk/efo/EFO_0008109	EFO_0008109	Dickkopf-related protein 3 measurement	3	3
http://www.ebi.ac.uk/efo/EFO_0008110	EFO_0008110	Dickkopf-related protein 4 measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0009928	EFO_0009928	Diuretic use measurement	3	342
http://purl.obolibrary.org/obo/HP_0012235	HP_0012235	Drug-induced agranulocytosis	10	271
http://www.ebi.ac.uk/efo/EFO_0009936	EFO_0009936	Drugs affecting bone structure and mineralization use measurement	3	80
http://www.ebi.ac.uk/efo/EFO_0009924	EFO_0009924	Drugs used in diabetes use measurement	8	461
http://www.ebi.ac.uk/efo/EFO_0004229	EFO_0004229	Dupuytren Contracture	3	67
http://purl.obolibrary.org/obo/HP_0100607	HP_0100607	Dysmenorrhea	8	6
http://www.ebi.ac.uk/efo/EFO_0008116	EFO_0008116	EGF-like module-containing mucin-like hormone receptor-like 2 measurement	1	5
http://purl.obolibrary.org/obo/HP_0000964	HP_0000964	Eczema	12	668
http://purl.obolibrary.org/obo/HP_0009926	HP_0009926	Epiphora	3	3
http://www.ebi.ac.uk/efo/EFO_1000244	EFO_1000244	Epithelioid Cell Uveal Melanoma	2	2
http://www.ebi.ac.uk/efo/EFO_0009272	EFO_0009272	Epstein Barr viral capsid antigen seropositivity	2	5
http://www.ebi.ac.uk/efo/EFO_0007790	EFO_0007790	Epstein Barr virus nuclear antigen 1 IgG measurement	5	30
http://www.ebi.ac.uk/efo/EFO_0009271	EFO_0009271	Epstein Barr virus nuclear antigen-1 seropositivity	2	11
http://www.ebi.ac.uk/efo/EFO_0000769	EFO_0000769	Epstein-Barr virus infection	2	20
http://www.ebi.ac.uk/efo/EFO_0010908	EFO_0010908	Epstein-Barr virus seropositivity	1	3
http://purl.obolibrary.org/obo/HP_0012219	HP_0012219	Erythema nodosum	2	1
http://www.ebi.ac.uk/efo/EFO_0000174	EFO_0000174	Ewing sarcoma	3	9
http://www.ebi.ac.uk/efo/EFO_0005921	EFO_0005921	FEV change measurement	10	1
http://www.ebi.ac.uk/efo/EFO_0004713	EFO_0004713	FEV/FEC ratio	32	515
http://purl.obolibrary.org/obo/HP_0009762	HP_0009762	Facial wrinkling	6	11
http://www.orpha.net/ORDO/Orphanet_768	Orphanet_768	Familial long QT syndrome	1	7
http://www.orpha.net/ORDO/Orphanet_166282	Orphanet_166282	Familial sick sinus syndrome	2	12
http://www.ebi.ac.uk/efo/EFO_0008127	EFO_0008127	Fc receptor-like protein 3 measurement	1	4
http://purl.obolibrary.org/obo/HP_0002373	HP_0002373	Febrile seizure (within the age range of 3 months to 6 years)	3	12
http://purl.obolibrary.org/obo/HP_0001945	HP_0001945	Fever	7	2
http://purl.obolibrary.org/obo/HP_0031284	HP_0031284	Flushing	1	8
http://www.orpha.net/ORDO/Orphanet_908	Orphanet_908	Fragile X syndrome	1	1
http://www.orpha.net/ORDO/Orphanet_282	Orphanet_282	Frontotemporal dementia	12	32
http://www.orpha.net/ORDO/Orphanet_98974	Orphanet_98974	Fuchs endothelial corneal dystrophy	2	6
http://www.ebi.ac.uk/efo/EFO_0008138	EFO_0008138	GDNF family receptor alpha-2 measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0006829	EFO_0006829	GFR change measurement	2	5
http://www.orpha.net/ORDO/Orphanet_101960	Orphanet_101960	Genetic chronic primary adrenal insufficiency	1	51
http://purl.obolibrary.org/obo/HP_0000225	HP_0000225	Gingival bleeding	5	1
http://www.ebi.ac.uk/efo/EFO_0007000	EFO_0007000	Gleason score measurement	2	12
http://www.ebi.ac.uk/efo/EFO_0009942	EFO_0009942	Glucocorticoid use measurement	4	167
http://purl.obolibrary.org/obo/HP_0003076	HP_0003076	Glycosuria	6	104
http://www.ebi.ac.uk/efo/EFO_0005297	EFO_0005297	Granulomatosis with Polyangiitis	3	23
http://www.ebi.ac.uk/efo/EFO_0004237	EFO_0004237	Graves disease	14	270
http://www.ebi.ac.uk/efo/EFO_0007805	EFO_0007805	HDL cholesterol change measurement	17	28
http://www.ebi.ac.uk/efo/EFO_0009780	EFO_0009780	HER2 negative breast carcinoma	6	4
http://www.ebi.ac.uk/efo/EFO_0020933	EFO_0020933	HIV resevoir measurement	3	13
http://www.ebi.ac.uk/efo/EFO_0000180	EFO_0000180	HIV-1 infection	12	71
http://www.ebi.ac.uk/efo/EFO_0009932	EFO_0009932	HMG CoA reductase inhibitor use measurement	3	663
http://www.ebi.ac.uk/efo/EFO_0004469	EFO_0004469	HOMA-B	6	31
http://www.ebi.ac.uk/efo/EFO_0004501	EFO_0004501	HOMA-IR	8	141
http://purl.obolibrary.org/obo/HP_0000738	HP_0000738	Hallucinations	1	1
http://purl.obolibrary.org/obo/HP_0001822	HP_0001822	Hallux valgus	6	4
http://www.ebi.ac.uk/efo/EFO_0003779	EFO_0003779	Hashimoto's thyroiditis	6	120
http://www.ebi.ac.uk/efo/EFO_0004541	EFO_0004541	HbA1c measurement	52	1425
http://purl.obolibrary.org/obo/HP_0002315	HP_0002315	Headache	16	83
http://purl.obolibrary.org/obo/HP_0002573	HP_0002573	Hematochezia	3	3
http://purl.obolibrary.org/obo/HP_0000790	HP_0000790	Hematuria	10	15
http://www.orpha.net/ORDO/Orphanet_141136	Orphanet_141136	Hemifacial microsomia	1	12
http://www.orpha.net/ORDO/Orphanet_2133	Orphanet_2133	Hemoglobin E disease	1	12
http://www.ebi.ac.uk/efo/EFO_1000965	EFO_1000965	Henoch-Schoenlein purpura	2	19
http://purl.obolibrary.org/obo/HP_0012115	HP_0012115	Hepatitis	5	11
http://www.ebi.ac.uk/efo/EFO_0006510	EFO_0006510	Herpes Zoster	12	62
http://www.ebi.ac.uk/efo/EFO_0009339	EFO_0009339	Herpes simplex virus 2 seropositivity	2	8
http://purl.obolibrary.org/obo/MONDO_0018309	MONDO_0018309	Hirschsprung disease	7	10
http://purl.obolibrary.org/obo/HP_0001007	HP_0001007	Hirsutism	1	6
http://www.ebi.ac.uk/efo/EFO_0000183	EFO_0000183	Hodgkins lymphoma	10	296
http://www.ebi.ac.uk/efo/EFO_1002031	EFO_1002031	Hodgkins lymphoma, mixed cellularity	1	45
http://purl.obolibrary.org/obo/MONDO_0007739	MONDO_0007739	Huntington disease	2	6
http://purl.obolibrary.org/obo/HP_0000975	HP_0000975	Hyperhidrosis	6	5
http://www.ebi.ac.uk/efo/EFO_0009189	EFO_0009189	Hyperthyroidism	9	15
http://www.ebi.ac.uk/efo/EFO_0004211	EFO_0004211	Hypertriglyceridemia	5	22
http://purl.obolibrary.org/obo/HP_0003146	HP_0003146	Hypocholesterolemia	1	4
http://www.ebi.ac.uk/efo/EFO_0004520	EFO_0004520	ICAM-1 measurement	7	144
http://www.ebi.ac.uk/efo/EFO_0004194	EFO_0004194	IGA glomerulonephritis	8	207
http://www.ebi.ac.uk/efo/EFO_0004627	EFO_0004627	IGF-1 measurement	8	1082
http://www.ebi.ac.uk/efo/EFO_0005118	EFO_0005118	IGFBP-1 measurement	1	132
http://www.ebi.ac.uk/efo/EFO_0004626	EFO_0004626	IGFBP-3 measurement	6	134
http://www.ebi.ac.uk/efo/EFO_0006929	EFO_0006929	IgG index	1	27
http://www.ebi.ac.uk/efo/EFO_0008366	EFO_0008366	IgG isotype profile measurement	5	3
http://www.ebi.ac.uk/efo/EFO_0009253	EFO_0009253	Immature Reticulocyte Fraction Measurement	1	76
http://www.ebi.ac.uk/efo/EFO_0009934	EFO_0009934	Immunosuppressant use measurement	3	16
http://purl.obolibrary.org/obo/HP_0000023	HP_0000023	Inguinal hernia	19	43
http://www.ebi.ac.uk/efo/EFO_0009941	EFO_0009941	Inhalant adrenergic use measurement	3	224
http://www.ebi.ac.uk/efo/EFO_0009961	EFO_0009961	Insulinogenic index measurement	1	18
http://purl.obolibrary.org/obo/HP_0002140	HP_0002140	Ischemic stroke	35	83
http://www.orpha.net/ORDO/Orphanet_35093	Orphanet_35093	Isolated scaphocephaly	1	1
http://www.ebi.ac.uk/efo/EFO_0007885	EFO_0007885	JT interval	2	9
http://www.orpha.net/ORDO/Orphanet_307	Orphanet_307	Juvenile myoclonic epilepsy	1	7
http://www.ebi.ac.uk/efo/EFO_0009949	EFO_0009949	KANNO antigen measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0004212	EFO_0004212	Keloid	7	7
http://www.orpha.net/ORDO/Orphanet_156071	Orphanet_156071	Keratoconus	4	112
http://purl.obolibrary.org/obo/HP_0002919	HP_0002919	Ketonuria	3	1
http://www.ebi.ac.uk/efo/EFO_1001354	EFO_1001354	Kleine-Levin Syndrome	1	3
http://purl.obolibrary.org/obo/HP_0030839	HP_0030839	Knee pain	9	9
http://www.ebi.ac.uk/efo/EFO_0008199	EFO_0008199	Kunitz-type protease inhibitor 1 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008200	EFO_0008200	Kunitz-type protease inhibitor 2 measurement	1	12
http://www.ebi.ac.uk/efo/EFO_0004808	EFO_0004808	L lactate dehydrogenase measurement	4	106
http://www.ebi.ac.uk/efo/EFO_0008202	EFO_0008202	L-Selectin measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0006524	EFO_0006524	L-arginine measurement	3	59
http://www.ebi.ac.uk/efo/EFO_0007941	EFO_0007941	LDH-related sciatica symptom severity measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0007804	EFO_0007804	LDL cholesterol change measurement	16	51
http://www.ebi.ac.uk/efo/EFO_0007930	EFO_0007930	LDL cholesterol:HDL cholesterol ratio	1	12
http://www.ebi.ac.uk/efo/EFO_0010556	EFO_0010556	Left ventricular mass to end-diastolic volume ratio	3	28
http://www.ebi.ac.uk/efo/EFO_0006792	EFO_0006792	Lewy body dementia	8	34
http://www.ebi.ac.uk/efo/EFO_0007021	EFO_0007021	Lewy body measurement	1	2
http://www.orpha.net/ORDO/Orphanet_93957	Orphanet_93957	Limb dystonia	1	4
http://www.ebi.ac.uk/efo/EFO_0009466	EFO_0009466	Löfgren’s syndrome	1	75
http://www.ebi.ac.uk/efo/EFO_0008225	EFO_0008225	MAP kinase-activated protein kinase 2 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008226	EFO_0008226	MAP kinase-activated protein kinase 3 measurement	3	5
http://www.ebi.ac.uk/efo/EFO_0008233	EFO_0008233	MHC class I polypeptide-related sequence A measurement	2	422
http://www.ebi.ac.uk/efo/EFO_0005133	EFO_0005133	MHPG measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0006519	EFO_0006519	MMR-related febrile seizures	1	8
http://www.orpha.net/ORDO/Orphanet_398934	Orphanet_398934	Malignant epithelial tumor of ovary	5	58
http://www.ebi.ac.uk/efo/EFO_0006862	EFO_0006862	Meniere disease	9	5
http://www.orpha.net/ORDO/Orphanet_2495	Orphanet_2495	Meningioma	2	15
http://purl.obolibrary.org/obo/HP_0000132	HP_0000132	Menorrhagia	13	13
http://purl.obolibrary.org/obo/HP_0001268	HP_0001268	Mental deterioration	4	10
http://www.orpha.net/ORDO/Orphanet_99701	Orphanet_99701	Mesial temporal lobe epilepsy with hippocampal sclerosis	1	2
http://purl.obolibrary.org/obo/HP_0001634	HP_0001634	Mitral valve prolapse	5	48
http://purl.obolibrary.org/obo/HP_0012594	HP_0012594	Moderate albuminuria	5	101
http://purl.obolibrary.org/obo/HP_0030775	HP_0030775	Modic type vertebral endplate changes	1	1
http://purl.obolibrary.org/obo/MONDO_0016820	MONDO_0016820	Moyamoya disease	2	66
http://www.ebi.ac.uk/efo/EFO_0004991	EFO_0004991	Myasthenia gravis	8	27
http://www.ebi.ac.uk/efo/EFO_0007386	EFO_0007386	Mycobacterium avium complex disease	1	5
http://purl.obolibrary.org/obo/HP_0000545	HP_0000545	Myopia	27	332
http://www.ebi.ac.uk/efo/EFO_0008239	EFO_0008239	N-acetyl-D-glucosamine kinase measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0600028	EFO_0600028	N-acylethanolamine measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008240	EFO_0008240	N-acylethanolamine-hydrolyzing acid amidase measurement	1	12
http://www.ebi.ac.uk/efo/EFO_0004999	EFO_0004999	N-glycan measurement	3	21
http://www.ebi.ac.uk/efo/EFO_0010921	EFO_0010921	N-terminal prohormone brain natriuretic peptide measurement	2	7
http://www.ebi.ac.uk/efo/EFO_0008250	EFO_0008250	NKG2-D type II integral membrane protein measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0004745	EFO_0004745	NT-proBNP measurement	3	8
http://www.ebi.ac.uk/efo/EFO_1000391	EFO_1000391	Nasal Cavity Polyp	16	52
http://purl.obolibrary.org/obo/HP_0030833	HP_0030833	Neck pain	7	2
http://www.orpha.net/ORDO/Orphanet_654	Orphanet_654	Nephroblastoma	1	12
http://purl.obolibrary.org/obo/HP_0031760	HP_0031760	Non-accomodative esotropia	1	5
http://www.ebi.ac.uk/efo/EFO_0009935	EFO_0009935	Non-steroidal anti-inflammatory and antirheumatic product use measurement	3	77
http://purl.obolibrary.org/obo/HP_0000639	HP_0000639	Nystagmus	1	1
http://www.ebi.ac.uk/efo/EFO_0008252	EFO_0008252	OCIA domain-containing protein 1 measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0008253	EFO_0008253	OX-2 membrane glycoprotein measurement	1	15
http://purl.obolibrary.org/obo/HP_0008770	HP_0008770	Obsessive-compulsive trait	1	1
http://www.ebi.ac.uk/efo/EFO_0009937	EFO_0009937	Opioid use measurement	5	75
http://purl.obolibrary.org/obo/HP_0010865	HP_0010865	Oppositional defiant disorder	2	3
http://purl.obolibrary.org/obo/HP_0000202	HP_0000202	Oral cleft	9	25
http://purl.obolibrary.org/obo/HP_0000155	HP_0000155	Oral ulcer	5	634
http://www.ebi.ac.uk/efo/EFO_0004992	EFO_0004992	Otitis media	10	9
http://purl.obolibrary.org/obo/HP_0000138	HP_0000138	Ovarian cyst	5	19
http://www.ebi.ac.uk/efo/EFO_0008379	EFO_0008379	P wave terminal force measurement	1	17
http://www.ebi.ac.uk/efo/EFO_0008254	EFO_0008254	P-Selectin measurement	2	19
http://www.ebi.ac.uk/efo/EFO_0006899	EFO_0006899	PCSK9 protein measurement	3	7
http://www.ebi.ac.uk/efo/EFO_0004462	EFO_0004462	PR interval	16	64
http://www.ebi.ac.uk/efo/EFO_0005095	EFO_0005095	PR segment	2	14
http://purl.obolibrary.org/obo/MONDO_0005180	MONDO_0005180	Parkinson disease	71	291
http://www.ebi.ac.uk/efo/EFO_0009923	EFO_0009923	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	4	65
http://www.ebi.ac.uk/efo/EFO_1001395	EFO_1001395	Phlebitis	5	5
http://www.ebi.ac.uk/efo/EFO_1000478	EFO_1000478	Pituitary Gland Adenoma	1	2
http://www.ebi.ac.uk/efo/EFO_1001909	EFO_1001909	Plantar Fasciitis	1	3
http://www.ebi.ac.uk/efo/EFO_1000481	EFO_1000481	Plantar Fibromatosis	1	3
http://www.orpha.net/ORDO/Orphanet_54247	Orphanet_54247	Posterior cortical atrophy	1	11
http://purl.obolibrary.org/obo/HP_0002172	HP_0002172	Postural instability	1	1
http://purl.obolibrary.org/obo/HP_0200023	HP_0200023	Priapism	1	2
http://www.orpha.net/ORDO/Orphanet_683	Orphanet_683	Progressive supranuclear palsy	8	30
http://purl.obolibrary.org/obo/HP_0000093	HP_0000093	Proteinuria	14	5
http://www.ebi.ac.uk/efo/EFO_0007742	EFO_0007742	QRS amplitude	4	24
http://www.ebi.ac.uk/efo/EFO_0005054	EFO_0005054	QRS complex	5	61
http://www.ebi.ac.uk/efo/EFO_0005055	EFO_0005055	QRS duration	15	44
http://www.ebi.ac.uk/efo/EFO_0004682	EFO_0004682	QT interval	28	156
http://www.ebi.ac.uk/efo/EFO_0004831	EFO_0004831	RR interval	3	31
http://www.orpha.net/ORDO/Orphanet_791	Orphanet_791	Retinitis pigmentosa	7	11
http://www.ebi.ac.uk/efo/EFO_0600012	EFO_0600012	S100 calcium-binding protein B measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0010928	EFO_0010928	SIR2-like protein 2 measurement	1	26
http://www.ebi.ac.uk/efo/EFO_0008287	EFO_0008287	SLAM family member 7 measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0020748	EFO_0020748	SPARC measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0008289	EFO_0008289	SPARC-like protein 1 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0010599	EFO_0010599	ST2 protein measurement	3	44
http://www.orpha.net/ORDO/Orphanet_797	Orphanet_797	Sarcoidosis	22	110
http://purl.obolibrary.org/obo/HP_0011868	HP_0011868	Sciatica	16	1
http://www.ebi.ac.uk/efo/EFO_0008277	EFO_0008277	Secreted frizzled-related protein 3 measurement	1	3
http://purl.obolibrary.org/obo/HP_0100806	HP_0100806	Sepsis	15	113
http://purl.obolibrary.org/obo/HP_0030834	HP_0030834	Shoulder pain	7	2
http://www.orpha.net/ORDO/Orphanet_232	Orphanet_232	Sickle cell anemia	2	32
http://www.ebi.ac.uk/efo/EFO_0000699	EFO_0000699	Sjogren syndrome	17	117
http://www.ebi.ac.uk/efo/EFO_0005681	EFO_0005681	Staphylococcus aureus infection	2	12
http://www.ebi.ac.uk/efo/EFO_0004276	EFO_0004276	Stevens-Johnson syndrome	15	322
http://purl.obolibrary.org/obo/HP_0000486	HP_0000486	Strabismus	9	12
http://purl.obolibrary.org/obo/HP_0025268	HP_0025268	Stuttering	7	5
http://www.ebi.ac.uk/efo/EFO_0008398	EFO_0008398	T wave morphology measurement	5	30
http://www.ebi.ac.uk/efo/EFO_0010812	EFO_0010812	T-cell immunoglobulin and mucin domain 1 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0008295	EFO_0008295	T-lymphocyte surface antigen Ly-9 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0004783	EFO_0004783	TEMPS-A questionnaire	5	1
http://www.ebi.ac.uk/efo/EFO_0010929	EFO_0010929	TNF-related activation-induced cytokine measurement	1	24
http://www.ebi.ac.uk/efo/EFO_0008300	EFO_0008300	TNF-related apoptosis-inducing ligand measurement	3	35
http://www.ebi.ac.uk/efo/EFO_0010930	EFO_0010930	TNF-related apoptosis-inducing ligand receptor 2 measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0004644	EFO_0004644	TPE interval measurement	4	91
http://www.ebi.ac.uk/efo/EFO_1001857	EFO_1001857	Takayasu arteritis	9	203
http://www.ebi.ac.uk/efo/EFO_1000566	EFO_1000566	Testicular Germ Cell Tumor	5	163
http://purl.obolibrary.org/obo/HP_0001636	HP_0001636	Tetralogy of Fallot	1	4
http://www.ebi.ac.uk/efo/EFO_0009933	EFO_0009933	Thyroid preparation use measurement	3	638
http://www.orpha.net/ORDO/Orphanet_79102	Orphanet_79102	Thyrotoxic periodic paralysis	6	84
http://purl.obolibrary.org/obo/HP_0000360	HP_0000360	Tinnitus	34	4
http://www.ebi.ac.uk/efo/EFO_0004895	EFO_0004895	Tourette syndrome	13	76
http://purl.obolibrary.org/obo/HP_0025246	HP_0025246	Trichilemmal cyst	2	5
http://www.orpha.net/ORDO/Orphanet_3389	Orphanet_3389	Tuberculosis	26	47
http://www.ebi.ac.uk/efo/EFO_0008313	EFO_0008313	UMP-CMP kinase measurement	1	10
http://purl.obolibrary.org/obo/HP_0000016	HP_0000016	Urinary retention	3	13
http://www.ebi.ac.uk/efo/EFO_1000616	EFO_1000616	Uveal Melanoma	7	7
http://www.ebi.ac.uk/efo/EFO_0009340	EFO_0009340	Varicella zoster virus seropositivity	4	19
http://purl.obolibrary.org/obo/HP_0002619	HP_0002619	Varicose veins	25	61
http://www.ebi.ac.uk/efo/EFO_0009926	EFO_0009926	Vasodilators used in cardiac diseases use measurement	3	77
http://purl.obolibrary.org/obo/HP_0004308	HP_0004308	Ventricular arrhythmia	2	1
http://www.ebi.ac.uk/efo/EFO_0004208	EFO_0004208	Vitiligo	11	353
http://purl.obolibrary.org/obo/MONDO_0018092	MONDO_0018092	Vogt-Koyanagi-Harada disease	1	34
http://www.ebi.ac.uk/efo/EFO_0008319	EFO_0008319	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008321	EFO_0008321	WNT1-inducible-signaling pathway protein 1 measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0009441	EFO_0009441	Waldenstrom macroglobulinemia	1	4
http://www.ebi.ac.uk/efo/EFO_0004869	EFO_0004869	YKL40 measurement	3	14
http://www.ebi.ac.uk/efo/EFO_0008010	EFO_0008010	[Pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008011	EFO_0008011	a disintegrin and metalloproteinase with thrombospondin motifs 13	2	27
http://www.ebi.ac.uk/efo/EFO_0010272	EFO_0010272	abdominal aortic calcification measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0009720	EFO_0009720	able to hear with hearing aids	3	3
http://www.ebi.ac.uk/efo/EFO_0010112	EFO_0010112	acetate measurement	5	49
http://www.ebi.ac.uk/efo/EFO_0010111	EFO_0010111	acetoacetate measurement	3	24
http://www.ebi.ac.uk/efo/EFO_0010989	EFO_0010989	acetone measurement	2	75
http://www.ebi.ac.uk/efo/EFO_0008013	EFO_0008013	acid sphingomyelinase-like phosphodiesterase 3a measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0003894	EFO_0003894	acne	8	168
http://www.ebi.ac.uk/efo/EFO_0005672	EFO_0005672	acute coronary syndrome	1	4
http://www.ebi.ac.uk/efo/EFO_0006831	EFO_0006831	acute insulin response measurement	4	9
http://www.ebi.ac.uk/efo/EFO_0000220	EFO_0000220	acute lymphoblastic leukemia	18	41
http://www.ebi.ac.uk/efo/EFO_0000222	EFO_0000222	acute myeloid leukemia	10	25
http://www.ebi.ac.uk/efo/EFO_0008583	EFO_0008583	acute myocardial infarction	5	2
http://www.ebi.ac.uk/efo/EFO_1000637	EFO_1000637	acute respiratory distress syndrome	4	3
http://www.ebi.ac.uk/efo/EFO_0007949	EFO_0007949	acute-on-chronic liver failure	1	19
http://www.ebi.ac.uk/efo/EFO_0005059	EFO_0005059	acylcarnitine measurement	75	38
http://www.ebi.ac.uk/efo/EFO_0010761	EFO_0010761	adenosine deaminase measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0004522	EFO_0004522	adhesion molecule measurement	1	30
http://www.ebi.ac.uk/efo/EFO_0004502	EFO_0004502	adiponectin measurement	24	188
http://www.ebi.ac.uk/efo/EFO_0004764	EFO_0004764	adipose tissue measurement	5	1
http://www.ebi.ac.uk/efo/EFO_0005423	EFO_0005423	adolescent idiopathic scoliosis	11	89
http://www.ebi.ac.uk/efo/EFO_0009176	EFO_0009176	adrenal suppression measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0010909	EFO_0010909	adrenomedullin measurement	1	23
http://www.ebi.ac.uk/efo/EFO_1002011	EFO_1002011	adult onset asthma	12	146
http://www.ebi.ac.uk/efo/EFO_0007135	EFO_0007135	adult-onset Still's disease	1	2
http://www.ebi.ac.uk/efo/EFO_0010762	EFO_0010762	advanced glycosylation end product-specific receptor ligand measurement	2	132
http://www.ebi.ac.uk/efo/EFO_0009658	EFO_0009658	adverse effect	68	10
http://www.ebi.ac.uk/efo/EFO_0008015	EFO_0008015	afamin measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008007	EFO_0008007	age at assessment	18	6
http://www.ebi.ac.uk/efo/EFO_0004918	EFO_0004918	age at diagnosis	22	125
http://www.ebi.ac.uk/efo/EFO_0009101	EFO_0009101	age at first birth measurement	12	408
http://www.ebi.ac.uk/efo/EFO_0009749	EFO_0009749	age at first sexual intercourse measurement	4	625
http://www.ebi.ac.uk/efo/EFO_0004703	EFO_0004703	age at menarche	27	435
http://www.ebi.ac.uk/efo/EFO_0004704	EFO_0004704	age at menopause	23	642
http://www.ebi.ac.uk/efo/EFO_0004847	EFO_0004847	age at onset	78	722
http://www.ebi.ac.uk/efo/EFO_0007888	EFO_0007888	age at voice drop	7	15
http://www.ebi.ac.uk/efo/EFO_0005782	EFO_0005782	age-related hearing impairment	14	131
http://www.ebi.ac.uk/efo/EFO_0001365	EFO_0001365	age-related macular degeneration	36	337
http://www.ebi.ac.uk/efo/EFO_1001758	EFO_1001758	ageusia	6	4
http://www.ebi.ac.uk/efo/EFO_0003015	EFO_0003015	aggressive behavior	6	1
http://purl.obolibrary.org/obo/GO_0007568	GO_0007568	aging	45	146
http://www.ebi.ac.uk/efo/EFO_0007627	EFO_0007627	airway imaging measurement	4	25
http://www.ebi.ac.uk/efo/EFO_0006898	EFO_0006898	airway wall thickness measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0009765	EFO_0009765	alanine measurement	7	155
http://www.ebi.ac.uk/efo/EFO_0005128	EFO_0005128	albumin:globulin ratio measurement	2	347
http://www.ebi.ac.uk/efo/EFO_0004285	EFO_0004285	albuminuria	10	165
http://www.ebi.ac.uk/efo/EFO_0007878	EFO_0007878	alcohol consumption measurement	90	712
http://www.ebi.ac.uk/efo/EFO_0008017	EFO_0008017	alcohol dehydrogenase [NADP+] measurement	1	5
http://purl.obolibrary.org/obo/MONDO_0007079	MONDO_0007079	alcohol dependence	45	98
http://www.ebi.ac.uk/efo/EFO_0007835	EFO_0007835	alcohol dependence measurement	13	102
http://www.ebi.ac.uk/efo/EFO_0004329	EFO_0004329	alcohol drinking	35	58
http://www.ebi.ac.uk/efo/EFO_0009458	EFO_0009458	alcohol use disorder measurement	55	309
http://www.ebi.ac.uk/efo/EFO_0004777	EFO_0004777	alcohol withdrawal	3	2
http://www.ebi.ac.uk/efo/EFO_1000802	EFO_1000802	alcoholic liver cirrhosis	4	112
http://www.ebi.ac.uk/efo/EFO_1002013	EFO_1002013	alcoholic pancreatitis	3	68
http://www.ebi.ac.uk/efo/EFO_0010219	EFO_0010219	aldosterone measurement	5	9
http://www.ebi.ac.uk/efo/EFO_0004533	EFO_0004533	alkaline phosphatase measurement	28	1584
http://purl.obolibrary.org/obo/MONDO_0005271	MONDO_0005271	allergic disease	41	722
http://www.ebi.ac.uk/efo/EFO_0005854	EFO_0005854	allergic rhinitis	24	708
http://www.ebi.ac.uk/efo/EFO_0005298	EFO_0005298	allergic sensitization measurement	2	52
http://www.ebi.ac.uk/efo/EFO_0006804	EFO_0006804	alloimmunization	2	2
http://www.ebi.ac.uk/efo/EFO_0004192	EFO_0004192	alopecia areata	4	71
http://www.ebi.ac.uk/efo/EFO_0010583	EFO_0010583	alpha fetoprotein measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0009323	EFO_0009323	alpha synuclein measurement	3	7
http://www.ebi.ac.uk/efo/EFO_0008018	EFO_0008018	alpha-1-antichymotrypsin complex measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008327	EFO_0008327	alpha-1-antitrypsin measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0008020	EFO_0008020	alpha-2-HS-glycoprotein measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0007893	EFO_0007893	alpha-carotene measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0007759	EFO_0007759	alpha-linolenic acid measurement	2	16
http://www.ebi.ac.uk/efo/EFO_0007144	EFO_0007144	amebiasis	1	2
http://www.ebi.ac.uk/efo/EFO_0005134	EFO_0005134	amino acid measurement	10	377
http://www.ebi.ac.uk/efo/EFO_0010459	EFO_0010459	aminoadipic acid measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0006934	EFO_0006934	amygdala volume	5	1
http://www.ebi.ac.uk/efo/EFO_0007646	EFO_0007646	amyloid plaque accumulation rate	1	1
http://www.ebi.ac.uk/efo/EFO_0005194	EFO_0005194	amyloid-beta measurement	39	15
http://purl.obolibrary.org/obo/MONDO_0004976	MONDO_0004976	amyotrophic lateral sclerosis	35	61
http://www.ebi.ac.uk/efo/EFO_0008544	EFO_0008544	analgesia requirement measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0004191	EFO_0004191	androgenetic alopecia	10	116
http://www.ebi.ac.uk/efo/EFO_0007972	EFO_0007972	androstenedione measurement	7	7
http://www.ebi.ac.uk/efo/EFO_0004272	EFO_0004272	anemia (phenotype)	22	1
http://www.ebi.ac.uk/efo/EFO_0003913	EFO_0003913	angina pectoris	26	302
http://www.ebi.ac.uk/efo/EFO_0005532	EFO_0005532	angioedema	5	3
http://www.ebi.ac.uk/efo/EFO_0008022	EFO_0008022	angiogenin measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0010600	EFO_0010600	angiopoietin-1 receptor measurement	2	60
http://www.ebi.ac.uk/efo/EFO_0008023	EFO_0008023	angiopoietin-1 receptor, soluble measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0006901	EFO_0006901	angiopoietin-2 measurement	2	18
http://www.ebi.ac.uk/efo/EFO_0006902	EFO_0006902	angiopoietin-2 receptor measurement	1	18
http://www.ebi.ac.uk/efo/EFO_0008024	EFO_0008024	angiostatin measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0004463	EFO_0004463	angiotensin converting enzyme activity measurement	1	20
http://www.ebi.ac.uk/efo/EFO_0006515	EFO_0006515	angiotensin-converting enzyme measurement	3	5
http://www.ebi.ac.uk/efo/EFO_0008025	EFO_0008025	angiotensinogen measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0009587	EFO_0009587	anhedonia measurement	4	9
http://www.ebi.ac.uk/efo/EFO_0003912	EFO_0003912	ankle brachial index	10	5
http://www.ebi.ac.uk/efo/EFO_1002021	EFO_1002021	ankle injury	1	1
http://www.ebi.ac.uk/efo/EFO_0003898	EFO_0003898	ankylosing spondylitis	26	121
http://www.ebi.ac.uk/efo/EFO_0008026	EFO_0008026	annexin A1 measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008027	EFO_0008027	annexin A2 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004215	EFO_0004215	anorexia nervosa	21	110
http://www.ebi.ac.uk/efo/EFO_0005668	EFO_0005668	anterior chamber depth measurement	1	4
http://www.ebi.ac.uk/efo/EFO_1000811	EFO_1000811	anterior uveitis	3	22
http://www.ebi.ac.uk/efo/EFO_0004302	EFO_0004302	anthropometric measurement	17	462
http://www.ebi.ac.uk/efo/EFO_0010904	EFO_0010904	anti-BK polyomavirus antibody measurement	2	14
http://www.ebi.ac.uk/efo/EFO_0009273	EFO_0009273	anti-Epstein Barr virus antibody measurement	5	52
http://www.ebi.ac.uk/efo/EFO_0005247	EFO_0005247	anti-Helicobacter pylori serum IgG measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0004769	EFO_0004769	anti-Mullerian hormone measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0010150	EFO_0010150	anti-anoctamin 2 antibody measurement	1	108
http://www.ebi.ac.uk/efo/EFO_0010903	EFO_0010903	anti-chlamydia trachomatis antibody measurement	6	11
http://www.ebi.ac.uk/efo/EFO_0007837	EFO_0007837	anti-citrullinated protein antibody seropositivity	1	27
http://www.ebi.ac.uk/efo/EFO_0010559	EFO_0010559	anti-drug antibody measurement	39	134
http://www.ebi.ac.uk/efo/EFO_0011037	EFO_0011037	anti-human herpes virus 6 antibody measurement	3	12
http://www.ebi.ac.uk/efo/EFO_0011038	EFO_0011038	anti-human herpes virus 7 antibody measurement	1	21
http://www.ebi.ac.uk/efo/EFO_0010899	EFO_0010899	anti-merkel cell virus antibody measurement	2	44
http://www.ebi.ac.uk/efo/EFO_0004826	EFO_0004826	anti-neutrophil antibody associated vasculitis	4	86
http://www.ebi.ac.uk/efo/EFO_0010900	EFO_0010900	anti-polyomavirus 2 antibody measurement	2	21
http://www.ebi.ac.uk/efo/EFO_0010085	EFO_0010085	anti-tetanus toxoid IgG measurement	1	39
http://www.ebi.ac.uk/efo/EFO_0009896	EFO_0009896	anti-thyroglobulin antibody measurement	5	5
http://www.ebi.ac.uk/efo/EFO_0004556	EFO_0004556	antibody measurement	2	20
http://www.ebi.ac.uk/efo/EFO_0005949	EFO_0005949	antinuclear antibody measurement	3	101
http://www.ebi.ac.uk/efo/EFO_0005119	EFO_0005119	antioxidant measurement	2	132
http://www.ebi.ac.uk/efo/EFO_0005200	EFO_0005200	antiphospholipid antibody measurement	2	12
http://www.ebi.ac.uk/efo/EFO_0007052	EFO_0007052	antisocial behaviour measurement	6	1145
http://www.ebi.ac.uk/efo/EFO_0007669	EFO_0007669	antitragus size	1	2
http://www.ebi.ac.uk/efo/EFO_0005230	EFO_0005230	anxiety	30	17
http://www.ebi.ac.uk/efo/EFO_0006788	EFO_0006788	anxiety disorder	19	5
http://www.ebi.ac.uk/efo/EFO_0007795	EFO_0007795	anxiety disorder measurement	7	23
http://www.ebi.ac.uk/efo/EFO_0009863	EFO_0009863	anxiety measurement	20	345
http://www.ebi.ac.uk/efo/EFO_0001666	EFO_0001666	aortic aneurysm	7	18
http://www.ebi.ac.uk/efo/EFO_0020865	EFO_0020865	aortic measurement	8	225
http://www.ebi.ac.uk/efo/EFO_0005037	EFO_0005037	aortic root size	3	29
http://www.ebi.ac.uk/efo/EFO_0000266	EFO_0000266	aortic stenosis	8	17
http://www.ebi.ac.uk/efo/EFO_0005239	EFO_0005239	aortic valve calcification	3	9
http://www.ebi.ac.uk/efo/EFO_0600025	EFO_0600025	aortic vascular smooth muscle cell calcification measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0600026	EFO_0600026	aortic vascular smooth muscle cell proliferation measurement	10	1
http://www.ebi.ac.uk/efo/EFO_0004614	EFO_0004614	apolipoprotein A 1 measurement	23	2141
http://www.ebi.ac.uk/efo/EFO_0007848	EFO_0007848	apolipoprotein A-IV measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0004615	EFO_0004615	apolipoprotein B measurement	23	1486
http://www.ebi.ac.uk/efo/EFO_0020157	EFO_0020157	apolipoprotein E (isoform E3) measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0008029	EFO_0008029	apolipoprotein E measurement	6	11
http://www.ebi.ac.uk/efo/EFO_0007149	EFO_0007149	appendicitis	17	1
http://www.ebi.ac.uk/efo/EFO_0004980	EFO_0004980	appendicular lean mass	6	3941
http://www.ebi.ac.uk/efo/EFO_0006808	EFO_0006808	arachidonic acid measurement	2	37
http://www.ebi.ac.uk/efo/EFO_0005108	EFO_0005108	arm span	1	132
http://www.ebi.ac.uk/efo/EFO_0004517	EFO_0004517	arterial stiffness measurement	9	7
http://www.ebi.ac.uk/efo/EFO_0008030	EFO_0008030	arylsulfatase B measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0010725	EFO_0010725	aseptic loosening	5	35
http://www.ebi.ac.uk/efo/EFO_0004881	EFO_0004881	asparaginase hypersensitivity	10	108
http://www.ebi.ac.uk/efo/EFO_1001507	EFO_1001507	asparaginase-induced acute pancreatitis	2	16
http://www.ebi.ac.uk/efo/EFO_0009766	EFO_0009766	asparagine measurement	7	20
http://www.ebi.ac.uk/efo/EFO_0004736	EFO_0004736	aspartate aminotransferase measurement	36	1364
http://www.ebi.ac.uk/efo/EFO_0010934	EFO_0010934	aspartate aminotransferase to alanine aminotransferase ratio	2	3
http://www.ebi.ac.uk/efo/EFO_0008031	EFO_0008031	aspartate aminotransferase, cytoplasmic measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0010462	EFO_0010462	aspartate measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0007013	EFO_0007013	aspirin use measurement	4	58
http://purl.obolibrary.org/obo/MONDO_0004979	MONDO_0004979	asthma	131	1293
http://www.ebi.ac.uk/efo/EFO_0007614	EFO_0007614	asthma exacerbation measurement	6	2
http://www.ebi.ac.uk/efo/EFO_0006522	EFO_0006522	asymmetrical dimethylarginine measurement	3	3
http://www.ebi.ac.uk/efo/EFO_0009306	EFO_0009306	atazanavir measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0000274	EFO_0000274	atopic eczema	24	268
http://www.ebi.ac.uk/efo/EFO_0007755	EFO_0007755	atopic march	7	31
http://www.ebi.ac.uk/efo/EFO_0002686	EFO_0002686	atopy	6	1
http://www.ebi.ac.uk/efo/EFO_0000275	EFO_0000275	atrial fibrillation	41	472
http://www.ebi.ac.uk/efo/EFO_1000826	EFO_1000826	atrophic gastritis	3	9
http://www.ebi.ac.uk/efo/EFO_1001492	EFO_1001492	atrophic macular degeneration	6	284
http://www.ebi.ac.uk/efo/EFO_0004321	EFO_0004321	attempted suicide	30	13
http://www.ebi.ac.uk/efo/EFO_0003888	EFO_0003888	attention deficit hyperactivity disorder	68	1363
http://www.ebi.ac.uk/efo/EFO_0007636	EFO_0007636	attention function measurement	6	8
http://www.ebi.ac.uk/efo/EFO_0009960	EFO_0009960	atypical femoral fracture	2	5
http://www.ebi.ac.uk/efo/EFO_0003758	EFO_0003758	autism	10	8
http://www.ebi.ac.uk/efo/EFO_0003756	EFO_0003756	autism spectrum disorder	34	1280
http://www.ebi.ac.uk/efo/EFO_0005426	EFO_0005426	autism spectrum disorder symptom	10	6
http://www.ebi.ac.uk/efo/EFO_0004866	EFO_0004866	autoantibody measurement	5	17
http://www.ebi.ac.uk/efo/EFO_0005140	EFO_0005140	autoimmune disease	8	3
http://www.ebi.ac.uk/efo/EFO_0006812	EFO_0006812	autoimmune thyroid disease	7	693
http://www.ebi.ac.uk/efo/EFO_0007887	EFO_0007887	autosomal dominant compelling helio-ophthalmic outburst syndrome	3	37
http://www.ebi.ac.uk/efo/EFO_0005318	EFO_0005318	axial length measurement	5	2
http://www.ebi.ac.uk/efo/EFO_0000279	EFO_0000279	azoospermia	2	13
http://www.ebi.ac.uk/efo/EFO_1000831	EFO_1000831	bacterial meningitis	3	2
http://www.ebi.ac.uk/efo/EFO_0010271	EFO_0010271	bacterial pathogen genotype measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0007825	EFO_0007825	balding measurement	20	1048
http://www.ebi.ac.uk/efo/EFO_0008032	EFO_0008032	basal cell adhesion molecule measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0004193	EFO_0004193	basal cell carcinoma	17	414
http://www.ebi.ac.uk/efo/EFO_0005090	EFO_0005090	basophil count	26	1027
http://www.ebi.ac.uk/efo/EFO_0007995	EFO_0007995	basophil percentage of granulocytes	1	176
http://www.ebi.ac.uk/efo/EFO_0007992	EFO_0007992	basophil percentage of leukocytes	4	588
http://www.ebi.ac.uk/efo/EFO_0006946	EFO_0006946	behavioural disinhibition measurement	18	11
http://www.ebi.ac.uk/efo/EFO_0000284	EFO_0000284	benign prostatic hyperplasia	16	49
http://www.ebi.ac.uk/efo/EFO_0005197	EFO_0005197	beta-2 microglobulin measurement	1	97
http://www.ebi.ac.uk/efo/EFO_0008033	EFO_0008033	beta-Ala-His dipeptidase measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004670	EFO_0004670	beta-amyloid 1-42 measurement	12	33
http://www.ebi.ac.uk/efo/EFO_0008034	EFO_0008034	beta-endorphin measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0008035	EFO_0008035	beta-nerve growth factor measurement	4	2
http://www.ebi.ac.uk/efo/EFO_0020050	EFO_0020050	bile acid measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0004267	EFO_0004267	biliary liver cirrhosis	4	105
http://www.ebi.ac.uk/efo/EFO_0004570	EFO_0004570	bilirubin measurement	58	816
http://www.ebi.ac.uk/efo/EFO_0005924	EFO_0005924	binge eating	6	2
http://purl.obolibrary.org/obo/PATO_0000047	PATO_0000047	biological sex	2	287
http://www.ebi.ac.uk/efo/EFO_0009963	EFO_0009963	bipolar I disorder	4	55
http://www.ebi.ac.uk/efo/EFO_0009964	EFO_0009964	bipolar II disorder	3	1
http://www.ebi.ac.uk/efo/EFO_0000289	EFO_0000289	bipolar disorder	116	506
http://www.ebi.ac.uk/efo/EFO_0006921	EFO_0006921	birth measurement	13	7
http://www.ebi.ac.uk/efo/EFO_0004344	EFO_0004344	birth weight	37	1114
http://www.ebi.ac.uk/efo/EFO_0010092	EFO_0010092	bitter alcoholic beverage consumption measurement	1	112
http://www.ebi.ac.uk/efo/EFO_0010089	EFO_0010089	bitter beverage consumption measurement	1	40
http://www.ebi.ac.uk/efo/EFO_0010093	EFO_0010093	bitter non-alcoholic beverage consumption measurement	1	48
http://www.ebi.ac.uk/efo/EFO_1000018	EFO_1000018	bladder disease	18	1
http://www.ebi.ac.uk/efo/EFO_0600071	EFO_0600071	blood glutathione peroxidase measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0007040	EFO_0007040	blood lead measurement	8	10
http://www.ebi.ac.uk/efo/EFO_0005664	EFO_0005664	blood metabolite measurement	58	1179
http://www.ebi.ac.uk/efo/EFO_0004325	EFO_0004325	blood pressure	29	110
http://www.ebi.ac.uk/efo/EFO_0006943	EFO_0006943	blood pressure change measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0007937	EFO_0007937	blood protein measurement	5274	5514
http://www.ebi.ac.uk/efo/EFO_0004304	EFO_0004304	blood sedimentation	3	9
http://www.ebi.ac.uk/efo/EFO_0004741	EFO_0004741	blood urea nitrogen measurement	11	1023
http://www.ebi.ac.uk/efo/EFO_0005106	EFO_0005106	body composition measurement	2	132
http://www.ebi.ac.uk/efo/EFO_0004341	EFO_0004341	body fat distribution	21	398
http://www.ebi.ac.uk/efo/EFO_0007800	EFO_0007800	body fat percentage	35	1052
http://www.ebi.ac.uk/efo/EFO_0004339	EFO_0004339	body height	79	3947
http://www.ebi.ac.uk/efo/EFO_0006784	EFO_0006784	body height at birth	2	94
http://www.ebi.ac.uk/efo/EFO_0004340	EFO_0004340	body mass index	231	3074
http://www.ebi.ac.uk/efo/EFO_0004338	EFO_0004338	body weight	47	2084
http://www.ebi.ac.uk/efo/EFO_0004566	EFO_0004566	body weight gain	5	2
http://www.ebi.ac.uk/efo/EFO_0004324	EFO_0004324	body weights and measures	14	51
http://www.ebi.ac.uk/efo/EFO_0003923	EFO_0003923	bone density	68	632
http://www.ebi.ac.uk/efo/EFO_0003931	EFO_0003931	bone fracture	85	69
http://www.ebi.ac.uk/efo/EFO_0004512	EFO_0004512	bone measurement	26	20
http://www.ebi.ac.uk/efo/EFO_0007621	EFO_0007621	bone mineral content measurement	20	17
http://www.ebi.ac.uk/efo/EFO_0020185	EFO_0020185	bone morphogenetic protein 10 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0020186	EFO_0020186	bone morphogenetic protein 6 measurement	3	13
http://www.ebi.ac.uk/efo/EFO_0020187	EFO_0020187	bone morphogenetic protein 7 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004514	EFO_0004514	bone quantitative ultrasound measurement	15	24
http://www.ebi.ac.uk/efo/EFO_0600084	EFO_0600084	bowel opening frequency	3	63
http://www.ebi.ac.uk/efo/EFO_0003870	EFO_0003870	brain aneurysm	21	173
http://www.ebi.ac.uk/efo/EFO_0005210	EFO_0005210	brain connectivity measurement	1706	19
http://www.ebi.ac.uk/efo/EFO_0004464	EFO_0004464	brain measurement	303	2254
http://www.ebi.ac.uk/efo/EFO_0003833	EFO_0003833	brain neoplasm	13	7
http://www.ebi.ac.uk/efo/EFO_0010605	EFO_0010605	brain stem volume measurement	1	31
http://www.ebi.ac.uk/efo/EFO_0006930	EFO_0006930	brain volume measurement	669	338
http://www.ebi.ac.uk/efo/EFO_0011018	EFO_0011018	brain-derived neurotrophic factor measurement	5	15
http://www.ebi.ac.uk/efo/EFO_0010129	EFO_0010129	breakfast skipping measurement	2	19
http://www.ebi.ac.uk/efo/EFO_0008040	EFO_0008040	breast cancer anti-estrogen resistance protein 3 measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0000305	EFO_0000305	breast carcinoma	129	439
http://www.ebi.ac.uk/efo/EFO_0003014	EFO_0003014	breast fibrocystic disease	4	1
http://www.ebi.ac.uk/efo/EFO_0003869	EFO_0003869	breast neoplasm	33	4
http://www.ebi.ac.uk/efo/EFO_0004884	EFO_0004884	breast size	3	21
http://www.ebi.ac.uk/efo/EFO_0009661	EFO_0009661	bronchitis	7	2
http://www.ebi.ac.uk/efo/EFO_0004571	EFO_0004571	butyrylcholinesterase measurement	3	96
http://www.ebi.ac.uk/efo/EFO_0008543	EFO_0008543	c3d:C3 ratio	1	3
http://www.ebi.ac.uk/efo/EFO_0008081	EFO_0008081	cGMP-specific 3',5'-cyclic phosphodiesterase measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0020209	EFO_0020209	cadherin-1 measurement	3	29
http://www.ebi.ac.uk/efo/EFO_0007872	EFO_0007872	caffeine metabolite measurement	6	25
http://www.ebi.ac.uk/efo/EFO_0007772	EFO_0007772	calcaneal bone quantitative ultrasound measurement	2	10
http://www.ebi.ac.uk/efo/EFO_0008061	EFO_0008061	calcineurin measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0004838	EFO_0004838	calcium measurement	24	1207
http://www.ebi.ac.uk/efo/EFO_0008063	EFO_0008063	calcium/calmodulin-dependent protein kinase type 1D measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0008064	EFO_0008064	calpain I measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0008065	EFO_0008065	calpastatin measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0000311	EFO_0000311	cancer	31	517
http://www.ebi.ac.uk/efo/EFO_0006999	EFO_0006999	cancer aggressiveness measurement	2	12
http://www.ebi.ac.uk/efo/EFO_0010603	EFO_0010603	cancer antigen 125 measurement	2	29
http://www.ebi.ac.uk/efo/EFO_0010585	EFO_0010585	cancer antigen 15.3 measurement	3	26
http://www.ebi.ac.uk/efo/EFO_0010584	EFO_0010584	cancer antigen 19.9 measurement	1	32
http://www.ebi.ac.uk/efo/EFO_0005127	EFO_0005127	cancer biomarker measurement	2	56
http://www.ebi.ac.uk/efo/EFO_0007191	EFO_0007191	cannabis dependence	5	4
http://www.ebi.ac.uk/efo/EFO_0010811	EFO_0010811	carbohydrate intake measurement	6	20
http://www.ebi.ac.uk/efo/EFO_0008066	EFO_0008066	carbohydrate sulfotransferase 15 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0006520	EFO_0006520	carbon monoxide exhalation measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0008067	EFO_0008067	carbonic anhydrase 13 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008068	EFO_0008068	carbonic anhydrase 6 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008069	EFO_0008069	carboxypeptidase B2 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_1001493	EFO_1001493	cardiac embolism	3	2
http://www.ebi.ac.uk/efo/EFO_0010071	EFO_0010071	cardiac troponin I measurement	6	85
http://www.ebi.ac.uk/efo/EFO_0005043	EFO_0005043	cardiac troponin T measurement	10	29
http://www.ebi.ac.uk/efo/EFO_1001976	EFO_1001976	cardioembolic stroke	10	9
http://www.ebi.ac.uk/efo/EFO_0000319	EFO_0000319	cardiovascular disease	39	17
http://www.ebi.ac.uk/efo/EFO_0005278	EFO_0005278	cardiovascular disease biomarker measurement	2	12
http://www.ebi.ac.uk/efo/EFO_0006919	EFO_0006919	cardiovascular event measurement	14	10
http://www.ebi.ac.uk/efo/EFO_0004298	EFO_0004298	cardiovascular measurement	7	1
http://www.ebi.ac.uk/efo/EFO_0010469	EFO_0010469	carnitine measurement	29	108
http://www.ebi.ac.uk/efo/EFO_0010470	EFO_0010470	carnosine measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004737	EFO_0004737	carotenoid measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0007117	EFO_0007117	carotid artery intima media thickness	26	145
http://www.ebi.ac.uk/efo/EFO_0009783	EFO_0009783	carotid atherosclerosis	2	12
http://www.ebi.ac.uk/efo/EFO_0006501	EFO_0006501	carotid plaque build	9	11
http://www.ebi.ac.uk/efo/EFO_0004143	EFO_0004143	carpal tunnel syndrome	10	63
http://www.ebi.ac.uk/efo/EFO_0007873	EFO_0007873	cartilage thickness measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0008070	EFO_0008070	caspase-3 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0010764	EFO_0010764	caspase-8 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0008071	EFO_0008071	catalase measurement	1	8
http://purl.obolibrary.org/obo/MONDO_0005129	MONDO_0005129	cataract	39	140
http://www.ebi.ac.uk/efo/EFO_0008072	EFO_0008072	cathepsin B measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0010611	EFO_0010611	cathepsin D measurement	3	48
http://www.ebi.ac.uk/efo/EFO_0010619	EFO_0010619	cathepsin L1 measurement	1	56
http://www.ebi.ac.uk/efo/EFO_0008073	EFO_0008073	cathepsin S measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0008074	EFO_0008074	cathepsin Z measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008075	EFO_0008075	cation-independent mannose-6-phosphate receptor measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004830	EFO_0004830	caudate nucleus volume	5	35
http://www.ebi.ac.uk/efo/EFO_0001060	EFO_0001060	celiac disease	28	222
http://www.ebi.ac.uk/efo/EFO_0008079	EFO_0008079	cell adhesion molecule-related/down-regulated by oncogenes measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0005213	EFO_0005213	central corneal thickness	11	572
http://www.ebi.ac.uk/efo/EFO_0000326	EFO_0000326	central nervous system cancer	13	128
http://purl.obolibrary.org/obo/MONDO_0044887	MONDO_0044887	central nervous system non-hodgkin lymphoma	1	3
http://www.ebi.ac.uk/efo/EFO_0009784	EFO_0009784	central serous retinopathy	1	10
http://www.ebi.ac.uk/efo/EFO_0010222	EFO_0010222	ceramide measurement	274	213
http://www.ebi.ac.uk/efo/EFO_0020864	EFO_0020864	cerebellar volume measurement	8	66
http://www.ebi.ac.uk/efo/EFO_0006790	EFO_0006790	cerebral amyloid angiopathy	11	9
http://www.ebi.ac.uk/efo/EFO_0007707	EFO_0007707	cerebral amyloid deposition measurement	8	12
http://www.ebi.ac.uk/efo/EFO_0006794	EFO_0006794	cerebrospinal fluid biomarker measurement	7	46
http://www.ebi.ac.uk/efo/EFO_1000059	EFO_1000059	cervical artery dissection	1	3
http://www.ebi.ac.uk/efo/EFO_0001061	EFO_0001061	cervical carcinoma	25	751
http://www.ebi.ac.uk/efo/EFO_0004573	EFO_0004573	chemerin measurement	4	32
http://www.ebi.ac.uk/efo/EFO_0008082	EFO_0008082	chemokine (C-C motif) ligand 27 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0008083	EFO_0008083	chemokine (C-X-C motif) ligand 1 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0005400	EFO_0005400	chemotherapy-induced alopecia	7	5
http://www.ebi.ac.uk/efo/EFO_0010978	EFO_0010978	chemotherapy-induced cytotoxicity measurement	69	9
http://purl.obolibrary.org/obo/MONDO_0000870	MONDO_0000870	childhood acute lymphoblastic leukemia	1	2
http://www.ebi.ac.uk/efo/EFO_0020103	EFO_0020103	childhood gender nonconformity	1	7
http://purl.obolibrary.org/obo/MONDO_0005405	MONDO_0005405	childhood onset asthma	29	470
http://www.ebi.ac.uk/efo/EFO_0007979	EFO_0007979	childhood trauma measurement	9	20
http://www.ebi.ac.uk/efo/EFO_0007842	EFO_0007842	chin morphology measurement	14	85
http://www.ebi.ac.uk/efo/EFO_0008084	EFO_0008084	chitotriosidase-1 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0009284	EFO_0009284	chloride measurement	3	67
http://www.ebi.ac.uk/efo/EFO_0005221	EFO_0005221	cholangiocarcinoma	4	8
http://www.ebi.ac.uk/efo/EFO_0004799	EFO_0004799	cholelithiasis	13	72
http://www.ebi.ac.uk/efo/EFO_0009132	EFO_0009132	cholesterol efflux capacity measurement	7	26
http://www.ebi.ac.uk/efo/EFO_0020943	EFO_0020943	cholesterol:total lipids ratio	14	1192
http://www.ebi.ac.uk/efo/EFO_0010340	EFO_0010340	cholesteryl ester 14:0 measurement	5	16
http://www.ebi.ac.uk/efo/EFO_0010341	EFO_0010341	cholesteryl ester 16:0 measurement	6	34
http://www.ebi.ac.uk/efo/EFO_0010342	EFO_0010342	cholesteryl ester 16:1 measurement	6	12
http://www.ebi.ac.uk/efo/EFO_0010343	EFO_0010343	cholesteryl ester 18:0 measurement	5	47
http://www.ebi.ac.uk/efo/EFO_0010344	EFO_0010344	cholesteryl ester 18:1 measurement	6	16
http://www.ebi.ac.uk/efo/EFO_0010345	EFO_0010345	cholesteryl ester 18:2 measurement	6	36
http://www.ebi.ac.uk/efo/EFO_0010346	EFO_0010346	cholesteryl ester 18:3 measurement	6	35
http://www.ebi.ac.uk/efo/EFO_0010347	EFO_0010347	cholesteryl ester 20:3 measurement	6	62
http://www.ebi.ac.uk/efo/EFO_0010348	EFO_0010348	cholesteryl ester 20:4 measurement	7	18
http://www.ebi.ac.uk/efo/EFO_0010349	EFO_0010349	cholesteryl ester 20:5 measurement	6	17
http://www.ebi.ac.uk/efo/EFO_0010350	EFO_0010350	cholesteryl ester 22:6 measurement	5	15
http://www.ebi.ac.uk/efo/EFO_0010351	EFO_0010351	cholesteryl ester measurement	51	1187
http://www.ebi.ac.uk/efo/EFO_0009133	EFO_0009133	cholesteryl ester transfer protein measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0020944	EFO_0020944	cholesteryl esters:total lipids ratio	14	1321
http://www.ebi.ac.uk/efo/EFO_0010116	EFO_0010116	choline measurement	5	371
http://www.ebi.ac.uk/efo/EFO_0009281	EFO_0009281	choroidal thickness measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0007593	EFO_0007593	chromatid break measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0006505	EFO_0006505	chronic bronchitis	13	27
http://www.ebi.ac.uk/efo/EFO_0009363	EFO_0009363	chronic central serous retinopathy	2	6
http://www.ebi.ac.uk/efo/EFO_0004239	EFO_0004239	chronic hepatitis B virus infection	11	294
http://www.ebi.ac.uk/efo/EFO_0004220	EFO_0004220	chronic hepatitis C virus infection	17	36
http://www.ebi.ac.uk/efo/EFO_0003884	EFO_0003884	chronic kidney disease	65	125
http://www.ebi.ac.uk/efo/EFO_0000095	EFO_0000095	chronic lymphocytic leukemia	20	181
http://www.ebi.ac.uk/efo/EFO_0010143	EFO_0010143	chronic mountain sickness	1	2
http://www.ebi.ac.uk/efo/EFO_0000339	EFO_0000339	chronic myelogenous leukemia	4	1
http://www.ebi.ac.uk/efo/EFO_0000341	EFO_0000341	chronic obstructive pulmonary disease	67	765
http://www.ebi.ac.uk/efo/EFO_1000024	EFO_1000024	chronic rhinosinusitis	4	19
http://www.ebi.ac.uk/efo/EFO_0007940	EFO_0007940	chronic venous insufficiency	1	2
http://www.ebi.ac.uk/efo/EFO_0008328	EFO_0008328	chronotype measurement	22	864
http://www.ebi.ac.uk/efo/EFO_0020901	EFO_0020901	chylomicron change measurement	2	1
http://www.ebi.ac.uk/efo/EFO_0008596	EFO_0008596	chylomicron measurement	40	542
http://www.ebi.ac.uk/efo/EFO_0006525	EFO_0006525	cigarettes per day measurement	21	240
http://www.ebi.ac.uk/efo/EFO_0007738	EFO_0007738	cingulate cortex measurement	7	4
http://www.ebi.ac.uk/efo/EFO_0004354	EFO_0004354	circadian rhythm	11	97
http://www.ebi.ac.uk/efo/EFO_0020102	EFO_0020102	circulating alpha-Klotho measurement	2	22
http://www.ebi.ac.uk/efo/EFO_0004739	EFO_0004739	circulating cell free DNA measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0001422	EFO_0001422	cirrhosis of liver	19	5
http://www.ebi.ac.uk/efo/EFO_0010114	EFO_0010114	citrate measurement	5	139
http://www.ebi.ac.uk/efo/EFO_0009777	EFO_0009777	citrulline measurement	2	32
http://www.ebi.ac.uk/efo/EFO_0003959	EFO_0003959	cleft lip	40	101
http://www.ebi.ac.uk/efo/EFO_0007653	EFO_0007653	clinical ideal cardiovascular health	1	9
http://www.ebi.ac.uk/efo/EFO_0004297	EFO_0004297	clinical laboratory measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0007056	EFO_0007056	clinical treatment	691	249
http://www.ebi.ac.uk/efo/EFO_0008532	EFO_0008532	clinically amyopathic dermatomyositis	1	2
http://www.ebi.ac.uk/efo/EFO_0010819	EFO_0010819	clonal hematopoiesis	1	4
http://www.ebi.ac.uk/efo/EFO_0007966	EFO_0007966	clopidogrel metabolite measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0008087	EFO_0008087	coagulation factor V measurement	4	5
http://www.ebi.ac.uk/efo/EFO_0004634	EFO_0004634	coagulation factor measurement	13	21
http://www.ebi.ac.uk/efo/EFO_0010445	EFO_0010445	cocaine use disorder	6	5
http://www.ebi.ac.uk/efo/EFO_0007836	EFO_0007836	coenzyme Q10 measurement	1	17
http://www.ebi.ac.uk/efo/EFO_0004330	EFO_0004330	coffee consumption	10	32
http://www.ebi.ac.uk/efo/EFO_0006781	EFO_0006781	coffee consumption measurement	12	262
http://www.ebi.ac.uk/efo/EFO_0007710	EFO_0007710	cognitive decline measurement	15	8
http://www.ebi.ac.uk/efo/EFO_0008354	EFO_0008354	cognitive function measurement	339	2018
http://www.ebi.ac.uk/efo/EFO_0007998	EFO_0007998	cognitive impairment measurement	3	10
http://www.ebi.ac.uk/efo/EFO_0007969	EFO_0007969	cognitive inhibition measurement	3	13
http://www.ebi.ac.uk/efo/EFO_1001293	EFO_1001293	collagenous colitis	1	11
http://www.ebi.ac.uk/efo/EFO_0008088	EFO_0008088	collectin-11 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_1001950	EFO_1001950	colon carcinoma	12	28
http://www.ebi.ac.uk/efo/EFO_0004288	EFO_0004288	colonic neoplasm	8	11
http://www.ebi.ac.uk/efo/EFO_0005406	EFO_0005406	colorectal adenoma	4	228
http://www.ebi.ac.uk/efo/EFO_0005842	EFO_0005842	colorectal cancer	98	566
http://www.ebi.ac.uk/efo/EFO_0008460	EFO_0008460	colorectal health	1	38
http://www.ebi.ac.uk/efo/EFO_0004860	EFO_0004860	common carotid intimal medial thickness	5	32
http://www.ebi.ac.uk/efo/EFO_0009819	EFO_0009819	comparative body size at age 10, self-reported	7	880
http://www.ebi.ac.uk/efo/EFO_0008089	EFO_0008089	complement C1q subcomponent measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0008090	EFO_0008090	complement C1r subcomponent measurement	3	16
http://www.ebi.ac.uk/efo/EFO_0008091	EFO_0008091	complement C1s subcomponent measurement	4	7
http://www.ebi.ac.uk/efo/EFO_0004983	EFO_0004983	complement C3 measurement	9	427
http://www.ebi.ac.uk/efo/EFO_0004984	EFO_0004984	complement C4 measurement	3	433
http://www.ebi.ac.uk/efo/EFO_0008092	EFO_0008092	complement C4b measurement	1	275
http://www.ebi.ac.uk/efo/EFO_0008093	EFO_0008093	complement component C7 measurement	3	14
http://www.ebi.ac.uk/efo/EFO_0008094	EFO_0008094	complement component C8 measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0020282	EFO_0020282	complement component C9 measurement	4	5
http://www.ebi.ac.uk/efo/EFO_0008095	EFO_0008095	complement decay-accelerating factor measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0008097	EFO_0008097	complement factor H measurement	6	4
http://www.ebi.ac.uk/efo/EFO_0600054	EFO_0600054	complement factor H-related protein 1 measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0008098	EFO_0008098	complement factor H-related protein 5 measurement	3	8
http://www.ebi.ac.uk/efo/EFO_0008099	EFO_0008099	complement factor I measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0006820	EFO_0006820	complicated disease course	1	1
http://www.ebi.ac.uk/efo/EFO_0011023	EFO_0011023	concussion	2	2
http://www.ebi.ac.uk/efo/EFO_0004216	EFO_0004216	conduct disorder	6	7
http://www.ebi.ac.uk/efo/EFO_0005269	EFO_0005269	congenital heart malformation	1	1
http://www.ebi.ac.uk/efo/EFO_0005938	EFO_0005938	congenital left-sided heart lesions	6	5
http://www.ebi.ac.uk/efo/EFO_0600032	EFO_0600032	congenital right-sided heart lesions	1	1
http://www.ebi.ac.uk/efo/EFO_0005319	EFO_0005319	contact dermatitis	8	4
http://www.ebi.ac.uk/efo/EFO_0008100	EFO_0008100	contactin-2 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008101	EFO_0008101	contactin-5 measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0005419	EFO_0005419	contrast sensitivity measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0010066	EFO_0010066	corneal hysteresis	7	16
http://www.ebi.ac.uk/efo/EFO_0010067	EFO_0010067	corneal resistance factor	8	779
http://www.ebi.ac.uk/efo/EFO_0004345	EFO_0004345	corneal topography	12	147
http://www.ebi.ac.uk/efo/EFO_1000881	EFO_1000881	coronary aneurysm	6	3
http://www.ebi.ac.uk/efo/EFO_0004723	EFO_0004723	coronary artery calcification	17	4
http://www.ebi.ac.uk/efo/EFO_0001645	EFO_0001645	coronary artery disease	96	1194
http://purl.obolibrary.org/obo/MONDO_0021661	MONDO_0021661	coronary atherosclerosis	2	2
http://www.ebi.ac.uk/efo/EFO_0007938	EFO_0007938	coronary atherosclerosis measurement	3	4
http://www.ebi.ac.uk/efo/EFO_0010736	EFO_0010736	cortical surface area measurement	8	1780
http://www.ebi.ac.uk/efo/EFO_0004840	EFO_0004840	cortical thickness	328	1568
http://www.ebi.ac.uk/efo/EFO_0005843	EFO_0005843	cortisol measurement	9	9
http://www.ebi.ac.uk/efo/EFO_0004642	EFO_0004642	cortisol secretion measurement	2	132
http://www.ebi.ac.uk/efo/EFO_0006508	EFO_0006508	cotinine glucuronidation measurement	1	16
http://www.ebi.ac.uk/efo/EFO_0007813	EFO_0007813	cotinine measurement	6	15
http://www.ebi.ac.uk/efo/EFO_0004534	EFO_0004534	creatine kinase measurement	7	256
http://www.ebi.ac.uk/efo/EFO_0010472	EFO_0010472	creatine measurement	7	14
http://www.ebi.ac.uk/efo/EFO_0004518	EFO_0004518	creatinine measurement	49	1347
http://www.ebi.ac.uk/efo/EFO_0005846	EFO_0005846	cryoglobulinemia	1	82
http://purl.obolibrary.org/obo/MONDO_0015474	MONDO_0015474	cryptosporidiosis	1	1
http://www.ebi.ac.uk/efo/EFO_0005944	EFO_0005944	cumulative dose response to bevacizumab	1	1
http://www.ebi.ac.uk/efo/EFO_0006939	EFO_0006939	cup-to-disc ratio measurement	7	237
http://www.ebi.ac.uk/efo/EFO_0006782	EFO_0006782	cups of coffee per day measurement	6	161
http://www.ebi.ac.uk/efo/EFO_0003834	EFO_0003834	cutaneous lupus erythematosus	1	322
http://www.ebi.ac.uk/efo/EFO_0000389	EFO_0000389	cutaneous melanoma	10	262
http://www.ebi.ac.uk/efo/EFO_0007773	EFO_0007773	cutaneous psoriasis measurement	2	22
http://www.ebi.ac.uk/efo/EFO_1001927	EFO_1001927	cutaneous squamous cell carcinoma	2	78
http://www.ebi.ac.uk/efo/EFO_0010593	EFO_0010593	cystatin B measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0004617	EFO_0004617	cystatin C measurement	19	15
http://www.ebi.ac.uk/efo/EFO_0008103	EFO_0008103	cystatin-D measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0008105	EFO_0008105	cystatin-SA measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008106	EFO_0008106	cystatin-SN measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004608	EFO_0004608	cystic fibrosis associated meconium ileus	2	8
http://www.ebi.ac.uk/efo/EFO_0001062	EFO_0001062	cytomegalovirus infection	3	1
http://www.ebi.ac.uk/efo/EFO_0004953	EFO_0004953	date of diagnosis	1	1
http://www.ebi.ac.uk/efo/EFO_0007828	EFO_0007828	daytime rest measurement	5	223
http://www.ebi.ac.uk/efo/EFO_0001063	EFO_0001063	deafness	1	4
http://www.ebi.ac.uk/efo/EFO_0008107	EFO_0008107	death-associated protein kinase 2 measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008322	EFO_0008322	decreased susceptibility to bacterial infection	4	1
http://www.ebi.ac.uk/efo/EFO_0007001	EFO_0007001	dehydroepiandrosterone sulphate measurement	6	55
http://www.ebi.ac.uk/efo/EFO_0008476	EFO_0008476	delayed reward discounting measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0007765	EFO_0007765	delta-6 desaturase measurement	2	13
http://www.ebi.ac.uk/efo/EFO_0020316	EFO_0020316	delta-like protein 1 measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0010781	EFO_0010781	delta/notch like EGF Repeat Containing protein measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0006503	EFO_0006503	dense area measurement	1	17
http://www.ebi.ac.uk/efo/EFO_0003819	EFO_0003819	dental caries	18	138
http://www.ebi.ac.uk/efo/EFO_0010083	EFO_0010083	dentate gyrus volume measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0010078	EFO_0010078	dentures	5	134
http://www.ebi.ac.uk/efo/EFO_0007704	EFO_0007704	depressive episode measurement	16	5
http://www.ebi.ac.uk/efo/EFO_0007006	EFO_0007006	depressive symptom measurement	79	941
http://www.ebi.ac.uk/efo/EFO_0000398	EFO_0000398	dermatomyositis	4	44
http://www.ebi.ac.uk/efo/EFO_0008108	EFO_0008108	dermatopontin measurement	1	2
http://www.ebi.ac.uk/efo/EFO_1000648	EFO_1000648	developmental dysplasia of the hip	3	4
http://www.ebi.ac.uk/efo/EFO_0000400	EFO_0000400	diabetes mellitus	33	9
http://www.ebi.ac.uk/efo/EFO_0006842	EFO_0006842	diabetes mellitus biomarker	3	11
http://www.ebi.ac.uk/efo/EFO_0009486	EFO_0009486	diabetic eye disease	10	2
http://www.ebi.ac.uk/efo/EFO_1001459	EFO_1001459	diabetic foot	2	3
http://www.ebi.ac.uk/efo/EFO_0000401	EFO_0000401	diabetic nephropathy	40	23
http://www.ebi.ac.uk/efo/EFO_0003770	EFO_0003770	diabetic retinopathy	14	4
http://www.ebi.ac.uk/efo/EFO_0020323	EFO_0020323	diablo homolog, mitochondrial measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0020055	EFO_0020055	diacylglycerol 32.2 measurement	2	17
http://www.ebi.ac.uk/efo/EFO_0020056	EFO_0020056	diacylglycerol 33:1 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0020058	EFO_0020058	diacylglycerol 34:0 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0010352	EFO_0010352	diacylglycerol 34:1 measurement	4	18
http://www.ebi.ac.uk/efo/EFO_0010353	EFO_0010353	diacylglycerol 34:2 measurement	4	34
http://www.ebi.ac.uk/efo/EFO_0020059	EFO_0020059	diacylglycerol 34:3 measurement	3	17
http://www.ebi.ac.uk/efo/EFO_0010354	EFO_0010354	diacylglycerol 36:1 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0010355	EFO_0010355	diacylglycerol 36:2 measurement	4	19
http://www.ebi.ac.uk/efo/EFO_0020062	EFO_0020062	diacylglycerol 36:3 measurement	4	27
http://www.ebi.ac.uk/efo/EFO_0020063	EFO_0020063	diacylglycerol 36:4 measurement	4	18
http://www.ebi.ac.uk/efo/EFO_0020064	EFO_0020064	diacylglycerol 36:5 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0020065	EFO_0020065	diacylglycerol 38:3 measurement	1	103
http://www.ebi.ac.uk/efo/EFO_0020066	EFO_0020066	diacylglycerol 38:4 measurement	3	98
http://www.ebi.ac.uk/efo/EFO_0020067	EFO_0020067	diacylglycerol 38:5 measurement	3	40
http://www.ebi.ac.uk/efo/EFO_0020068	EFO_0020068	diacylglycerol 42:7 measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0020070	EFO_0020070	diacylglycerol 44:6 measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0020069	EFO_0020069	diacylglycerol 44:7 measurement	1	32
http://www.ebi.ac.uk/efo/EFO_0006336	EFO_0006336	diastolic blood pressure	109	2107
http://www.ebi.ac.uk/efo/EFO_0006945	EFO_0006945	diastolic blood pressure change measurement	17	18
http://www.ebi.ac.uk/efo/EFO_0020324	EFO_0020324	dickkopf-like protein 1 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0010620	EFO_0010620	dickkopf‐related protein 1 measurement	4	11
http://www.ebi.ac.uk/efo/EFO_0008111	EFO_0008111	diet measurement	131	565
http://www.ebi.ac.uk/efo/EFO_0008470	EFO_0008470	dietary potassium intake measurement	4	1
http://www.ebi.ac.uk/efo/EFO_1002017	EFO_1002017	differentiated thyroid carcinoma	4	1
http://www.ebi.ac.uk/efo/EFO_0000403	EFO_0000403	diffuse large B-cell lymphoma	11	46
http://www.ebi.ac.uk/efo/EFO_0009369	EFO_0009369	diffusing capacity of the lung for carbon monoxide	2	9
http://www.ebi.ac.uk/efo/EFO_0000405	EFO_0000405	digestive system disease	27	8
http://purl.obolibrary.org/obo/MONDO_0043424	MONDO_0043424	digestive system infectious disorder	1	15
http://www.ebi.ac.uk/efo/EFO_0004841	EFO_0004841	digit length ratio	5	39
http://www.ebi.ac.uk/efo/EFO_0010223	EFO_0010223	diglyceride measurement	89	93
http://www.ebi.ac.uk/efo/EFO_0007763	EFO_0007763	dihomo-gamma-linolenic acid measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0004909	EFO_0004909	dihydrotestosterone measurement	2	18
http://www.ebi.ac.uk/efo/EFO_0000407	EFO_0000407	dilated cardiomyopathy	9	72
http://www.ebi.ac.uk/efo/EFO_0010476	EFO_0010476	dimethylglycine measurement	6	4
http://www.ebi.ac.uk/efo/EFO_0007936	EFO_0007936	disease prognosis measurement	4	157
http://www.ebi.ac.uk/efo/EFO_0008336	EFO_0008336	disease progression measurement	27	161
http://www.ebi.ac.uk/efo/EFO_0004952	EFO_0004952	disease recurrence	7	10
http://www.ebi.ac.uk/efo/EFO_0006832	EFO_0006832	disposition index measurement	5	15
http://www.ebi.ac.uk/efo/EFO_0009959	EFO_0009959	diverticular disease	9	6
http://www.ebi.ac.uk/efo/EFO_1001460	EFO_1001460	diverticulitis	3	5
http://www.ebi.ac.uk/efo/EFO_0020876	EFO_0020876	docosahexaenoic acid change measurement	2	1
http://www.ebi.ac.uk/efo/EFO_0007761	EFO_0007761	docosahexaenoic acid measurement	10	310
http://www.ebi.ac.uk/efo/EFO_0006809	EFO_0006809	docosapentaenoic acid measurement	5	47
http://www.ebi.ac.uk/efo/EFO_0007892	EFO_0007892	donor genotype effect measurement	13	8
http://www.ebi.ac.uk/efo/EFO_0001757	EFO_0001757	dose response design	1	11
http://www.ebi.ac.uk/efo/EFO_0004315	EFO_0004315	drinking behavior	3	9
http://www.ebi.ac.uk/efo/EFO_0003890	EFO_0003890	drug dependence	16	4
http://www.ebi.ac.uk/efo/EFO_0007010	EFO_0007010	drug use measurement	560	13
http://www.ebi.ac.uk/efo/EFO_1000904	EFO_1000904	drug-Induced dyskinesia	1	2
http://www.ebi.ac.uk/efo/EFO_0004228	EFO_0004228	drug-induced liver injury	31	87
http://www.ebi.ac.uk/efo/EFO_0008112	EFO_0008112	dual specificity mitogen-activated protein kinase kinase 2 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0008113	EFO_0008113	dual specificity mitogen-activated protein kinase kinase 4 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0004607	EFO_0004607	duodenal ulcer	10	22
http://www.ebi.ac.uk/efo/EFO_0008114	EFO_0008114	dynein light chain roadblock-type 1 measurement	1	11
http://www.ebi.ac.uk/efo/EFO_1001869	EFO_1001869	dysentery	2	2
http://www.ebi.ac.uk/efo/EFO_0007889	EFO_0007889	dysmenorrheic pain measurement	3	5
http://www.ebi.ac.uk/efo/EFO_0004575	EFO_0004575	e-selectin measurement	9	75
http://www.ebi.ac.uk/efo/EFO_0020340	EFO_0020340	e3 ubiquitin-protein ligase mdm2 measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0007665	EFO_0007665	ear protrusion	1	2
http://www.ebi.ac.uk/efo/EFO_0004885	EFO_0004885	early cardiac repolarization measurement	2	1
http://www.ebi.ac.uk/efo/EFO_0011015	EFO_0011015	educational attainment	22	6743
http://www.ebi.ac.uk/efo/EFO_0007760	EFO_0007760	eicosapentaenoic acid measurement	2	16
http://www.ebi.ac.uk/efo/EFO_0005527	EFO_0005527	ejection fraction measurement	2	18
http://www.ebi.ac.uk/efo/EFO_0008117	EFO_0008117	elafin measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0004327	EFO_0004327	electrocardiography	16	1046
http://www.ebi.ac.uk/efo/EFO_0004357	EFO_0004357	electroencephalogram measurement	15	11
http://www.ebi.ac.uk/efo/EFO_0007803	EFO_0007803	emotional symptom measurement	159	3
http://www.ebi.ac.uk/efo/EFO_0000464	EFO_0000464	emphysema	19	16
http://www.ebi.ac.uk/efo/EFO_0005850	EFO_0005850	emphysema pattern measurement	2	29
http://www.ebi.ac.uk/efo/EFO_0005241	EFO_0005241	employment status	693	10
http://www.ebi.ac.uk/efo/EFO_0008118	EFO_0008118	endoglin measurement	1	16
http://www.ebi.ac.uk/efo/EFO_1001512	EFO_1001512	endometrial carcinoma	13	53
http://www.ebi.ac.uk/efo/EFO_1001514	EFO_1001514	endometrial endometrioid carcinoma	1	12
http://www.ebi.ac.uk/efo/EFO_0004230	EFO_0004230	endometrial neoplasm	6	10
http://www.ebi.ac.uk/efo/EFO_0001065	EFO_0001065	endometriosis	33	265
http://www.ebi.ac.uk/efo/EFO_0008120	EFO_0008120	endothelial cell-selective adhesion molecule measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0010912	EFO_0010912	endothelial cell-specific molecule 1 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0006900	EFO_0006900	endothelial growth factor measurement	3	22
http://www.ebi.ac.uk/efo/EFO_0008121	EFO_0008121	endothelin-converting enzyme 1 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0005109	EFO_0005109	energy expenditure	1	132
http://www.ebi.ac.uk/efo/EFO_0008005	EFO_0008005	energy expenditure measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0003939	EFO_0003939	energy intake	9	154
http://www.ebi.ac.uk/efo/EFO_0009374	EFO_0009374	energy intake measurement	3	12
http://www.ebi.ac.uk/efo/EFO_0005092	EFO_0005092	entorhinal cortical volume	11	13
http://purl.obolibrary.org/obo/MONDO_0024290	MONDO_0024290	enuresis	1	3
http://www.ebi.ac.uk/efo/EFO_0008361	EFO_0008361	environmental tobacco smoke exposure measurement	7	1
http://www.ebi.ac.uk/efo/EFO_0010913	EFO_0010913	eosinophil cationic protein measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0004842	EFO_0004842	eosinophil count	36	2452
http://www.ebi.ac.uk/efo/EFO_0007996	EFO_0007996	eosinophil percentage of granulocytes	1	665
http://www.ebi.ac.uk/efo/EFO_0007991	EFO_0007991	eosinophil percentage of leukocytes	4	1917
http://www.ebi.ac.uk/efo/EFO_0004232	EFO_0004232	eosinophilic esophagitis	7	90
http://www.ebi.ac.uk/efo/EFO_0008122	EFO_0008122	eotaxin measurement	4	36
http://www.ebi.ac.uk/efo/EFO_0008123	EFO_0008123	ephrin type-A receptor 1 measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0008124	EFO_0008124	ephrin type-B receptor 2 measurement	4	9
http://www.ebi.ac.uk/efo/EFO_0010947	EFO_0010947	epidermal growth factor measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0000474	EFO_0000474	epilepsy	28	42
http://www.ebi.ac.uk/efo/EFO_0004333	EFO_0004333	episodic memory	21	4
http://www.ebi.ac.uk/efo/EFO_0004234	EFO_0004234	erectile dysfunction	10	2
http://www.ebi.ac.uk/efo/EFO_0009331	EFO_0009331	erosive tooth wear measurement	2	18
http://www.ebi.ac.uk/efo/EFO_0007807	EFO_0007807	erythrocyte cadmium measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004305	EFO_0004305	erythrocyte count	40	2099
http://www.ebi.ac.uk/efo/EFO_0005047	EFO_0005047	erythrocyte measurement	2	187
http://www.ebi.ac.uk/efo/EFO_0008391	EFO_0008391	erythropoetin measurement	2	14
http://www.ebi.ac.uk/efo/EFO_0000478	EFO_0000478	esophageal adenocarcinoma	12	86
http://www.ebi.ac.uk/efo/EFO_0002916	EFO_0002916	esophageal carcinoma	14	69
http://www.ebi.ac.uk/efo/EFO_0009544	EFO_0009544	esophageal disease	16	8
http://www.ebi.ac.uk/efo/EFO_0005922	EFO_0005922	esophageal squamous cell carcinoma	1	33
http://www.ebi.ac.uk/efo/EFO_0009545	EFO_0009545	esophageal varices	9	7
http://www.ebi.ac.uk/efo/EFO_0003108	EFO_0003108	essential tremor	4	8
http://www.ebi.ac.uk/efo/EFO_0020904	EFO_0020904	esterified cholesterol change measurement	30	4
http://www.ebi.ac.uk/efo/EFO_0008589	EFO_0008589	esterified cholesterol measurement	42	358
http://www.ebi.ac.uk/efo/EFO_0020970	EFO_0020970	esterified stigmasterol measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0004697	EFO_0004697	estradiol measurement	34	353
http://www.ebi.ac.uk/efo/EFO_0011007	EFO_0011007	estrogen measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0008125	EFO_0008125	estrogen receptor measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0005512	EFO_0005512	estrogen receptor status	3	1
http://www.ebi.ac.uk/efo/EFO_1000650	EFO_1000650	estrogen-receptor negative breast cancer	15	91
http://www.ebi.ac.uk/efo/EFO_1000649	EFO_1000649	estrogen-receptor positive breast cancer	19	7
http://www.ebi.ac.uk/efo/EFO_0007971	EFO_0007971	estrone conjugate measurement	3	8
http://www.ebi.ac.uk/efo/EFO_0007970	EFO_0007970	estrone measurement	6	13
http://www.ebi.ac.uk/efo/EFO_0000482	EFO_0000482	event free survival time	9	2
http://www.ebi.ac.uk/efo/EFO_0007875	EFO_0007875	excessive daytime sleepiness measurement	8	9
http://www.ebi.ac.uk/efo/EFO_0009332	EFO_0009332	executive function measurement	19	4
http://www.ebi.ac.uk/efo/EFO_0000483	EFO_0000483	exercise	3	2
http://www.ebi.ac.uk/efo/EFO_0004328	EFO_0004328	exercise test	25	8
http://www.ebi.ac.uk/efo/EFO_0004235	EFO_0004235	exfoliation syndrome	6	5
http://www.ebi.ac.uk/efo/EFO_0008126	EFO_0008126	extracellular matrix protein 1 measurement	1	6
http://purl.obolibrary.org/obo/MONDO_0019472	MONDO_0019472	extranodal nasal NK/T cell lymphoma	2	36
http://www.ebi.ac.uk/efo/EFO_0004317	EFO_0004317	extraversion	2	7
http://www.ebi.ac.uk/efo/EFO_0003949	EFO_0003949	eye color	15	22
http://www.ebi.ac.uk/efo/EFO_0004731	EFO_0004731	eye measurement	166	18
http://www.ebi.ac.uk/efo/EFO_0007858	EFO_0007858	eye morphology measurement	24	7
http://www.ebi.ac.uk/efo/EFO_0007699	EFO_0007699	eye movement measurement	12	9
http://www.ebi.ac.uk/efo/EFO_0009360	EFO_0009360	eyelid sagging measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0009892	EFO_0009892	facial attractiveness measurement	7	2
http://www.ebi.ac.uk/efo/EFO_0007823	EFO_0007823	facial hair thickness measurement	5	2
http://www.ebi.ac.uk/efo/EFO_0007856	EFO_0007856	facial height measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0004743	EFO_0004743	facial morphology	5	2
http://www.ebi.ac.uk/efo/EFO_0007841	EFO_0007841	facial morphology measurement	388	73
http://www.ebi.ac.uk/efo/EFO_0006942	EFO_0006942	facial pigmentation measurement	8	22
http://www.ebi.ac.uk/efo/EFO_0007855	EFO_0007855	facial width measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0009368	EFO_0009368	factor VII activating protease measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0004619	EFO_0004619	factor VII measurement	5	35
http://www.ebi.ac.uk/efo/EFO_0004630	EFO_0004630	factor VIII measurement	4	52
http://www.ebi.ac.uk/efo/EFO_0004694	EFO_0004694	factor XI measurement	3	9
http://purl.obolibrary.org/obo/MONDO_0001336	MONDO_0001336	familial hyperlipidemia	5	437
http://www.ebi.ac.uk/efo/EFO_0000493	EFO_0000493	family history	128	7
http://www.ebi.ac.uk/efo/EFO_0009268	EFO_0009268	family history of Alzheimer’s disease	19	225
http://www.ebi.ac.uk/efo/EFO_0005606	EFO_0005606	family history of breast cancer	2	1
http://www.ebi.ac.uk/efo/EFO_0006953	EFO_0006953	family history of lung cancer	9	14
http://www.ebi.ac.uk/efo/EFO_0004465	EFO_0004465	fasting blood glucose measurement	64	420
http://www.ebi.ac.uk/efo/EFO_0004466	EFO_0004466	fasting blood insulin measurement	39	165
http://www.ebi.ac.uk/efo/EFO_0005409	EFO_0005409	fat body mass	61	46
http://www.ebi.ac.uk/efo/EFO_0010809	EFO_0010809	fat intake measurement	38	20
http://www.ebi.ac.uk/efo/EFO_0005110	EFO_0005110	fatty acid measurement	131	1114
http://www.ebi.ac.uk/efo/EFO_0009588	EFO_0009588	"feeling ""fed-up"" measurement"	4	101
http://www.ebi.ac.uk/efo/EFO_0009599	EFO_0009599	feeling emotionally hurt measurement	1	162
http://www.ebi.ac.uk/efo/EFO_0009598	EFO_0009598	feeling miserable measurement	6	181
http://www.ebi.ac.uk/efo/EFO_0009597	EFO_0009597	feeling nervous measurement	7	453
http://www.ebi.ac.uk/efo/EFO_0009596	EFO_0009596	feeling tense measurement	4	70
http://www.ebi.ac.uk/efo/EFO_0004511	EFO_0004511	femoral neck bone geometry	6	8
http://www.ebi.ac.uk/efo/EFO_0007785	EFO_0007785	femoral neck bone mineral density	24	125
http://www.ebi.ac.uk/efo/EFO_0010076	EFO_0010076	femoral neck size	1	5
http://www.ebi.ac.uk/efo/EFO_0004459	EFO_0004459	ferritin measurement	11	296
http://www.ebi.ac.uk/efo/EFO_0006923	EFO_0006923	fertility measurement	18	7
http://www.ebi.ac.uk/efo/EFO_0007959	EFO_0007959	fetal genotype effect measurement	15	144
http://www.ebi.ac.uk/efo/EFO_0004576	EFO_0004576	fetal hemoglobin measurement	6	17
http://www.ebi.ac.uk/efo/EFO_0008128	EFO_0008128	fetuin-B measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0004623	EFO_0004623	fibrinogen measurement	17	187
http://www.ebi.ac.uk/efo/EFO_0020376	EFO_0020376	fibroblast growth factor 10 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0010782	EFO_0010782	fibroblast growth factor 19 measurement	4	14
http://www.ebi.ac.uk/efo/EFO_0008129	EFO_0008129	fibroblast growth factor 2 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0009381	EFO_0009381	fibroblast growth factor 23 measurement	6	56
http://www.ebi.ac.uk/efo/EFO_0010784	EFO_0010784	fibroblast growth factor 5 measurement	3	3
http://www.ebi.ac.uk/efo/EFO_0020384	EFO_0020384	fibroblast growth factor 7 measurement	3	6
http://www.ebi.ac.uk/efo/EFO_0020390	EFO_0020390	fibroblast growth factor receptor 3 measurement	3	6
http://www.ebi.ac.uk/efo/EFO_0008131	EFO_0008131	fibronectin fragment 3 measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008132	EFO_0008132	fibronectin fragment 4 measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008133	EFO_0008133	fibronectin measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008134	EFO_0008134	ficolin-1 measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008135	EFO_0008135	ficolin-2 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0020392	EFO_0020392	ficolin-3 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010139	EFO_0010139	fish consumption measurement	8	8
http://www.ebi.ac.uk/efo/EFO_0600007	EFO_0600007	fish oil supplement exposure measurement	9	15
http://www.ebi.ac.uk/efo/EFO_0007671	EFO_0007671	folding of antihelix	1	2
http://www.ebi.ac.uk/efo/EFO_0005111	EFO_0005111	folic acid measurement	3	142
http://www.ebi.ac.uk/efo/EFO_0004768	EFO_0004768	follicle stimulating hormone measurement	6	2
http://purl.obolibrary.org/obo/MONDO_0018906	MONDO_0018906	follicular lymphoma	7	1
http://www.ebi.ac.uk/efo/EFO_0010614	EFO_0010614	follistatin measurement	2	23
http://www.ebi.ac.uk/efo/EFO_0007016	EFO_0007016	food allergy measurement	7	5
http://www.ebi.ac.uk/efo/EFO_0004314	EFO_0004314	forced expiratory volume	53	716
http://www.ebi.ac.uk/efo/EFO_0009285	EFO_0009285	fractional shortening	1	20
http://www.ebi.ac.uk/efo/EFO_0009885	EFO_0009885	frailty measurement	2	55
http://www.ebi.ac.uk/efo/EFO_0003963	EFO_0003963	freckles	5	18
http://www.ebi.ac.uk/efo/EFO_0020959	EFO_0020959	free brassicasterol measurement	4	4
http://www.ebi.ac.uk/efo/EFO_0020905	EFO_0020905	free cholesterol change measurement	30	6
http://www.ebi.ac.uk/efo/EFO_0008591	EFO_0008591	free cholesterol measurement	66	1171
http://www.ebi.ac.uk/efo/EFO_0020945	EFO_0020945	free cholesterol:total lipids ratio	14	1220
http://www.ebi.ac.uk/efo/EFO_0020961	EFO_0020961	free lanosterol measurement	8	4
http://www.ebi.ac.uk/efo/EFO_0009855	EFO_0009855	frontal fibrosing alopecia	1	54
http://www.ebi.ac.uk/efo/EFO_0004800	EFO_0004800	frontal theta oscillation measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0009303	EFO_0009303	fructosamine measurement	3	25
http://www.ebi.ac.uk/efo/EFO_0007849	EFO_0007849	functional brain measurement	41	46
http://www.ebi.ac.uk/efo/EFO_0007680	EFO_0007680	gait measurement	7	298
http://www.ebi.ac.uk/efo/EFO_0008136	EFO_0008136	galactoside 34-L-fucosyltransferase measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0010615	EFO_0010615	galanin peptides measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0020932	EFO_0020932	galectin-1 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0008137	EFO_0008137	galectin-3 measurement	3	52
http://www.ebi.ac.uk/efo/EFO_0004606	EFO_0004606	gallbladder neoplasm	3	3
http://www.ebi.ac.uk/efo/EFO_0004210	EFO_0004210	gallstones	12	135
http://www.ebi.ac.uk/efo/EFO_0007762	EFO_0007762	gamma-linolenic acid measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0600005	EFO_0600005	ganglion cell inner plexiform layer thickness measurement	1	69
http://www.ebi.ac.uk/efo/EFO_0007628	EFO_0007628	gas trapping measurement	1	67
http://www.ebi.ac.uk/efo/EFO_0000503	EFO_0000503	gastric adenocarcinoma	1	15
http://www.ebi.ac.uk/efo/EFO_0000178	EFO_0000178	gastric carcinoma	18	77
http://www.ebi.ac.uk/efo/EFO_1001252	EFO_1001252	gastric cardia carcinoma	1	5
http://www.ebi.ac.uk/efo/EFO_0003948	EFO_0003948	gastroesophageal reflux disease	22	132
http://www.ebi.ac.uk/efo/EFO_0005917	EFO_0005917	generalised epilepsy	2	24
http://www.ebi.ac.uk/efo/EFO_1001892	EFO_1001892	generalized anxiety disorder	6	32
http://www.ebi.ac.uk/efo/EFO_0010233	EFO_0010233	genotoxic compound exposure measurement	14	3
http://www.ebi.ac.uk/efo/EFO_0010080	EFO_0010080	geographic atrophy lesion growth	1	5
http://www.ebi.ac.uk/efo/EFO_0005112	EFO_0005112	gestational age	12	137
http://www.ebi.ac.uk/efo/EFO_0009698	EFO_0009698	gestational blood glucose measurement	11	97
http://www.ebi.ac.uk/efo/EFO_0004593	EFO_0004593	gestational diabetes	7	3
http://www.ebi.ac.uk/efo/EFO_0007964	EFO_0007964	gestational serum measurement	8	5
http://www.ebi.ac.uk/efo/EFO_0600001	EFO_0600001	ghrelin measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0000516	EFO_0000516	glaucoma	37	92
http://www.ebi.ac.uk/efo/EFO_0000519	EFO_0000519	glioblastoma multiforme	4	56
http://www.ebi.ac.uk/efo/EFO_0005543	EFO_0005543	glioma	18	91
http://www.ebi.ac.uk/efo/EFO_0005208	EFO_0005208	glomerular filtration rate	54	2544
http://purl.obolibrary.org/obo/MONDO_0002462	MONDO_0002462	glomerulonephritis	4	156
http://www.ebi.ac.uk/efo/EFO_0008465	EFO_0008465	glucagon-like peptide-1 measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0020881	EFO_0020881	glucose change measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0004468	EFO_0004468	glucose measurement	37	652
http://www.ebi.ac.uk/efo/EFO_0009392	EFO_0009392	glucose metabolism decline measurement	6	7
http://www.ebi.ac.uk/efo/EFO_0004307	EFO_0004307	glucose tolerance test	23	107
http://www.ebi.ac.uk/efo/EFO_0008464	EFO_0008464	glucose-dependent insulinotropic peptide measurement	2	44
http://www.ebi.ac.uk/efo/EFO_0010487	EFO_0010487	glutamate measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0009768	EFO_0009768	glutamine measurement	7	180
http://www.ebi.ac.uk/efo/EFO_0007630	EFO_0007630	glycerophospholipid measurement	69	84
http://www.ebi.ac.uk/efo/EFO_0009767	EFO_0009767	glycine measurement	18	187
http://www.ebi.ac.uk/efo/EFO_0020896	EFO_0020896	glycoprotein change measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0004555	EFO_0004555	glycoprotein measurement	6	426
http://www.ebi.ac.uk/efo/EFO_0008139	EFO_0008139	glypican-5 measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0004283	EFO_0004283	goiter	5	30
http://www.ebi.ac.uk/efo/EFO_0007975	EFO_0007975	gondoic acid measurement	1	16
http://www.ebi.ac.uk/efo/EFO_0004274	EFO_0004274	gout	34	101
http://www.ebi.ac.uk/efo/EFO_0008140	EFO_0008140	gp41 C34 peptide, HIV measurement	1	200
http://www.ebi.ac.uk/efo/EFO_0009403	EFO_0009403	granule cell layer dentate gyrus volume	2	13
http://www.ebi.ac.uk/efo/EFO_0008141	EFO_0008141	granulins measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0008142	EFO_0008142	granulocyte colony-stimulating factor measurement	4	9
http://www.ebi.ac.uk/efo/EFO_0007987	EFO_0007987	granulocyte count	5	644
http://www.ebi.ac.uk/efo/EFO_0007997	EFO_0007997	granulocyte percentage of myeloid white cells	1	701
http://www.ebi.ac.uk/efo/EFO_0008144	EFO_0008144	granulysin measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0008145	EFO_0008145	granzyme A measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0020420	EFO_0020420	grb2-related adapter protein 2 measurement	4	9
http://www.ebi.ac.uk/efo/EFO_0005420	EFO_0005420	grey matter volume measurement	5	1
http://www.ebi.ac.uk/efo/EFO_0006941	EFO_0006941	grip strength measurement	29	717
http://www.ebi.ac.uk/efo/EFO_0009181	EFO_0009181	growth differentiation factor 15 measurement	5	48
http://www.ebi.ac.uk/efo/EFO_0008146	EFO_0008146	growth-regulated alpha protein measurement	2	14
http://www.ebi.ac.uk/efo/EFO_0020430	EFO_0020430	growth/differentiation factor 9 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0009595	EFO_0009595	guilt measurement	3	116
http://www.ebi.ac.uk/efo/EFO_0007874	EFO_0007874	gut microbiome measurement	2305	1261
http://www.ebi.ac.uk/efo/EFO_0003924	EFO_0003924	hair color	21	577
http://www.ebi.ac.uk/efo/EFO_0007822	EFO_0007822	hair colour measurement	27	118
http://www.ebi.ac.uk/efo/EFO_0005038	EFO_0005038	hair morphology	3	4
http://www.ebi.ac.uk/efo/EFO_0007821	EFO_0007821	hair morphology measurement	4	8
http://www.ebi.ac.uk/efo/EFO_0007824	EFO_0007824	hair shape measurement	3	65
http://www.ebi.ac.uk/efo/EFO_0009902	EFO_0009902	handedness	15	72
http://www.ebi.ac.uk/efo/EFO_0004640	EFO_0004640	haptoglobin measurement	8	16
http://www.ebi.ac.uk/efo/EFO_0006859	EFO_0006859	head and neck malignant neoplasia	5	35
http://www.ebi.ac.uk/efo/EFO_0000181	EFO_0000181	head and neck squamous cell carcinoma	2	98
http://www.ebi.ac.uk/efo/EFO_0005114	EFO_0005114	head circumference	1	132
http://www.ebi.ac.uk/efo/EFO_0010130	EFO_0010130	health study participation	29	26
http://www.ebi.ac.uk/efo/EFO_0011014	EFO_0011014	health-related quality of life measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0009762	EFO_0009762	healthspan	2	3
http://www.ebi.ac.uk/efo/EFO_0004238	EFO_0004238	hearing loss	22	26
http://www.ebi.ac.uk/efo/EFO_0007616	EFO_0007616	hearing measurement	37	3
http://www.ebi.ac.uk/efo/EFO_0008365	EFO_0008365	heart amyloid deposition measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0003144	EFO_0003144	heart failure	20	49
http://www.ebi.ac.uk/efo/EFO_0004311	EFO_0004311	heart function measurement	9	43
http://www.ebi.ac.uk/efo/EFO_0004326	EFO_0004326	heart rate	25	242
http://www.ebi.ac.uk/efo/EFO_0009184	EFO_0009184	heart rate response to exercise	7	62
http://www.ebi.ac.uk/efo/EFO_0009185	EFO_0009185	heart rate response to recovery post exercise	6	56
http://www.ebi.ac.uk/efo/EFO_0008003	EFO_0008003	heart rate variability measurement	7	44
http://purl.obolibrary.org/obo/MONDO_0002078	MONDO_0002078	heart septal defect	1	2
http://www.ebi.ac.uk/efo/EFO_0010915	EFO_0010915	heat shock 27 kDa protein measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0009270	EFO_0009270	heel bone mineral density	26	3134
http://www.ebi.ac.uk/efo/EFO_0005201	EFO_0005201	height growth measurement	3	6
http://www.ebi.ac.uk/efo/EFO_0005851	EFO_0005851	height-adjusted body mass index	1	5
http://www.ebi.ac.uk/efo/EFO_0007670	EFO_0007670	helix rolling	1	4
http://www.ebi.ac.uk/efo/EFO_0008538	EFO_0008538	helping behavior measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004348	EFO_0004348	hematocrit	40	2386
http://www.ebi.ac.uk/efo/EFO_0004503	EFO_0004503	hematological measurement	6	118
http://www.ebi.ac.uk/efo/EFO_0007629	EFO_0007629	hemoglobin A1 measurement	7	1331
http://www.ebi.ac.uk/efo/EFO_0004509	EFO_0004509	hemoglobin measurement	52	2563
http://www.ebi.ac.uk/efo/EFO_0008148	EFO_0008148	hemojuvelin measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0009473	EFO_0009473	hemolysis	13	74
http://www.ebi.ac.uk/efo/EFO_0009552	EFO_0009552	hemorrhoid	31	1
http://www.ebi.ac.uk/efo/EFO_0008150	EFO_0008150	heparin cofactor 2 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0008151	EFO_0008151	hepatitis A virus cellular receptor 2 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0004197	EFO_0004197	hepatitis B virus infection	9	112
http://www.ebi.ac.uk/efo/EFO_0005129	EFO_0005129	hepatitis C induced liver cirrhosis	1	19
http://www.ebi.ac.uk/efo/EFO_0003047	EFO_0003047	hepatitis C virus infection	7	28
http://www.ebi.ac.uk/efo/EFO_0000182	EFO_0000182	hepatocellular carcinoma	21	113
http://www.ebi.ac.uk/efo/EFO_0006903	EFO_0006903	hepatocyte growth factor measurement	7	28
http://www.ebi.ac.uk/efo/EFO_0008153	EFO_0008153	hepatocyte growth factor receptor measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0007902	EFO_0007902	hepcidin:transferrin saturation ratio	1	6
http://www.ebi.ac.uk/efo/EFO_0006513	EFO_0006513	hereditary hemochromatosis type 1	1	3
http://www.ebi.ac.uk/efo/EFO_0004240	EFO_0004240	heroin dependence	3	3
http://www.ebi.ac.uk/efo/EFO_0007631	EFO_0007631	hexose measurement	2	7
http://www.ebi.ac.uk/efo/EFO_0004612	EFO_0004612	high density lipoprotein cholesterol measurement	356	3635
http://www.ebi.ac.uk/efo/EFO_0008592	EFO_0008592	high density lipoprotein particle size measurement	4	478
http://www.ebi.ac.uk/efo/EFO_0007702	EFO_0007702	hip bone mineral density	14	36
http://www.ebi.ac.uk/efo/EFO_0004844	EFO_0004844	hip bone size	5	96
http://www.ebi.ac.uk/efo/EFO_0005093	EFO_0005093	hip circumference	13	330
http://www.ebi.ac.uk/efo/EFO_0004685	EFO_0004685	hip geometry	2	17
http://www.ebi.ac.uk/efo/EFO_0007942	EFO_0007942	hip osteoarthritis symptom severity measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0009394	EFO_0009394	hippocampal CA1 volume	2	10
http://www.ebi.ac.uk/efo/EFO_0009395	EFO_0009395	hippocampal CA3 volume	2	8
http://www.ebi.ac.uk/efo/EFO_0009396	EFO_0009396	hippocampal CA4 volume	2	11
http://www.ebi.ac.uk/efo/EFO_0009401	EFO_0009401	hippocampal amigdala transition area volume	2	3
http://www.ebi.ac.uk/efo/EFO_0005039	EFO_0005039	hippocampal atrophy	4	10
http://www.ebi.ac.uk/efo/EFO_0009404	EFO_0009404	hippocampal fissure volume	2	2
http://www.ebi.ac.uk/efo/EFO_0005678	EFO_0005678	hippocampal sclerosis of aging	2	3
http://www.ebi.ac.uk/efo/EFO_0009398	EFO_0009398	hippocampal tail volume	2	19
http://www.ebi.ac.uk/efo/EFO_0005035	EFO_0005035	hippocampal volume	30	37
http://www.ebi.ac.uk/efo/EFO_0009397	EFO_0009397	hippocampus molecular layer volume	2	11
http://www.ebi.ac.uk/efo/EFO_0020886	EFO_0020886	histidine change measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0009769	EFO_0009769	histidine measurement	7	125
http://www.ebi.ac.uk/efo/EFO_0004578	EFO_0004578	homocysteine measurement	12	223
http://www.ebi.ac.uk/efo/EFO_0004730	EFO_0004730	hormone measurement	22	252
http://www.ebi.ac.uk/efo/EFO_0003961	EFO_0003961	hormone replacement therapy	11	2
http://www.ebi.ac.uk/efo/EFO_0009695	EFO_0009695	household income	5	442
http://www.ebi.ac.uk/efo/EFO_0008156	EFO_0008156	human Chorionic Gonadotropin measurement	1	17
http://www.ebi.ac.uk/efo/EFO_0007048	EFO_0007048	human herpesvirus 6 seropositivity	9	19
http://www.ebi.ac.uk/efo/EFO_0001668	EFO_0001668	human papilloma virus infection	6	2
http://www.ebi.ac.uk/efo/EFO_0005276	EFO_0005276	hydroxy-leucine measurement	1	3
http://www.ebi.ac.uk/efo/EFO_1000971	EFO_1000971	hyperemesis gravidarum	2	7
http://www.ebi.ac.uk/efo/EFO_0005246	EFO_0005246	hypersomnia	3	6
http://www.ebi.ac.uk/efo/EFO_0000537	EFO_0000537	hypertension	63	689
http://www.ebi.ac.uk/efo/EFO_0000538	EFO_0000538	hypertrophic cardiomyopathy	8	108
http://www.ebi.ac.uk/efo/EFO_0009104	EFO_0009104	hyperuricemia	4	10
http://www.ebi.ac.uk/efo/EFO_0007321	EFO_0007321	hypopharynx cancer	1	2
http://www.ebi.ac.uk/efo/EFO_0004209	EFO_0004209	hypospadias	3	51
http://www.ebi.ac.uk/efo/EFO_0004705	EFO_0004705	hypothyroidism	22	343
http://www.ebi.ac.uk/efo/EFO_0009094	EFO_0009094	idiopathic dilated cardiomyopathy	1	4
http://www.ebi.ac.uk/efo/EFO_1001930	EFO_1001930	idiopathic osteonecrosis of the femoral head	7	16
http://www.ebi.ac.uk/efo/EFO_0000768	EFO_0000768	idiopathic pulmonary fibrosis	6	108
http://www.ebi.ac.uk/efo/EFO_0005624	EFO_0005624	ileocolitis	1	1
http://www.ebi.ac.uk/efo/EFO_0005431	EFO_0005431	illegal drug consumption	2	3
http://www.ebi.ac.uk/efo/EFO_0000540	EFO_0000540	immune system disease	3	44
http://www.ebi.ac.uk/efo/EFO_0010128	EFO_0010128	immunoglobulin isotype switching measurement	5	45
http://www.ebi.ac.uk/efo/EFO_0006785	EFO_0006785	infant body height	1	102
http://www.ebi.ac.uk/efo/EFO_0006316	EFO_0006316	infant expressive language ability	1	1
http://www.ebi.ac.uk/efo/EFO_0004577	EFO_0004577	infant head circumference	3	25
http://www.ebi.ac.uk/efo/EFO_0008370	EFO_0008370	infant white matter volume measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0004707	EFO_0004707	infantile hypertrophic pyloric stenosis	3	16
http://www.ebi.ac.uk/efo/EFO_0004872	EFO_0004872	inflammatory biomarker measurement	4	130
http://www.ebi.ac.uk/efo/EFO_0003767	EFO_0003767	inflammatory bowel disease	29	759
http://purl.obolibrary.org/obo/GO_0006954	GO_0006954	inflammatory response	1	23
http://www.ebi.ac.uk/efo/EFO_1000636	EFO_1000636	inflammatory skin disease	1	47
http://www.ebi.ac.uk/efo/EFO_1001488	EFO_1001488	influenza A (H1N1)	3	134
http://www.ebi.ac.uk/efo/EFO_0004363	EFO_0004363	information processing speed	17	13
http://www.ebi.ac.uk/efo/EFO_0008157	EFO_0008157	inorganic pyrophosphatase measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008158	EFO_0008158	inosine-5'-monophosphate dehydrogenase 1 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008159	EFO_0008159	inosine-5'-monophosphate dehydrogenase 2 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004698	EFO_0004698	insomnia	27	6
http://www.ebi.ac.uk/efo/EFO_0007876	EFO_0007876	insomnia measurement	9	830
http://www.ebi.ac.uk/efo/EFO_0004628	EFO_0004628	insulin like growth factor measurement	9	2
http://www.ebi.ac.uk/efo/EFO_0004467	EFO_0004467	insulin measurement	28	164
http://www.ebi.ac.uk/efo/EFO_0008160	EFO_0008160	insulin receptor measurement	1	16
http://www.ebi.ac.uk/efo/EFO_0002614	EFO_0002614	insulin resistance	16	2
http://www.ebi.ac.uk/efo/EFO_0008473	EFO_0008473	insulin response measurement	6	9
http://www.ebi.ac.uk/efo/EFO_0004471	EFO_0004471	insulin sensitivity measurement	11	153
http://www.ebi.ac.uk/efo/EFO_0008161	EFO_0008161	insulin-like growth factor-binding protein 7 measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008162	EFO_0008162	integrin alpha-I: beta-1 complex measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0004337	EFO_0004337	intelligence	34	1730
http://www.ebi.ac.uk/efo/EFO_0008163	EFO_0008163	intercellular adhesion molecule 2 measurement	3	21
http://www.ebi.ac.uk/efo/EFO_0008164	EFO_0008164	intercellular adhesion molecule 5 measurement	3	34
http://www.ebi.ac.uk/efo/EFO_0006517	EFO_0006517	interferon alpha measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0020483	EFO_0020483	interferon alpha-2 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0008165	EFO_0008165	interferon gamma measurement	7	5
http://www.ebi.ac.uk/efo/EFO_0020484	EFO_0020484	interferon gamma receptor 1 measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0004754	EFO_0004754	interleukin 1 receptor antagonist measurement	6	29
http://www.ebi.ac.uk/efo/EFO_0008169	EFO_0008169	interleukin 1 receptor-like 2 measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004750	EFO_0004750	interleukin 10 measurement	6	22
http://www.ebi.ac.uk/efo/EFO_0004753	EFO_0004753	interleukin 12 measurement	5	17
http://www.ebi.ac.uk/efo/EFO_0008170	EFO_0008170	interleukin 12 receptor subunit beta-1 measurement	4	7
http://www.ebi.ac.uk/efo/EFO_0008171	EFO_0008171	interleukin 13 measurement	4	2
http://www.ebi.ac.uk/efo/EFO_0008172	EFO_0008172	interleukin 15 receptor subunit alpha measurement	4	4
http://www.ebi.ac.uk/efo/EFO_0008173	EFO_0008173	interleukin 16 measurement	3	19
http://www.ebi.ac.uk/efo/EFO_0008174	EFO_0008174	interleukin 17 measurement	17	2
http://www.ebi.ac.uk/efo/EFO_0008175	EFO_0008175	interleukin 17 receptor A measurement	3	5
http://www.ebi.ac.uk/efo/EFO_0008176	EFO_0008176	interleukin 17 receptor B measurement	4	14
http://www.ebi.ac.uk/efo/EFO_0008177	EFO_0008177	interleukin 17 receptor D measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004581	EFO_0004581	interleukin 18 measurement	8	55
http://www.ebi.ac.uk/efo/EFO_0008178	EFO_0008178	interleukin 18 receptor 1 measurement	4	77
http://www.ebi.ac.uk/efo/EFO_0008179	EFO_0008179	interleukin 18 receptor accessory protein measurement	3	130
http://www.ebi.ac.uk/efo/EFO_0008180	EFO_0008180	interleukin 19 measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008332	EFO_0008332	interleukin 2 receptor antagonist measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008181	EFO_0008181	interleukin 23 receptor measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0008183	EFO_0008183	interleukin 27 receptor subunit alpha measurement	2	28
http://www.ebi.ac.uk/efo/EFO_0008185	EFO_0008185	interleukin 5 measurement	4	11
http://www.ebi.ac.uk/efo/EFO_0008186	EFO_0008186	interleukin 5 receptor subunit alpha measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0008187	EFO_0008187	interleukin 6 receptor subunit alpha measurement	6	11
http://www.ebi.ac.uk/efo/EFO_0008188	EFO_0008188	interleukin 6 receptor subunit beta measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0008189	EFO_0008189	interleukin 7 measurement	5	9
http://www.ebi.ac.uk/efo/EFO_0008190	EFO_0008190	interleukin 7 receptor subunit alpha measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0008191	EFO_0008191	interleukin 8 measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0008192	EFO_0008192	interleukin 9 measurement	4	3
http://www.ebi.ac.uk/efo/EFO_0004812	EFO_0004812	interleukin-1 beta measurement	5	64
http://www.ebi.ac.uk/efo/EFO_0020487	EFO_0020487	interleukin-1 receptor type 1 measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0010786	EFO_0010786	interleukin-10 receptor B measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0020491	EFO_0020491	interleukin-11 receptor subunit alpha measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0020492	EFO_0020492	interleukin-12 receptor subunit beta-2 measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0020493	EFO_0020493	interleukin-13 receptor subunit alpha-1 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0020498	EFO_0020498	interleukin-22 measurement	3	14
http://www.ebi.ac.uk/efo/EFO_0020499	EFO_0020499	interleukin-22 receptor subunit alpha-1 measurement	3	4
http://www.ebi.ac.uk/efo/EFO_0020500	EFO_0020500	interleukin-22 receptor subunit alpha-2 measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0010916	EFO_0010916	interleukin-27 measurement	2	62
http://www.ebi.ac.uk/efo/EFO_0020504	EFO_0020504	interleukin-3 receptor subunit alpha measurement	3	14
http://www.ebi.ac.uk/efo/EFO_0600070	EFO_0600070	interleukin-6 gene expression measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0004810	EFO_0004810	interleukin-6 measurement	24	169
http://www.ebi.ac.uk/efo/EFO_0004814	EFO_0004814	interleukin-6 receptor measurement	4	6
http://www.ebi.ac.uk/efo/EFO_0004811	EFO_0004811	interleukin-8 measurement	5	1
http://www.ebi.ac.uk/efo/EFO_0008595	EFO_0008595	intermediate density lipoprotein measurement	43	951
http://www.ebi.ac.uk/efo/EFO_0007758	EFO_0007758	intermittent Staphylococcus aureus carrier status	1	4
http://www.ebi.ac.uk/efo/EFO_0008193	EFO_0008193	interstitial collagenase measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0004244	EFO_0004244	interstitial lung disease	15	52
http://www.ebi.ac.uk/efo/EFO_0010075	EFO_0010075	intertrochanteric region size	1	10
http://www.ebi.ac.uk/efo/EFO_0009702	EFO_0009702	intra-individual reaction time variability measurement	2	1
http://www.ebi.ac.uk/efo/EFO_0005669	EFO_0005669	intracerebral hemorrhage	14	12
http://www.ebi.ac.uk/efo/EFO_0004886	EFO_0004886	intracranial volume measurement	6	25
http://www.ebi.ac.uk/efo/EFO_0004695	EFO_0004695	intraocular pressure measurement	28	905
http://www.ebi.ac.uk/efo/EFO_0004461	EFO_0004461	iron biomarker measurement	16	121
http://www.ebi.ac.uk/efo/EFO_0009594	EFO_0009594	irritability measurement	12	119
http://www.ebi.ac.uk/efo/EFO_0000555	EFO_0000555	irritable bowel syndrome	27	158
http://www.ebi.ac.uk/efo/EFO_0009793	EFO_0009793	isoleucine measurement	7	62
http://www.ebi.ac.uk/efo/EFO_0007881	EFO_0007881	job-related exhaustion measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0005413	EFO_0005413	joint damage measurement	11	3
http://www.ebi.ac.uk/efo/EFO_0000557	EFO_0000557	juvenile dermatomyositis	1	19
http://www.ebi.ac.uk/efo/EFO_0002609	EFO_0002609	juvenile idiopathic arthritis	12	73
http://www.ebi.ac.uk/efo/EFO_0010573	EFO_0010573	kallikrein-11 measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0008194	EFO_0008194	kallikrein-12 measurement	1	13
http://www.ebi.ac.uk/efo/EFO_0020515	EFO_0020515	kallikrein-5 measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0008195	EFO_0008195	kallikrein-7 measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0010622	EFO_0010622	kallikrein‐6 measurement	2	78
http://www.ebi.ac.uk/efo/EFO_0008196	EFO_0008196	kallistatin measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0010176	EFO_0010176	keratinocyte carcinoma	3	273
http://purl.obolibrary.org/obo/MONDO_0002367	MONDO_0002367	kidney cancer	1	11
http://www.ebi.ac.uk/efo/EFO_0003086	EFO_0003086	kidney disease	14	159
http://www.ebi.ac.uk/efo/EFO_0600044	EFO_0600044	kidney volume	1	28
http://www.ebi.ac.uk/efo/EFO_0008197	EFO_0008197	killer cell immunoglobulin-like receptor 2DL4 measurement	1	95
http://www.ebi.ac.uk/efo/EFO_0020521	EFO_0020521	kin of IRRE-like protein 3 measurement	3	22
http://www.ebi.ac.uk/efo/EFO_0008201	EFO_0008201	kynureninase measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008529	EFO_0008529	kynurenine measurement	3	12
http://www.ebi.ac.uk/efo/EFO_0008203	EFO_0008203	lactadherin measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0020882	EFO_0020882	lactate change measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0007745	EFO_0007745	lactate measurement	6	38
http://www.ebi.ac.uk/efo/EFO_0005425	EFO_0005425	language impairment	5	26
http://www.ebi.ac.uk/efo/EFO_0007797	EFO_0007797	language measurement	10	41
http://www.ebi.ac.uk/efo/EFO_0005524	EFO_0005524	large artery stroke	15	16
http://www.ebi.ac.uk/efo/EFO_0006352	EFO_0006352	laryngeal squamous cell carcinoma	2	129
http://www.ebi.ac.uk/efo/EFO_1001870	EFO_1001870	late-onset Alzheimers disease	8	57
http://www.ebi.ac.uk/efo/EFO_1001490	EFO_1001490	late-onset myasthenia gravis	2	17
http://www.ebi.ac.uk/efo/EFO_0009706	EFO_0009706	latent autoimmune diabetes in adults	3	37
http://www.ebi.ac.uk/efo/EFO_0008487	EFO_0008487	lateral ventricle volume measurement	3	17
http://www.ebi.ac.uk/efo/EFO_0008372	EFO_0008372	laterality measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0004995	EFO_0004995	lean body mass	69	157
http://www.ebi.ac.uk/efo/EFO_0009890	EFO_0009890	lean mass-adjusted fat body mass	4	5
http://www.ebi.ac.uk/efo/EFO_0010918	EFO_0010918	lectin-like oxidized LDL receptor 1 measurement	1	47
http://www.ebi.ac.uk/efo/EFO_0004294	EFO_0004294	left atrial function	4	45
http://www.ebi.ac.uk/efo/EFO_0600035	EFO_0600035	left atrial volume measurement	2	7
http://www.ebi.ac.uk/efo/EFO_0006793	EFO_0006793	left inferior lateral ventricle volume measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008204	EFO_0008204	left ventricular diastolic function measurement	19	21
http://www.ebi.ac.uk/efo/EFO_0008373	EFO_0008373	left ventricular ejection fraction measurement	8	66
http://www.ebi.ac.uk/efo/EFO_0008205	EFO_0008205	left ventricular structural measurement	16	90
http://www.ebi.ac.uk/efo/EFO_0008206	EFO_0008206	left ventricular systolic function measurement	8	19
http://www.ebi.ac.uk/efo/EFO_0004913	EFO_0004913	lentiform nucleus measurement	3	3
http://www.ebi.ac.uk/efo/EFO_0001054	EFO_0001054	leprosy	8	120
http://www.ebi.ac.uk/efo/EFO_0005000	EFO_0005000	leptin measurement	22	151
http://www.ebi.ac.uk/efo/EFO_0004635	EFO_0004635	leptin receptor measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0008207	EFO_0008207	leucine carboxyl methyltransferase 1 measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0009770	EFO_0009770	leucine measurement	7	104
http://www.ebi.ac.uk/efo/EFO_0010788	EFO_0010788	leukemia inhibitory factor receptor measurement	3	13
http://www.ebi.ac.uk/efo/EFO_0004308	EFO_0004308	leukocyte count	140	3475
http://www.ebi.ac.uk/efo/EFO_0008209	EFO_0008209	leukocyte immunoglobulin-like receptor subfamily B member 2 measurement	1	47
http://www.ebi.ac.uk/efo/EFO_0004233	EFO_0004233	leukopenia	10	6
http://www.ebi.ac.uk/efo/EFO_0010724	EFO_0010724	lifestyle measurement	23	590
http://www.ebi.ac.uk/efo/EFO_1001017	EFO_1001017	limited scleroderma	3	5
http://www.ebi.ac.uk/efo/EFO_0006807	EFO_0006807	linoleic acid measurement	10	548
http://www.ebi.ac.uk/efo/EFO_0006811	EFO_0006811	linolenic acid measurement	1	37
http://www.ebi.ac.uk/efo/EFO_0007845	EFO_0007845	lip morphology measurement	63	17
http://www.ebi.ac.uk/efo/EFO_0020859	EFO_0020859	lipid change measurement	29	2
http://www.ebi.ac.uk/efo/EFO_0004529	EFO_0004529	lipid measurement	65	1479
http://www.ebi.ac.uk/efo/EFO_0006925	EFO_0006925	lipoprotein A measurement	19	34
http://www.ebi.ac.uk/efo/EFO_0004732	EFO_0004732	lipoprotein measurement	12	579
http://www.ebi.ac.uk/efo/EFO_0008432	EFO_0008432	lipoprotein-associated phospholipase A(2) change measurement	2	21
http://www.ebi.ac.uk/efo/EFO_0004746	EFO_0004746	lipoprotein-associated phospholipase A(2) measurement	6	80
http://www.ebi.ac.uk/efo/EFO_0008374	EFO_0008374	liver amyloid deposition measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0006845	EFO_0006845	liver disease biomarker	3	80
http://www.ebi.ac.uk/efo/EFO_0004582	EFO_0004582	liver enzyme measurement	1	53
http://www.ebi.ac.uk/efo/EFO_0010821	EFO_0010821	liver fat measurement	6	102
http://www.ebi.ac.uk/efo/EFO_0010576	EFO_0010576	liver fibrosis measurement	8	170
http://www.ebi.ac.uk/efo/EFO_0010056	EFO_0010056	liver iron measurement	2	90
http://www.ebi.ac.uk/efo/EFO_1001513	EFO_1001513	liver neoplasm	5	36
http://www.ebi.ac.uk/efo/EFO_0600048	EFO_0600048	liver volume	1	40
http://www.ebi.ac.uk/efo/EFO_0010177	EFO_0010177	lobar intracerebral hemorrhage	2	9
http://www.ebi.ac.uk/efo/EFO_0007667	EFO_0007667	lobe attachment	3	8
http://www.ebi.ac.uk/efo/EFO_0007666	EFO_0007666	lobe size	1	7
http://www.ebi.ac.uk/efo/EFO_0007865	EFO_0007865	loneliness measurement	11	53
http://www.ebi.ac.uk/efo/EFO_0004300	EFO_0004300	longevity	24	63
http://www.ebi.ac.uk/efo/EFO_0005937	EFO_0005937	longitudinal BMI measurement	18	13
http://www.ebi.ac.uk/efo/EFO_0007645	EFO_0007645	longitudinal alcohol consumption measurement	10	49
http://www.ebi.ac.uk/efo/EFO_0008210	EFO_0008210	low affinity immunoglobulin epsilon Fc receptor measurement	1	12
http://www.ebi.ac.uk/efo/EFO_0008212	EFO_0008212	low affinity immunoglobulin gamma Fc region receptor III-B measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004611	EFO_0004611	low density lipoprotein cholesterol measurement	273	2913
http://www.ebi.ac.uk/efo/EFO_0008593	EFO_0008593	low density lipoprotein particle size measurement	4	229
http://www.ebi.ac.uk/efo/EFO_0009946	EFO_0009946	low density lipoprotein triglyceride measurement	10	34
http://www.ebi.ac.uk/efo/EFO_1001022	EFO_1001022	low tension glaucoma	2	3
http://www.ebi.ac.uk/efo/EFO_0008008	EFO_0008008	lower urinary tract symptom	16	49
http://www.ebi.ac.uk/efo/EFO_0004994	EFO_0004994	lumbar disc degeneration	9	51
http://www.ebi.ac.uk/efo/EFO_1002005	EFO_1002005	lumbar disc herniation	1	1
http://www.ebi.ac.uk/efo/EFO_0000571	EFO_0000571	lung adenocarcinoma	20	304
http://www.ebi.ac.uk/efo/EFO_0001071	EFO_0001071	lung carcinoma	57	922
http://www.ebi.ac.uk/efo/EFO_0009797	EFO_0009797	lung disease associated with cystic fibrosis	1	38
http://www.ebi.ac.uk/efo/EFO_0600046	EFO_0600046	lung volume	1	13
http://www.ebi.ac.uk/efo/EFO_0007002	EFO_0007002	luteinizing hormone measurement	5	1
http://www.ebi.ac.uk/efo/EFO_0004587	EFO_0004587	lymphocyte count	227	3147
http://www.ebi.ac.uk/efo/EFO_0007993	EFO_0007993	lymphocyte percentage of leukocytes	4	1797
http://www.ebi.ac.uk/efo/EFO_0004289	EFO_0004289	lymphoid leukemia	5	29
http://www.ebi.ac.uk/efo/EFO_0000574	EFO_0000574	lymphoma	13	83
http://www.ebi.ac.uk/efo/EFO_0005002	EFO_0005002	lysine measurement	5	39
http://www.ebi.ac.uk/efo/EFO_0020941	EFO_0020941	lysophosphatidylcholine 15:0 measurement	7	3
http://www.ebi.ac.uk/efo/EFO_0010358	EFO_0010358	lysophosphatidylcholine 16:1 measurement	6	9
http://www.ebi.ac.uk/efo/EFO_0010359	EFO_0010359	lysophosphatidylcholine 18:0 measurement	6	8
http://www.ebi.ac.uk/efo/EFO_0010361	EFO_0010361	lysophosphatidylcholine 18:2 measurement	6	17
http://www.ebi.ac.uk/efo/EFO_0010362	EFO_0010362	lysophosphatidylcholine 20:3 measurement	6	33
http://www.ebi.ac.uk/efo/EFO_0010363	EFO_0010363	lysophosphatidylcholine 20:4 measurement	8	13
http://www.ebi.ac.uk/efo/EFO_0010364	EFO_0010364	lysophosphatidylcholine 20:5 measurement	6	10
http://www.ebi.ac.uk/efo/EFO_0010365	EFO_0010365	lysophosphatidylcholine 22:6 measurement	6	8
http://www.ebi.ac.uk/efo/EFO_0010224	EFO_0010224	lysophosphatidylcholine measurement	71	75
http://www.ebi.ac.uk/efo/EFO_0010366	EFO_0010366	lysophosphatidylethanolamine 16:0 measurement	6	3
http://www.ebi.ac.uk/efo/EFO_0010367	EFO_0010367	lysophosphatidylethanolamine 18:0 measurement	6	3
http://www.ebi.ac.uk/efo/EFO_0010369	EFO_0010369	lysophosphatidylethanolamine 18:2 measurement	6	12
http://www.ebi.ac.uk/efo/EFO_0010370	EFO_0010370	lysophosphatidylethanolamine 20:4 measurement	6	14
http://www.ebi.ac.uk/efo/EFO_0010371	EFO_0010371	lysophosphatidylethanolamine 22:6 measurement	6	6
http://www.ebi.ac.uk/efo/EFO_0010225	EFO_0010225	lysophosphatidylethanolamine measurement	35	72
http://www.ebi.ac.uk/efo/EFO_0008215	EFO_0008215	lysosomal protective protein measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008216	EFO_0008216	lysozyme C measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008217	EFO_0008217	macrophage colony stimulating factor measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0008219	EFO_0008219	macrophage inflammatory protein 1b measurement	1	242
http://www.ebi.ac.uk/efo/EFO_0008220	EFO_0008220	macrophage metalloelastase measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008221	EFO_0008221	macrophage migration inhibitory factor measurement	3	3
http://www.ebi.ac.uk/efo/EFO_0008222	EFO_0008222	macrophage scavenger receptor types I and II measurement	1	9
http://www.ebi.ac.uk/efo/EFO_1002009	EFO_1002009	macular telangiectasia type 2	3	5
http://www.ebi.ac.uk/efo/EFO_1001253	EFO_1001253	maculopapular eruption	6	17
http://www.ebi.ac.uk/efo/EFO_0004845	EFO_0004845	magnesium measurement	8	24
http://www.ebi.ac.uk/efo/EFO_0007903	EFO_0007903	magnesium:calcium ratio	1	18
http://www.ebi.ac.uk/efo/EFO_0008449	EFO_0008449	magnesium:creatinine ratio measurement	1	4
http://purl.obolibrary.org/obo/MONDO_0002009	MONDO_0002009	major depressive disorder	18	156
http://www.ebi.ac.uk/efo/EFO_0001068	EFO_0001068	malaria	11	44
http://www.ebi.ac.uk/efo/EFO_0006861	EFO_0006861	male breast carcinoma	2	5
http://www.ebi.ac.uk/efo/EFO_0008486	EFO_0008486	male homosexuality	3	3
http://www.ebi.ac.uk/efo/EFO_0005941	EFO_0005941	mammographic density measurement	7	86
http://www.ebi.ac.uk/efo/EFO_0006502	EFO_0006502	mammographic density percentage	2	37
http://www.ebi.ac.uk/efo/EFO_0007705	EFO_0007705	manic episode measurement	45	2
http://www.ebi.ac.uk/efo/EFO_0008223	EFO_0008223	mannan-binding lectin serine protease 1 measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008224	EFO_0008224	mannose-binding protein C measurement	1	15
http://www.ebi.ac.uk/efo/EFO_1000630	EFO_1000630	marginal zone B-cell lymphoma	4	65
http://www.ebi.ac.uk/efo/EFO_0600067	EFO_0600067	mastiha supplement exposure measurement	7	28
http://www.ebi.ac.uk/efo/EFO_0004875	EFO_0004875	mathematical ability	10	3239
http://www.ebi.ac.uk/efo/EFO_0008227	EFO_0008227	matrilysin measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0010588	EFO_0010588	matrix metalloproteinase 1 measurement	5	29
http://www.ebi.ac.uk/efo/EFO_0010589	EFO_0010589	matrix metalloproteinase 10 measurement	3	6
http://www.ebi.ac.uk/efo/EFO_0010590	EFO_0010590	matrix metalloproteinase 12 measurement	1	74
http://www.ebi.ac.uk/efo/EFO_0010591	EFO_0010591	matrix metalloproteinase 7 measurement	3	76
http://www.ebi.ac.uk/efo/EFO_0008466	EFO_0008466	matrix metalloproteinase 8 measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0004744	EFO_0004744	matrix metalloproteinase measurement	5	81
http://www.ebi.ac.uk/efo/EFO_0011036	EFO_0011036	matrix metalloproteinase–degraded type I collagen measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0004887	EFO_0004887	maximal oxygen uptake measurement	8	161
http://www.ebi.ac.uk/efo/EFO_0008431	EFO_0008431	maximal voluntary ventilation	1	2
http://www.ebi.ac.uk/efo/EFO_0009264	EFO_0009264	maximum cigarettes per day measurement	4	11
http://www.ebi.ac.uk/efo/EFO_0006340	EFO_0006340	mean arterial pressure	17	943
http://www.ebi.ac.uk/efo/EFO_0004527	EFO_0004527	mean corpuscular hemoglobin	39	381
http://www.ebi.ac.uk/efo/EFO_0004528	EFO_0004528	mean corpuscular hemoglobin concentration	51	2141
http://www.ebi.ac.uk/efo/EFO_0004526	EFO_0004526	mean corpuscular volume	47	3208
http://www.ebi.ac.uk/efo/EFO_0008399	EFO_0008399	mean fractional anisotropy measurement	76	100
http://www.ebi.ac.uk/efo/EFO_0004584	EFO_0004584	mean platelet volume	30	2633
http://www.ebi.ac.uk/efo/EFO_0010701	EFO_0010701	mean reticulocyte volume	4	2298
http://www.ebi.ac.uk/efo/EFO_0008228	EFO_0008228	mediator of RNA polymerase II transcription subunit 1 measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0000756	EFO_0000756	melanoma	41	132
http://www.ebi.ac.uk/efo/EFO_0008229	EFO_0008229	melanoma-derived growth regulatory protein measurement	2	10
http://www.ebi.ac.uk/efo/EFO_0010919	EFO_0010919	melusin measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0010920	EFO_0010920	membrane-bound aminopeptidase P measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0004254	EFO_0004254	membranous glomerulonephritis	5	462
http://www.ebi.ac.uk/efo/EFO_0004874	EFO_0004874	memory performance	36	29
http://www.ebi.ac.uk/efo/EFO_0004249	EFO_0004249	meningococcal infection	1	4
http://www.ebi.ac.uk/efo/EFO_0007786	EFO_0007786	menstrual cycle measurement	4	19
http://www.ebi.ac.uk/efo/EFO_0008230	EFO_0008230	mental development measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0000677	EFO_0000677	mental or behavioural disorder	42	7
http://www.ebi.ac.uk/efo/EFO_0004323	EFO_0004323	mental process	1	3
http://www.ebi.ac.uk/efo/EFO_0010906	EFO_0010906	merkel cell virus seropositivity	4	21
http://www.ebi.ac.uk/efo/EFO_0020565	EFO_0020565	mesothelin measurement	2	18
http://www.ebi.ac.uk/efo/EFO_0000589	EFO_0000589	metabolic disease	6	2
http://www.ebi.ac.uk/efo/EFO_0005115	EFO_0005115	metabolic rate measurement	1	132
http://www.ebi.ac.uk/efo/EFO_0000195	EFO_0000195	metabolic syndrome	23	451
http://www.ebi.ac.uk/efo/EFO_0004725	EFO_0004725	metabolite measurement	306	749
http://www.ebi.ac.uk/efo/EFO_0008231	EFO_0008231	metalloproteinase inhibitor 3 measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0007675	EFO_0007675	metastasis measurement	4	40
http://www.ebi.ac.uk/efo/EFO_1001480	EFO_1001480	metastatic colorectal cancer	3	4
http://www.ebi.ac.uk/efo/EFO_0004701	EFO_0004701	methamphetamine dependence	2	3
http://www.ebi.ac.uk/efo/EFO_0008232	EFO_0008232	methionine aminopeptidase 2 measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0009771	EFO_0009771	methionine measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0008511	EFO_0008511	metopic craniosynostosis	1	2
http://www.ebi.ac.uk/efo/EFO_0010316	EFO_0010316	middle temporal gyrus volume measurement	9	14
http://www.ebi.ac.uk/efo/EFO_0008468	EFO_0008468	midregional pro atrial natriuretic peptide measurement	1	9
http://purl.obolibrary.org/obo/MONDO_0005277	MONDO_0005277	migraine disorder	34	600
http://purl.obolibrary.org/obo/MONDO_0005475	MONDO_0005475	migraine with aura	7	18
http://purl.obolibrary.org/obo/MONDO_0011847	MONDO_0011847	migraine without aura, susceptibility to, 4	7	25
http://www.ebi.ac.uk/efo/EFO_0006819	EFO_0006819	mild disease course	1	1
http://www.ebi.ac.uk/efo/EFO_0006312	EFO_0006312	mitochondrial DNA measurement	17	548
http://www.ebi.ac.uk/efo/EFO_0600008	EFO_0600008	mitochondrial heteroplasmy measurement	1	89
http://www.ebi.ac.uk/efo/EFO_0000203	EFO_0000203	monoclonal gammopathy	7	3
http://www.ebi.ac.uk/efo/EFO_0010596	EFO_0010596	monocyte chemotactic protein 1 measurement	2	23
http://www.ebi.ac.uk/efo/EFO_0010789	EFO_0010789	monocyte chemotactic protein-2 measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0010790	EFO_0010790	monocyte chemotactic protein-4 measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0005091	EFO_0005091	monocyte count	44	2294
http://www.ebi.ac.uk/efo/EFO_0007989	EFO_0007989	monocyte percentage of leukocytes	4	2102
http://www.ebi.ac.uk/efo/EFO_0007956	EFO_0007956	monocyte:lymphocyte ratio	1	2
http://www.ebi.ac.uk/efo/EFO_0008236	EFO_0008236	monokine induced by gamma interferon measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0004247	EFO_0004247	mood disorder	16	217
http://www.ebi.ac.uk/efo/EFO_0008475	EFO_0008475	mood instability measurement	11	179
http://www.ebi.ac.uk/efo/EFO_0004352	EFO_0004352	mortality	24	128
http://www.ebi.ac.uk/efo/EFO_0007783	EFO_0007783	mosaic loss of chromosome Y measurement	4	188
http://www.ebi.ac.uk/efo/EFO_0008377	EFO_0008377	mosquito bite reaction itch intensity measurement	3	642
http://www.ebi.ac.uk/efo/EFO_0006928	EFO_0006928	motion sickness	1	41
http://www.ebi.ac.uk/efo/EFO_0010749	EFO_0010749	motor function measurement	4	3
http://www.ebi.ac.uk/efo/EFO_0007955	EFO_0007955	mouth morphology measurement	6	1
http://www.ebi.ac.uk/efo/EFO_0004246	EFO_0004246	mucocutaneous lymph node syndrome	12	73
http://www.ebi.ac.uk/efo/EFO_1001898	EFO_1001898	mucositis	3	10
http://www.ebi.ac.uk/efo/EFO_0009439	EFO_0009439	multiple births measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0001378	EFO_0001378	multiple myeloma	26	109
http://purl.obolibrary.org/obo/MONDO_0005301	MONDO_0005301	multiple sclerosis	57	769
http://www.ebi.ac.uk/efo/EFO_0010100	EFO_0010100	multisite chronic pain	4	97
http://www.ebi.ac.uk/efo/EFO_0004515	EFO_0004515	muscle measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0000198	EFO_0000198	myelodysplastic syndrome	6	6
http://www.ebi.ac.uk/efo/EFO_0007988	EFO_0007988	myeloid white cell count	28	1868
http://www.ebi.ac.uk/efo/EFO_0011039	EFO_0011039	myeloperoxidase (MPO)-DNA complex measurement	2	12
http://www.ebi.ac.uk/efo/EFO_0005243	EFO_0005243	myeloperoxidase measurement	4	161
http://www.ebi.ac.uk/efo/EFO_0004251	EFO_0004251	myeloproliferative disorder	3	31
http://www.ebi.ac.uk/efo/EFO_0007053	EFO_0007053	myelosuppression	2	3
http://www.ebi.ac.uk/efo/EFO_0000612	EFO_0000612	myocardial infarction	38	513
http://www.ebi.ac.uk/efo/EFO_0005057	EFO_0005057	myoglobin measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004145	EFO_0004145	myopathy	4	3
http://www.ebi.ac.uk/efo/EFO_0009177	EFO_0009177	myopic maculopathy severity measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0000783	EFO_0000783	myositis	6	221
http://www.ebi.ac.uk/efo/EFO_0010993	EFO_0010993	n-acetyl neuraminic acid measurement	1	16
http://purl.obolibrary.org/obo/MONDO_0016158	MONDO_0016158	narcolepsy-cataplexy syndrome	10	89
http://www.ebi.ac.uk/efo/EFO_0004252	EFO_0004252	nasopharyngeal neoplasm	9	88
http://www.ebi.ac.uk/efo/EFO_0008243	EFO_0008243	natural cytotoxicity triggering receptor 3 measurement	1	78
http://www.ebi.ac.uk/efo/EFO_0009265	EFO_0009265	nausea and vomiting of pregnancy severity measurement	1	13
http://www.ebi.ac.uk/efo/EFO_0011043	EFO_0011043	neck circumference	3	4
http://www.ebi.ac.uk/efo/EFO_0004537	EFO_0004537	neonatal systemic lupus erythematosus	1	39
http://www.ebi.ac.uk/efo/EFO_0000096	EFO_0000096	neoplasm of mature B-cells	4	77
http://www.ebi.ac.uk/efo/EFO_0004253	EFO_0004253	nephrolithiasis	12	76
http://www.ebi.ac.uk/efo/EFO_0004255	EFO_0004255	nephrotic syndrome	14	59
http://www.ebi.ac.uk/efo/EFO_0010070	EFO_0010070	nerve conduction amplitude	1	6
NA	NCIT_C74532	nervousness	2	25
http://www.ebi.ac.uk/efo/EFO_0020590	EFO_0020590	netrin receptor UNC5C measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0008244	EFO_0008244	neurexophilin-1 measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0000621	EFO_0000621	neuroblastoma	13	48
http://www.ebi.ac.uk/efo/EFO_0006797	EFO_0006797	neurofibrillary tangles measurement	9	10
http://www.ebi.ac.uk/efo/EFO_0009178	EFO_0009178	neurofilament light chain measurement	6	6
http://www.ebi.ac.uk/efo/EFO_0008246	EFO_0008246	neurogenic locus notch homolog protein 1 measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0020599	EFO_0020599	neurogenic locus notch homolog protein 2 measurement	4	13
http://www.ebi.ac.uk/efo/EFO_0004346	EFO_0004346	neuroimaging measurement	488	747
http://www.ebi.ac.uk/efo/EFO_0004256	EFO_0004256	neuromyelitis optica	3	77
http://www.ebi.ac.uk/efo/EFO_0005762	EFO_0005762	neuropathic pain	5	23
http://www.ebi.ac.uk/efo/EFO_0007660	EFO_0007660	neuroticism measurement	30	1260
http://www.ebi.ac.uk/efo/EFO_0008247	EFO_0008247	neutral ceramidase measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0004833	EFO_0004833	neutrophil count	37	2586
http://www.ebi.ac.uk/efo/EFO_0007994	EFO_0007994	neutrophil percentage of granulocytes	1	620
http://www.ebi.ac.uk/efo/EFO_0007990	EFO_0007990	neutrophil percentage of leukocytes	4	1800
http://www.ebi.ac.uk/efo/EFO_0000625	EFO_0000625	nevus	5	7
http://www.ebi.ac.uk/efo/EFO_0004632	EFO_0004632	nevus count	5	8
http://www.ebi.ac.uk/efo/EFO_0003768	EFO_0003768	nicotine dependence	24	34
http://www.ebi.ac.uk/efo/EFO_0009262	EFO_0009262	nicotine dependence symptom count	4	6
http://www.ebi.ac.uk/efo/EFO_0006507	EFO_0006507	nicotine glucuronidation measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0007794	EFO_0007794	nicotine metabolite ratio	9	15
http://www.ebi.ac.uk/efo/EFO_0009362	EFO_0009362	nicotine withdrawal measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008249	EFO_0008249	nidogen-1 measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0005536	EFO_0005536	nitric oxide exhalation measurement	6	27
http://www.ebi.ac.uk/efo/EFO_0004708	EFO_0004708	nodular sclerosis Hodgkin lymphoma	3	32
http://www.ebi.ac.uk/efo/EFO_0007931	EFO_0007931	non-HDL cholesterol:HDL cholesterol ratio	1	7
http://www.ebi.ac.uk/efo/EFO_0005952	EFO_0005952	non-Hodgkins lymphoma	14	192
http://www.ebi.ac.uk/efo/EFO_0003095	EFO_0003095	non-alcoholic fatty liver disease	27	314
http://www.ebi.ac.uk/efo/EFO_1001249	EFO_1001249	non-alcoholic steatohepatitis	3	8
http://www.ebi.ac.uk/efo/EFO_0006504	EFO_0006504	non-dense area measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0010095	EFO_0010095	non-grapefruit juice consumption measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0010178	EFO_0010178	non-lobar intracerebral hemorrhage	2	16
http://www.ebi.ac.uk/efo/EFO_0009260	EFO_0009260	non-melanoma skin carcinoma	5	120
http://www.ebi.ac.uk/efo/EFO_0008251	EFO_0008251	non-receptor tyrosine-protein kinase TYK2 measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0003060	EFO_0003060	non-small cell lung carcinoma	13	63
http://www.ebi.ac.uk/efo/EFO_0009087	EFO_0009087	non-typhoidal Salmonella bacteremia	1	2
http://purl.obolibrary.org/obo/PATO_0000461	PATO_0000461	normal	28	25
http://www.ebi.ac.uk/efo/EFO_0007843	EFO_0007843	nose morphology measurement	277	27
http://www.ebi.ac.uk/efo/EFO_0010512	EFO_0010512	nucleoside measurement	6	11
http://www.ebi.ac.uk/efo/EFO_0006931	EFO_0006931	nucleus accumbens volume	5	5
http://www.ebi.ac.uk/efo/EFO_0009102	EFO_0009102	number of children ever born measurement	5	8
http://www.ebi.ac.uk/efo/EFO_0009438	EFO_0009438	number of pregnancies measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0007041	EFO_0007041	obese body mass index status	2	28
http://www.ebi.ac.uk/efo/EFO_0001073	EFO_0001073	obesity	39	35
http://www.ebi.ac.uk/efo/EFO_0004242	EFO_0004242	obsessive-compulsive disorder	21	9
http://www.ebi.ac.uk/efo/EFO_0003918	EFO_0003918	obstructive sleep apnea	6	7
http://www.ebi.ac.uk/efo/EFO_0010145	EFO_0010145	occipital lobe volume measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0020977	EFO_0020977	occupational attainment	1	74
http://www.ebi.ac.uk/efo/EFO_0010723	EFO_0010723	ocular sarcoidosis	4	2
http://purl.obolibrary.org/obo/GO_0042476	GO_0042476	odontogenesis	3	32
http://www.ebi.ac.uk/efo/EFO_0006810	EFO_0006810	oleic acid measurement	2	37
http://www.ebi.ac.uk/efo/EFO_0005206	EFO_0005206	oligoclonal band measurement	2	38
http://www.ebi.ac.uk/efo/EFO_0010119	EFO_0010119	omega-3 polyunsaturated fatty acid measurement	8	331
http://www.ebi.ac.uk/efo/EFO_0005680	EFO_0005680	omega-6 polyunsaturated fatty acid measurement	13	430
http://www.ebi.ac.uk/efo/EFO_0010732	EFO_0010732	omega-6:omega-3 polyunsaturated fatty acid ratio	1	8
http://www.ebi.ac.uk/efo/EFO_0004190	EFO_0004190	open-angle glaucoma	37	106
http://www.ebi.ac.uk/efo/EFO_0005611	EFO_0005611	opioid dependence	10	7
http://www.ebi.ac.uk/efo/EFO_0010140	EFO_0010140	opioid overdose severity measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0010702	EFO_0010702	opioid use disorder	5	5
http://www.ebi.ac.uk/efo/EFO_0006940	EFO_0006940	optic cup area measurement	6	70
http://www.ebi.ac.uk/efo/EFO_0006937	EFO_0006937	optic disc area measurement	6	55
http://www.ebi.ac.uk/efo/EFO_0006936	EFO_0006936	optic disc measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0004832	EFO_0004832	optic disc size measurement	9	247
http://www.ebi.ac.uk/efo/EFO_0005570	EFO_0005570	oral cavity cancer	8	41
http://www.ebi.ac.uk/efo/EFO_0007960	EFO_0007960	organochlorine pesticide measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0009776	EFO_0009776	ornithine measurement	2	47
http://www.ebi.ac.uk/efo/EFO_1001931	EFO_1001931	oropharynx cancer	8	54
http://www.ebi.ac.uk/efo/EFO_0005895	EFO_0005895	ossification of the posterior longitudinal ligament of the spine	1	6
http://www.ebi.ac.uk/efo/EFO_0004261	EFO_0004261	osteitis deformans	2	24
http://purl.obolibrary.org/obo/MONDO_0005178	MONDO_0005178	osteoarthritis	68	175
http://www.ebi.ac.uk/efo/EFO_1000789	EFO_1000789	osteoarthritis, hand	13	17
http://www.ebi.ac.uk/efo/EFO_0004616	EFO_0004616	osteoarthritis, hip, osteoarthritis, knee	35	121
http://www.ebi.ac.uk/efo/EFO_1000786	EFO_1000786	osteoarthritis, hip, osteoarthritis, knee	27	194
http://www.ebi.ac.uk/efo/EFO_0010232	EFO_0010232	osteocalcin measurement	3	21
http://www.ebi.ac.uk/efo/EFO_0004259	EFO_0004259	osteonecrosis	11	5
http://www.ebi.ac.uk/efo/EFO_0003882	EFO_0003882	osteoporosis	35	150
http://www.ebi.ac.uk/efo/EFO_0005918	EFO_0005918	osteoprotegerin measurement	4	30
http://www.ebi.ac.uk/efo/EFO_0000637	EFO_0000637	osteosarcoma	2	3
http://www.ebi.ac.uk/efo/EFO_0004213	EFO_0004213	otosclerosis	2	1
http://www.ebi.ac.uk/efo/EFO_0006951	EFO_0006951	ototoxicity	3	5
http://www.ebi.ac.uk/efo/EFO_0001075	EFO_0001075	ovarian carcinoma	34	161
http://www.ebi.ac.uk/efo/EFO_1000042	EFO_1000042	ovarian clear cell adenocarcinoma	1	4
http://www.ebi.ac.uk/efo/EFO_1001515	EFO_1001515	ovarian endometrioid carcinoma	3	13
http://www.ebi.ac.uk/efo/EFO_0006462	EFO_0006462	ovarian mucinous adenocarcinoma	2	24
http://www.ebi.ac.uk/efo/EFO_1001516	EFO_1001516	ovarian serous carcinoma	12	60
http://www.ebi.ac.uk/efo/EFO_0000638	EFO_0000638	overall survival	19	12
http://www.ebi.ac.uk/efo/EFO_0005682	EFO_0005682	oxygen saturation measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0010245	EFO_0010245	oxytocin measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0004763	EFO_0004763	p-tau measurement	21	15
http://www.ebi.ac.uk/efo/EFO_0007709	EFO_0007709	p-tau:beta-amyloid 1-42 ratio measurement	2	10
http://www.ebi.ac.uk/efo/EFO_0006526	EFO_0006526	pack-years measurement	6	7
http://www.ebi.ac.uk/efo/EFO_0003843	EFO_0003843	pain	40	6
http://www.ebi.ac.uk/efo/EFO_0010639	EFO_0010639	pain measurement	59	2
http://www.ebi.ac.uk/efo/EFO_0006933	EFO_0006933	pallidum volume	5	18
http://www.ebi.ac.uk/efo/EFO_0007973	EFO_0007973	palmitoleic acid measurement	1	23
http://www.ebi.ac.uk/efo/EFO_0600049	EFO_0600049	pancreas fat measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0600045	EFO_0600045	pancreas volume	1	40
http://www.ebi.ac.uk/efo/EFO_0002618	EFO_0002618	pancreatic carcinoma	35	92
http://www.ebi.ac.uk/efo/EFO_0000278	EFO_0000278	pancreatitis	10	18
http://www.ebi.ac.uk/efo/EFO_0000641	EFO_0000641	papillary thyroid carcinoma	1	1
http://www.ebi.ac.uk/efo/EFO_0010618	EFO_0010618	pappalysin‐1 measurement	2	39
http://www.ebi.ac.uk/efo/EFO_0004752	EFO_0004752	parathyroid hormone measurement	4	2
http://www.ebi.ac.uk/efo/EFO_0020101	EFO_0020101	parenchymal hematoma	1	9
http://www.ebi.ac.uk/efo/EFO_0005939	EFO_0005939	parental genotype effect measurement	36	368
http://www.ebi.ac.uk/efo/EFO_0007796	EFO_0007796	parental longevity	35	193
http://www.ebi.ac.uk/efo/EFO_0010146	EFO_0010146	parietal lobe volume measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0004263	EFO_0004263	partial epilepsy	6	8
http://www.ebi.ac.uk/efo/EFO_0004310	EFO_0004310	partial thromboplastin time	4	61
http://www.ebi.ac.uk/efo/EFO_0008255	EFO_0008255	particulate matter air pollution measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0004207	EFO_0004207	pathological myopia	8	7
http://www.ebi.ac.uk/efo/EFO_0009718	EFO_0009718	peak expiratory flow	5	265
http://www.ebi.ac.uk/efo/EFO_0008000	EFO_0008000	peak insulin response measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0007017	EFO_0007017	peanut allergy measurement	6	25
http://www.ebi.ac.uk/efo/EFO_0004710	EFO_0004710	pelvic organ prolapse	12	11
http://www.ebi.ac.uk/efo/EFO_1000749	EFO_1000749	pemphigus	1	20
http://www.ebi.ac.uk/efo/EFO_0008601	EFO_0008601	pemphigus foliaceus	2	30
http://www.ebi.ac.uk/efo/EFO_0004719	EFO_0004719	pemphigus vulgaris	4	27
http://www.ebi.ac.uk/efo/EFO_0010923	EFO_0010923	pentraxin-related protein PTX3 measurement	1	21
http://www.ebi.ac.uk/efo/EFO_0010149	EFO_0010149	pepsinogen I/II ratio	1	10
http://purl.obolibrary.org/obo/MONDO_0004247	MONDO_0004247	peptic ulcer disease	3	2
http://www.ebi.ac.uk/efo/EFO_0008256	EFO_0008256	peptidyl-prolyl cis-trans isomerase D measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0008257	EFO_0008257	peptidyl-prolyl cis-trans isomerase E measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0009304	EFO_0009304	percent glycated albumin	1	9
http://www.ebi.ac.uk/efo/EFO_0005627	EFO_0005627	perianal Crohn's disease	1	1
http://www.ebi.ac.uk/efo/EFO_0007890	EFO_0007890	pericardial adipose tissue measurement	7	8
http://www.ebi.ac.uk/efo/EFO_0007780	EFO_0007780	periodontal measurement	10	6
http://www.ebi.ac.uk/efo/EFO_0000649	EFO_0000649	periodontitis	32	15
http://www.ebi.ac.uk/efo/EFO_0004265	EFO_0004265	peripheral arterial disease	20	176
http://www.ebi.ac.uk/efo/EFO_0003100	EFO_0003100	peripheral neuropathy	17	12
http://www.ebi.ac.uk/efo/EFO_0003875	EFO_0003875	peripheral vascular disease	15	7
http://www.ebi.ac.uk/efo/EFO_0008258	EFO_0008258	persulfide dioxygenase ETHE1, mitochondrial measurement	2	38
http://www.ebi.ac.uk/efo/EFO_0005001	EFO_0005001	phenylalanine measurement	8	48
http://www.ebi.ac.uk/efo/EFO_0020047	EFO_0020047	phosphatidate measurement	30	107
http://www.ebi.ac.uk/efo/EFO_0010374	EFO_0010374	phosphatidylcholine 32:2 measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0010378	EFO_0010378	phosphatidylcholine 34:4 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010381	EFO_0010381	phosphatidylcholine 36:3 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010382	EFO_0010382	phosphatidylcholine 36:4 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010383	EFO_0010383	phosphatidylcholine 36:5 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010384	EFO_0010384	phosphatidylcholine 38:2 measurement	5	8
http://www.ebi.ac.uk/efo/EFO_0010386	EFO_0010386	phosphatidylcholine 38:4 measurement	5	20
http://www.ebi.ac.uk/efo/EFO_0010387	EFO_0010387	phosphatidylcholine 38:5 measurement	6	15
http://www.ebi.ac.uk/efo/EFO_0010388	EFO_0010388	phosphatidylcholine 38:6 measurement	3	19
http://www.ebi.ac.uk/efo/EFO_0010227	EFO_0010227	phosphatidylcholine ether measurement	2	15
http://www.ebi.ac.uk/efo/EFO_0010226	EFO_0010226	phosphatidylcholine measurement	712	424
http://www.ebi.ac.uk/efo/EFO_0010229	EFO_0010229	phosphatidylethanolamine ether measurement	2	23
http://www.ebi.ac.uk/efo/EFO_0010228	EFO_0010228	phosphatidylethanolamine measurement	423	117
http://www.ebi.ac.uk/efo/EFO_0010230	EFO_0010230	phosphatidylinositol measurement	145	183
http://www.ebi.ac.uk/efo/EFO_0020049	EFO_0020049	phosphatidylserines measurement	61	15
http://www.ebi.ac.uk/efo/EFO_0008259	EFO_0008259	phospholipase A2, membrane associated measurement	3	5
http://www.ebi.ac.uk/efo/EFO_0020903	EFO_0020903	phospholipid change measurement	28	5
http://www.ebi.ac.uk/efo/EFO_0004639	EFO_0004639	phospholipid measurement	65	1437
http://www.ebi.ac.uk/efo/EFO_0020946	EFO_0020946	phospholipids:total lipids ratio	14	1344
http://www.ebi.ac.uk/efo/EFO_0004861	EFO_0004861	phosphorus measurement	2	42
http://www.ebi.ac.uk/efo/EFO_0003940	EFO_0003940	physical activity	20	138
http://www.ebi.ac.uk/efo/EFO_0008002	EFO_0008002	physical activity measurement	160	592
http://www.ebi.ac.uk/efo/EFO_0004862	EFO_0004862	phytosterol measurement	1	19
http://purl.obolibrary.org/obo/MONDO_0010896	MONDO_0010896	pigment dispersion syndrome	1	4
http://www.ebi.ac.uk/efo/EFO_0021425	EFO_0021425	pigmentary glaucoma	1	4
http://www.ebi.ac.uk/efo/EFO_0010626	EFO_0010626	placenta growth factor measurement	3	8
http://www.ebi.ac.uk/efo/EFO_0005659	EFO_0005659	plasma beta-amyloid 1-40 measurement	2	7
http://www.ebi.ac.uk/efo/EFO_0600016	EFO_0600016	plasma beta-amyloid 1-40:1-42 ratio measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0005660	EFO_0005660	plasma beta-amyloid 1-42 measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0007787	EFO_0007787	plasma betaine measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0008260	EFO_0008260	plasma kallikrein measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0600050	EFO_0600050	plasma leucine rich alpha-2-glycoprotein 1 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0006309	EFO_0006309	plasma plasminogen measurement	3	8
http://www.ebi.ac.uk/efo/EFO_0008261	EFO_0008261	plasma protease C1 inhibitor measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0004792	EFO_0004792	plasminogen activator inhibitor 1 measurement	9	60
http://purl.obolibrary.org/obo/GO_0070527	GO_0070527	platelet aggregation	8	3
http://www.ebi.ac.uk/efo/EFO_0004309	EFO_0004309	platelet count	48	3599
http://www.ebi.ac.uk/efo/EFO_0007985	EFO_0007985	platelet crit	4	2567
http://www.ebi.ac.uk/efo/EFO_0010598	EFO_0010598	platelet endothelial cell adhesion molecule measurement	3	16
http://www.ebi.ac.uk/efo/EFO_0008262	EFO_0008262	platelet glycoprotein 4 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0008263	EFO_0008263	platelet glycoprotein VI measurement	1	26
http://www.ebi.ac.uk/efo/EFO_0004985	EFO_0004985	platelet reactivity measurement	13	45
http://www.ebi.ac.uk/efo/EFO_0008264	EFO_0008264	platelet-derived growth factor BB measurement	4	17
http://www.ebi.ac.uk/efo/EFO_0008265	EFO_0008265	platelet-derived growth factor receptor beta measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0010154	EFO_0010154	platinum measurement	1	5
http://www.ebi.ac.uk/efo/EFO_1001114	EFO_1001114	pneumococcal meningitis	4	4
http://www.ebi.ac.uk/efo/EFO_0003106	EFO_0003106	pneumonia	24	35
http://purl.obolibrary.org/obo/MONDO_0002076	MONDO_0002076	pneumothorax	6	7
http://www.ebi.ac.uk/efo/EFO_0007961	EFO_0007961	polybrominated biphenyl measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0007962	EFO_0007962	polybrominated diphenyl ether measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0007042	EFO_0007042	polychlorinated biphenyls measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0000660	EFO_0000660	polycystic ovary syndrome	17	60
http://www.ebi.ac.uk/efo/EFO_0008267	EFO_0008267	polymeric immunoglobulin receptor measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0003063	EFO_0003063	polymyositis	4	40
http://www.ebi.ac.uk/efo/EFO_0009562	EFO_0009562	polyneuropathy	7	4
http://www.ebi.ac.uk/efo/EFO_0010907	EFO_0010907	polyomavirus 2 seropositivity	4	25
http://purl.obolibrary.org/obo/MONDO_0021400	MONDO_0021400	polyp of colon	4	144
http://purl.obolibrary.org/obo/MONDO_0021416	MONDO_0021416	polyp of gallbladder	2	11
http://purl.obolibrary.org/obo/MONDO_0021392	MONDO_0021392	polyp of large intestine	2	1
http://www.ebi.ac.uk/efo/EFO_0010733	EFO_0010733	polyunsaturated fatty acid measurement	7	388
http://purl.obolibrary.org/obo/GO_0060279	GO_0060279	positive regulation of ovulation	1	3
http://www.ebi.ac.uk/efo/EFO_0009955	EFO_0009955	post-operative acute kidney injury	1	3
http://www.ebi.ac.uk/efo/EFO_0001358	EFO_0001358	post-traumatic stress disorder	18	118
http://www.ebi.ac.uk/efo/EFO_0009283	EFO_0009283	potassium measurement	8	103
http://www.ebi.ac.uk/efo/EFO_0000668	EFO_0000668	preeclampsia	18	13
http://www.ebi.ac.uk/efo/EFO_0008462	EFO_0008462	pregnancy induced alloimmunization	4	1
http://www.ebi.ac.uk/efo/EFO_0003917	EFO_0003917	premature birth	6	3
http://www.ebi.ac.uk/efo/EFO_0009400	EFO_0009400	presubiculum volume	2	5
http://www.ebi.ac.uk/efo/EFO_1001506	EFO_1001506	primary angle closure glaucoma	4	23
http://www.ebi.ac.uk/efo/EFO_1001486	EFO_1001486	primary biliary cirrhosis	11	321
http://www.ebi.ac.uk/efo/EFO_0600095	EFO_0600095	primary dental caries	2	1
http://www.ebi.ac.uk/efo/EFO_0007004	EFO_0007004	progesterone measurement	5	20
http://www.ebi.ac.uk/efo/EFO_0009782	EFO_0009782	progesterone-receptor positive breast cancer	6	4
http://www.ebi.ac.uk/efo/EFO_0008268	EFO_0008268	programmed cell death 1 ligand 2 measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0004625	EFO_0004625	progranulin measurement	4	17
http://www.ebi.ac.uk/efo/EFO_0004920	EFO_0004920	progression free survival	12	9
http://www.ebi.ac.uk/efo/EFO_0009322	EFO_0009322	proliferative diabetic retinopathy	4	14
http://www.ebi.ac.uk/efo/EFO_0009773	EFO_0009773	proline measurement	3	7
http://www.ebi.ac.uk/efo/EFO_0008269	EFO_0008269	properdin measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008270	EFO_0008270	proprotein convertase subtilisin/kexin type 7 measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0009312	EFO_0009312	proprotein convertase subtilisin/kexin type 9 measurement	5	21
http://purl.obolibrary.org/obo/MONDO_0008315	MONDO_0008315	prostate cancer	5	26
http://www.ebi.ac.uk/efo/EFO_0001663	EFO_0001663	prostate carcinoma	79	924
http://www.ebi.ac.uk/efo/EFO_0004624	EFO_0004624	prostate specific antigen measurement	12	90
http://www.ebi.ac.uk/efo/EFO_0004633	EFO_0004633	protein C measurement	3	31
http://www.ebi.ac.uk/efo/EFO_0010742	EFO_0010742	protein binding measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0010810	EFO_0010810	protein intake measurement	3	23
http://www.ebi.ac.uk/efo/EFO_0008271	EFO_0008271	protein jagged-1 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0004747	EFO_0004747	protein measurement	19	394
http://www.ebi.ac.uk/efo/EFO_0020685	EFO_0020685	protein nov homolog measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0010926	EFO_0010926	proteinase-activated receptor 1 measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0008390	EFO_0008390	prothrombin time measurement	4	37
http://www.ebi.ac.uk/efo/EFO_0008272	EFO_0008272	proto-oncogene tyrosine-protein kinase receptor Ret measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0010629	EFO_0010629	pro‐interleukin‐16 measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0021126	EFO_0021126	pseudouridine measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0000676	EFO_0000676	psoriasis	49	352
http://www.ebi.ac.uk/efo/EFO_1001494	EFO_1001494	psoriasis vulgaris	5	142
http://www.ebi.ac.uk/efo/EFO_0003778	EFO_0003778	psoriatic arthritis	12	668
http://purl.obolibrary.org/obo/MONDO_0002025	MONDO_0002025	psychiatric disorder	8	3
http://www.ebi.ac.uk/efo/EFO_0009945	EFO_0009945	psychological resilience measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0008337	EFO_0008337	psychosis predisposition measurement	11	3
http://www.ebi.ac.uk/efo/EFO_0006783	EFO_0006783	psychosocial stress measurement	16	1
http://www.ebi.ac.uk/efo/EFO_0009182	EFO_0009182	psychotic symptom measurement	34	5
http://www.ebi.ac.uk/efo/EFO_0005940	EFO_0005940	psychotic symptoms	10	16
http://www.ebi.ac.uk/efo/EFO_0001382	EFO_0001382	puberty	1	6
http://www.ebi.ac.uk/efo/EFO_0005677	EFO_0005677	puberty onset measurement	8	224
http://purl.obolibrary.org/obo/MONDO_0001437	MONDO_0001437	pulmonary alveolar proteinosis	1	22
http://www.ebi.ac.uk/efo/EFO_0001361	EFO_0001361	pulmonary arterial hypertension	3	27
http://www.ebi.ac.uk/efo/EFO_0006347	EFO_0006347	pulmonary artery enlargement	2	8
http://www.ebi.ac.uk/efo/EFO_0009448	EFO_0009448	pulmonary fibrosis	3	1
http://www.ebi.ac.uk/efo/EFO_0003892	EFO_0003892	pulmonary function measurement	38	287
http://purl.obolibrary.org/obo/MONDO_0018469	MONDO_0018469	pulmonary non-tuberculous mycobacterial infection	1	3
http://www.ebi.ac.uk/efo/EFO_1000049	EFO_1000049	pulmonary tuberculosis	5	19
http://www.ebi.ac.uk/efo/EFO_0005763	EFO_0005763	pulse pressure measurement	38	1598
http://www.ebi.ac.uk/efo/EFO_0006932	EFO_0006932	putamen volume	6	20
http://www.ebi.ac.uk/efo/EFO_1001141	EFO_1001141	pyelonephritis	2	1
http://www.ebi.ac.uk/efo/EFO_0005408	EFO_0005408	pyroglutamine measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0010117	EFO_0010117	pyruvate measurement	2	104
http://www.ebi.ac.uk/efo/EFO_0009366	EFO_0009366	quality of life during menstruation measurement	17	11
http://www.ebi.ac.uk/efo/EFO_0009704	EFO_0009704	radiation-induced brain injury	1	1
http://www.ebi.ac.uk/efo/EFO_0007933	EFO_0007933	radius bone mineral density	4	8
http://www.ebi.ac.uk/efo/EFO_0006836	EFO_0006836	rapid kidney function decline	1	5
http://www.ebi.ac.uk/efo/EFO_0008393	EFO_0008393	reaction time measurement	4	154
http://www.ebi.ac.uk/efo/EFO_0005229	EFO_0005229	reading	3	6
http://www.ebi.ac.uk/efo/EFO_0005301	EFO_0005301	reading and spelling ability	13	1
http://www.ebi.ac.uk/efo/EFO_0004350	EFO_0004350	reasoning	4	2
http://www.ebi.ac.uk/efo/EFO_0020700	EFO_0020700	receptor tyrosine-protein kinase erbb-2 measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0020703	EFO_0020703	receptor-type tyrosine-protein kinase flt3 measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0004863	EFO_0004863	recombination rate	4	6
http://www.ebi.ac.uk/efo/EFO_1000657	EFO_1000657	rectum cancer	10	21
http://www.ebi.ac.uk/efo/EFO_0007978	EFO_0007978	red blood cell density measurement	7	1720
http://www.ebi.ac.uk/efo/EFO_0005192	EFO_0005192	red blood cell distribution width	25	2299
http://www.ebi.ac.uk/efo/EFO_0009703	EFO_0009703	red blood cell folate measurement	2	11
http://purl.obolibrary.org/obo/MONDO_0004892	MONDO_0004892	refractive error	12	666
http://www.ebi.ac.uk/efo/EFO_0009266	EFO_0009266	refractory celiac disease	1	1
http://www.ebi.ac.uk/efo/EFO_0009785	EFO_0009785	remission	11	28
http://www.ebi.ac.uk/efo/EFO_0010815	EFO_0010815	remnant cholesterol measurement	1	276
http://www.ebi.ac.uk/efo/EFO_0000681	EFO_0000681	renal cell carcinoma	10	37
http://www.ebi.ac.uk/efo/EFO_0004742	EFO_0004742	renal system measurement	10	100
http://www.ebi.ac.uk/efo/EFO_0005199	EFO_0005199	renal transplant outcome measurement	15	3
http://www.ebi.ac.uk/efo/EFO_0010616	EFO_0010616	renin measurement	2	13
http://www.ebi.ac.uk/efo/EFO_0008273	EFO_0008273	repulsive guidance molecule A measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0004819	EFO_0004819	resistin measurement	6	15
http://www.ebi.ac.uk/efo/EFO_0007939	EFO_0007939	respiratory symptom measurement	25	9
http://www.ebi.ac.uk/efo/EFO_0007683	EFO_0007683	response to CAPOX-B	2	4
http://www.ebi.ac.uk/efo/EFO_0004653	EFO_0004653	response to TNF antagonist	18	6
http://www.ebi.ac.uk/efo/EFO_0005526	EFO_0005526	response to alcohol	5	2
http://www.ebi.ac.uk/efo/EFO_0007044	EFO_0007044	response to allogeneic hematopoietic stem cell transplant	16	22
http://www.ebi.ac.uk/efo/EFO_0006337	EFO_0006337	response to allopurinol	3	2
http://www.ebi.ac.uk/efo/EFO_0010735	EFO_0010735	response to angiotensin receptor blocker	3	1
http://www.ebi.ac.uk/efo/EFO_0005325	EFO_0005325	response to angiotensin-converting enzyme inhibitor	11	22
http://www.ebi.ac.uk/efo/EFO_0007838	EFO_0007838	response to anti-thyroid drug	2	111
http://www.ebi.ac.uk/efo/EFO_0007918	EFO_0007918	response to anti-tuberculosis drug	5	3
http://purl.obolibrary.org/obo/GO_0046677	GO_0046677	response to antibiotic	1	1
http://purl.obolibrary.org/obo/GO_0061476	GO_0061476	response to anticoagulant	8	17
http://purl.obolibrary.org/obo/GO_0036277	GO_0036277	response to anticonvulsant	25	4
http://purl.obolibrary.org/obo/GO_0036276	GO_0036276	response to antidepressant	30	1
http://www.ebi.ac.uk/efo/EFO_0005405	EFO_0005405	response to antihypertensive drug	4	3
http://purl.obolibrary.org/obo/GO_0097327	GO_0097327	response to antineoplastic agent	41	6
http://purl.obolibrary.org/obo/GO_0097332	GO_0097332	response to antipsychotic drug	16	25
http://www.ebi.ac.uk/efo/EFO_0009261	EFO_0009261	response to aripiprazole	1	1
http://purl.obolibrary.org/obo/GO_0061477	GO_0061477	response to aromatase inhibitor	8	11
http://www.ebi.ac.uk/efo/EFO_0007766	EFO_0007766	response to beta blocker	16	18
http://www.ebi.ac.uk/efo/EFO_0006992	EFO_0006992	response to biological dust exposure	1	2
http://www.ebi.ac.uk/efo/EFO_0009958	EFO_0009958	response to bisphosphonate	5	10
http://www.ebi.ac.uk/efo/EFO_0007592	EFO_0007592	response to bleomycin	1	1
http://www.ebi.ac.uk/efo/EFO_0007767	EFO_0007767	response to calcium channel blocker	4	3
http://www.ebi.ac.uk/efo/EFO_0008484	EFO_0008484	response to carbamazepine	10	15
http://www.ebi.ac.uk/efo/EFO_0007682	EFO_0007682	response to cetuximab	4	12
http://purl.obolibrary.org/obo/GO_0072718	GO_0072718	response to cisplatin	12	19
http://www.ebi.ac.uk/efo/EFO_0006329	EFO_0006329	response to citalopram	8	1
http://purl.obolibrary.org/obo/GO_0097338	GO_0097338	response to clozapine	7	66
http://www.ebi.ac.uk/efo/EFO_0006997	EFO_0006997	response to cold medicine	3	4
http://www.ebi.ac.uk/efo/EFO_0007965	EFO_0007965	response to combination chemotherapy	5	16
http://purl.obolibrary.org/obo/GO_0031960	GO_0031960	response to corticosteroid	18	4
http://www.ebi.ac.uk/efo/EFO_0600093	EFO_0600093	response to cosmetics	1	2
http://www.ebi.ac.uk/efo/EFO_0006916	EFO_0006916	response to dalcetrapib	1	1
http://www.ebi.ac.uk/efo/EFO_0008395	EFO_0008395	response to darapladib	9	49
http://www.ebi.ac.uk/efo/EFO_0007919	EFO_0007919	response to diclofenac	1	1
http://www.ebi.ac.uk/efo/EFO_0005403	EFO_0005403	response to dietary potassium supplementation	1	4
http://www.ebi.ac.uk/efo/EFO_0006995	EFO_0006995	response to diisocyanate	1	11
http://purl.obolibrary.org/obo/GO_0036270	GO_0036270	response to diuretic	16	15
http://purl.obolibrary.org/obo/GO_1902519	GO_1902519	response to docetaxel	6	7
http://purl.obolibrary.org/obo/GO_0042493	GO_0042493	response to drug	12	26
http://www.ebi.ac.uk/efo/EFO_0007871	EFO_0007871	response to escitalopram	8	1
http://www.ebi.ac.uk/efo/EFO_0007768	EFO_0007768	response to exercise	4	5
http://purl.obolibrary.org/obo/GO_1901557	GO_1901557	response to fenofibrate	18	34
http://www.ebi.ac.uk/efo/EFO_0006994	EFO_0006994	response to gases and fumes exposure	1	2
http://purl.obolibrary.org/obo/GO_0036272	GO_0036272	response to gemcitabine	7	3
http://www.ebi.ac.uk/efo/EFO_0007684	EFO_0007684	response to high fat food intake	1	7
http://www.ebi.ac.uk/efo/EFO_0005401	EFO_0005401	response to high sodium diet	2	4
http://www.ebi.ac.uk/efo/EFO_0005202	EFO_0005202	response to hydrochlorothiazide	6	1
http://www.ebi.ac.uk/efo/EFO_0007859	EFO_0007859	response to interferon	6	1
http://purl.obolibrary.org/obo/GO_0035456	GO_0035456	response to interferon beta	43	138
http://www.ebi.ac.uk/efo/EFO_0009748	EFO_0009748	response to ketamine	5	4
http://www.ebi.ac.uk/efo/EFO_0009372	EFO_0009372	response to ketogenic diet	1	1
http://www.ebi.ac.uk/efo/EFO_0007661	EFO_0007661	response to lamotrigine	4	13
http://www.ebi.ac.uk/efo/EFO_0010747	EFO_0010747	response to levodopa	4	5
http://purl.obolibrary.org/obo/GO_0010226	GO_0010226	response to lithium ion	12	7
http://www.ebi.ac.uk/efo/EFO_0005402	EFO_0005402	response to low sodium diet	1	3
http://www.ebi.ac.uk/efo/EFO_0007853	EFO_0007853	response to mercaptopurine	5	4
http://purl.obolibrary.org/obo/GO_1901558	GO_1901558	response to metformin	5	7
http://www.ebi.ac.uk/efo/EFO_0020996	EFO_0020996	response to methazolamide	1	302
http://purl.obolibrary.org/obo/GO_0031427	GO_0031427	response to methotrexate	7	5
http://www.ebi.ac.uk/efo/EFO_0006993	EFO_0006993	response to mineral dust exposure	1	2
http://www.ebi.ac.uk/efo/EFO_0007612	EFO_0007612	response to montelukast	1	1
http://www.ebi.ac.uk/efo/EFO_0600034	EFO_0600034	response to neuromuscular blocker	1	4
http://www.ebi.ac.uk/efo/EFO_0005533	EFO_0005533	response to non-steroidal anti-inflammatory	5	2
http://www.ebi.ac.uk/efo/EFO_0008541	EFO_0008541	response to opioid	5	13
http://www.ebi.ac.uk/efo/EFO_0007925	EFO_0007925	response to paliperidone	5	2
http://www.ebi.ac.uk/efo/EFO_0007779	EFO_0007779	response to pazopanib	1	66
http://www.ebi.ac.uk/efo/EFO_0010152	EFO_0010152	response to phenylephrine	4	3
http://www.ebi.ac.uk/efo/EFO_0006345	EFO_0006345	response to phenytoin	3	4
http://www.ebi.ac.uk/efo/EFO_0008344	EFO_0008344	response to placebo	8	7
http://www.ebi.ac.uk/efo/EFO_0009131	EFO_0009131	response to polyunsaturated fatty acid supplementation	3	5
http://purl.obolibrary.org/obo/GO_0009314	GO_0009314	response to radiation	36	53
http://www.ebi.ac.uk/efo/EFO_0600080	EFO_0600080	response to recombinant tissue-plasminogen activator	1	9
http://www.ebi.ac.uk/efo/EFO_0006802	EFO_0006802	response to red blood cell transfusion	2	2
http://purl.obolibrary.org/obo/GO_0061479	GO_0061479	response to reverse transcriptase inhibitor	10	11
http://purl.obolibrary.org/obo/GO_0097336	GO_0097336	response to risperidone	2	2
http://www.ebi.ac.uk/efo/EFO_0005658	EFO_0005658	response to selective serotonin reuptake inhibitor	25	5
http://purl.obolibrary.org/obo/GO_1903491	GO_1903491	response to simvastatin	6	13
http://purl.obolibrary.org/obo/GO_0036273	GO_0036273	response to statin	25	113
http://www.ebi.ac.uk/efo/EFO_0020976	EFO_0020976	response to steroid	3	8
http://www.ebi.ac.uk/efo/EFO_0008324	EFO_0008324	response to sulfasalazine	4	17
http://www.ebi.ac.uk/efo/EFO_0007922	EFO_0007922	response to sulfonylurea	4	11
http://www.ebi.ac.uk/efo/EFO_0009951	EFO_0009951	response to surgery	11	22
http://www.ebi.ac.uk/efo/EFO_0010808	EFO_0010808	response to tafenoquine	3	1
http://www.ebi.ac.uk/efo/EFO_0007917	EFO_0007917	response to tetracyclic antidepressant	2	3
http://www.ebi.ac.uk/efo/EFO_0007981	EFO_0007981	response to thiazide	4	4
http://www.ebi.ac.uk/efo/EFO_0007633	EFO_0007633	response to thioamide	2	98
http://www.ebi.ac.uk/efo/EFO_0006317	EFO_0006317	response to thiopurine	20	32
http://www.ebi.ac.uk/efo/EFO_0600024	EFO_0600024	response to tofacitinib	6	19
http://www.ebi.ac.uk/efo/EFO_0600065	EFO_0600065	response to tolvaptan	1	2
http://www.ebi.ac.uk/efo/EFO_0007916	EFO_0007916	response to tricyclic antidepressant	2	3
http://www.ebi.ac.uk/efo/EFO_0020986	EFO_0020986	response to ustekinumab	2	11
http://www.ebi.ac.uk/efo/EFO_0004645	EFO_0004645	response to vaccine	31	262
http://www.ebi.ac.uk/efo/EFO_0006950	EFO_0006950	response to vincristine	2	8
http://www.ebi.ac.uk/efo/EFO_0010648	EFO_0010648	response to vitamin B3	5	7
http://www.ebi.ac.uk/efo/EFO_0009167	EFO_0009167	response to warfarin	1	11
http://www.ebi.ac.uk/efo/EFO_0010748	EFO_0010748	response to zonisamide	2	3
http://www.ebi.ac.uk/efo/EFO_0004351	EFO_0004351	resting heart rate	9	35
http://www.ebi.ac.uk/efo/EFO_0004270	EFO_0004270	restless legs syndrome	10	33
http://www.ebi.ac.uk/efo/EFO_0007986	EFO_0007986	reticulocyte count	17	2903
http://www.ebi.ac.uk/efo/EFO_0010700	EFO_0010700	reticulocyte measurement	9	2774
http://www.ebi.ac.uk/efo/EFO_0010698	EFO_0010698	retinal break	4	4
http://www.ebi.ac.uk/efo/EFO_0005773	EFO_0005773	retinal detachment	20	4
http://www.ebi.ac.uk/efo/EFO_0010554	EFO_0010554	retinal vasculature measurement	11	89
http://www.ebi.ac.uk/efo/EFO_0008274	EFO_0008274	retinoic acid receptor responder protein 2 measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0020973	EFO_0020973	revision of total hip arthroplasty	2	3
http://www.ebi.ac.uk/efo/EFO_0020974	EFO_0020974	revision of total joint arthroplasty	2	21
http://www.ebi.ac.uk/efo/EFO_0020972	EFO_0020972	revision of total knee arthroplasty	2	32
http://www.ebi.ac.uk/efo/EFO_1001161	EFO_1001161	rheumatic heart disease	5	66
http://www.ebi.ac.uk/efo/EFO_0000685	EFO_0000685	rheumatoid arthritis	85	742
http://www.ebi.ac.uk/efo/EFO_0005767	EFO_0005767	rheumatoid factor measurement	2	1
http://www.ebi.ac.uk/efo/EFO_0007791	EFO_0007791	rheumatoid factor seropositivity measurement	2	28
http://www.ebi.ac.uk/efo/EFO_0008579	EFO_0008579	risk-taking behaviour	8	1020
http://www.ebi.ac.uk/efo/EFO_0007877	EFO_0007877	risky sexual behaviour measurement	4	252
http://www.ebi.ac.uk/efo/EFO_1001250	EFO_1001250	rotator cuff tear	7	1
http://www.ebi.ac.uk/efo/EFO_0007622	EFO_0007622	sRAGE measurement	1	66
http://www.ebi.ac.uk/efo/EFO_0020948	EFO_0020948	salicylic acid measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0010637	EFO_0010637	salivary metabolite measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0010142	EFO_0010142	same-sex sexual behavior	9	1
http://www.ebi.ac.uk/efo/EFO_0008276	EFO_0008276	scavenger receptor class F member 1 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0005411	EFO_0005411	schizoaffective disorder	2	1
http://purl.obolibrary.org/obo/MONDO_0005090	MONDO_0005090	schizophrenia	139	2244
http://www.ebi.ac.uk/efo/EFO_0007927	EFO_0007927	schizophrenia symptom severity measurement	7	2
http://www.ebi.ac.uk/efo/EFO_0004268	EFO_0004268	sclerosing cholangitis	12	86
http://www.ebi.ac.uk/efo/EFO_0010606	EFO_0010606	sclerostin measurement	1	6
http://www.ebi.ac.uk/efo/EFO_0004273	EFO_0004273	scoliosis	9	3
http://www.ebi.ac.uk/efo/EFO_0003956	EFO_0003956	seasonal allergic rhinitis	19	68
http://www.ebi.ac.uk/efo/EFO_0007753	EFO_0007753	seasonal gut microbiome measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0006876	EFO_0006876	seasonality measurement	4	10
http://www.ebi.ac.uk/efo/EFO_0006331	EFO_0006331	selenium measurement	4	4
http://www.ebi.ac.uk/efo/EFO_0004778	EFO_0004778	self rated health	5	50
http://www.ebi.ac.uk/efo/EFO_0004784	EFO_0004784	self reported educational attainment	26	3788
http://www.ebi.ac.uk/efo/EFO_0008278	EFO_0008278	semaphorin-3A measurement	1	15
http://purl.obolibrary.org/obo/GO_0050913	GO_0050913	sensory perception of bitter taste	6	24
http://purl.obolibrary.org/obo/GO_0007608	GO_0007608	sensory perception of smell	7	37
http://purl.obolibrary.org/obo/GO_0007605	GO_0007605	sensory perception of sound	1	6
http://www.ebi.ac.uk/efo/EFO_0009774	EFO_0009774	serine measurement	1	22
http://www.ebi.ac.uk/efo/EFO_0008280	EFO_0008280	serine protease 27 measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0008281	EFO_0008281	serine/threonine-protein kinase 17B measurement	1	9
http://www.ebi.ac.uk/efo/EFO_0004912	EFO_0004912	serum IgA measurement	5	99
http://www.ebi.ac.uk/efo/EFO_0004579	EFO_0004579	serum IgE measurement	12	93
http://www.ebi.ac.uk/efo/EFO_0005193	EFO_0005193	serum IgG glycosylation measurement	6	52
http://www.ebi.ac.uk/efo/EFO_0004565	EFO_0004565	serum IgG measurement	6	19
http://www.ebi.ac.uk/efo/EFO_0004993	EFO_0004993	serum IgM measurement	4	117
http://www.ebi.ac.uk/efo/EFO_0600043	EFO_0600043	serum N-desmethylclozapine measurement	1	10
http://www.ebi.ac.uk/efo/EFO_0005416	EFO_0005416	serum ST2 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0004735	EFO_0004735	serum alanine aminotransferase measurement	46	1212
http://www.ebi.ac.uk/efo/EFO_0004535	EFO_0004535	serum albumin measurement	27	1310
http://www.ebi.ac.uk/efo/EFO_0005415	EFO_0005415	serum alpha-1-antitrypsin measurement	2	16
http://www.ebi.ac.uk/efo/EFO_0004728	EFO_0004728	serum amyloid A protein measurement	2	10
http://www.ebi.ac.uk/efo/EFO_0008282	EFO_0008282	serum amyloid A-1 protein measurement	2	11
http://www.ebi.ac.uk/efo/EFO_0008283	EFO_0008283	serum amyloid P-component measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0005760	EFO_0005760	serum carcinoembryonic antigen measurement	2	47
http://www.ebi.ac.uk/efo/EFO_0005139	EFO_0005139	serum ceruloplasmin measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0600041	EFO_0600041	serum clozapine measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0600042	EFO_0600042	serum clozapine-to-N-desmethylclozapine ratio measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0007947	EFO_0007947	serum galactose-deficient IgA1 measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0004532	EFO_0004532	serum gamma-glutamyl transferase measurement	30	2004
http://www.ebi.ac.uk/efo/EFO_0004504	EFO_0004504	serum hepcidin measurement	2	25
http://www.ebi.ac.uk/efo/EFO_0005421	EFO_0005421	serum homoarginine measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0010127	EFO_0010127	serum immunoglobulin measurement	1	28
http://www.ebi.ac.uk/efo/EFO_0006332	EFO_0006332	serum iron measurement	7	78
http://www.ebi.ac.uk/efo/EFO_0005849	EFO_0005849	serum lipase activity measurement	2	28
http://www.ebi.ac.uk/efo/EFO_0600064	EFO_0600064	serum lipopolysaccharide activity	1	33
http://www.ebi.ac.uk/efo/EFO_0005653	EFO_0005653	serum metabolite measurement	216	553
http://www.ebi.ac.uk/efo/EFO_0004568	EFO_0004568	serum non-albumin protein measurement	3	1079
http://www.ebi.ac.uk/efo/EFO_0005266	EFO_0005266	serum selenium measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0009795	EFO_0009795	serum urea measurement	10	464
http://www.ebi.ac.uk/efo/EFO_0006927	EFO_0006927	severe aplastic anemia	1	37
http://www.ebi.ac.uk/efo/EFO_0006346	EFO_0006346	severe cutaneous adverse reaction	3	14
http://www.ebi.ac.uk/efo/EFO_0004696	EFO_0004696	sex hormone-binding globulin measurement	37	2585
http://www.ebi.ac.uk/efo/EFO_0008343	EFO_0008343	sex interaction measurement	49	2
http://www.ebi.ac.uk/efo/EFO_0004820	EFO_0004820	sex ratio	2	1
http://www.ebi.ac.uk/efo/EFO_0008286	EFO_0008286	sialic acid-binding Ig-like lectin 9 measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0007118	EFO_0007118	sitting height ratio	1	15
http://www.ebi.ac.uk/efo/EFO_0008006	EFO_0008006	skin aging measurement	6	38
http://www.ebi.ac.uk/efo/EFO_1001489	EFO_1001489	skin and soft tissue Staphylococcus aureus infection	2	12
http://www.ebi.ac.uk/efo/EFO_0007891	EFO_0007891	skin barrier function measurement	1	2
http://purl.obolibrary.org/obo/MONDO_0004641	MONDO_0004641	skin carcinoma in situ	5	1
http://www.ebi.ac.uk/efo/EFO_0000701	EFO_0000701	skin disease	60	8
http://www.ebi.ac.uk/efo/EFO_0005766	EFO_0005766	skin fluorescence measurement	2	1
http://www.ebi.ac.uk/efo/EFO_0009586	EFO_0009586	skin hydration measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004198	EFO_0004198	skin neoplasm	55	1
http://www.ebi.ac.uk/efo/EFO_0003784	EFO_0003784	skin pigmentation	19	32
http://www.ebi.ac.uk/efo/EFO_0007009	EFO_0007009	skin pigmentation measurement	22	16
http://www.ebi.ac.uk/efo/EFO_0600094	EFO_0600094	skin roughness measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0004795	EFO_0004795	skin sensitivity to sun	3	15
http://www.ebi.ac.uk/efo/EFO_0003877	EFO_0003877	sleep apnea	10	4
http://www.ebi.ac.uk/efo/EFO_0007817	EFO_0007817	sleep apnea measurement	25	42
http://www.ebi.ac.uk/efo/EFO_0005271	EFO_0005271	sleep duration	36	703
http://www.ebi.ac.uk/efo/EFO_0004870	EFO_0004870	sleep measurement	16	221
http://www.ebi.ac.uk/efo/EFO_0005272	EFO_0005272	sleep quality	5	2
http://www.ebi.ac.uk/efo/EFO_1001495	EFO_1001495	small artery occlusion	1	4
http://www.ebi.ac.uk/efo/EFO_0000702	EFO_0000702	small cell lung carcinoma	2	25
http://www.ebi.ac.uk/efo/EFO_1001928	EFO_1001928	small intestine neuroendocrine tumor	1	2
http://www.ebi.ac.uk/efo/EFO_0008288	EFO_0008288	small nuclear ribonucleoprotein F measurement	1	9
http://www.ebi.ac.uk/efo/EFO_1001504	EFO_1001504	small vessel stroke	13	9
http://www.ebi.ac.uk/efo/EFO_0004318	EFO_0004318	smoking behavior	43	1001
http://www.ebi.ac.uk/efo/EFO_0005671	EFO_0005671	smoking behaviour measurement	74	353
http://www.ebi.ac.uk/efo/EFO_0004319	EFO_0004319	smoking cessation	12	183
http://www.ebi.ac.uk/efo/EFO_0005670	EFO_0005670	smoking initiation	15	710
http://www.ebi.ac.uk/efo/EFO_0006527	EFO_0006527	smoking status measurement	87	1719
http://www.ebi.ac.uk/efo/EFO_0008341	EFO_0008341	snoring measurement	8	121
http://www.ebi.ac.uk/efo/EFO_0005427	EFO_0005427	social communication impairment	2	2
http://www.ebi.ac.uk/efo/EFO_0010552	EFO_0010552	social environment measurement	21	5
http://www.ebi.ac.uk/efo/EFO_0009592	EFO_0009592	social interaction measurement	26	91
http://www.ebi.ac.uk/efo/EFO_0009282	EFO_0009282	sodium measurement	21	182
http://www.ebi.ac.uk/efo/EFO_0007850	EFO_0007850	solar lentigines measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0007650	EFO_0007650	soluble interleukin-2 receptor subunit alpha measurement	4	4
http://www.ebi.ac.uk/efo/EFO_0004460	EFO_0004460	soluble transferrin receptor measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0010151	EFO_0010151	soluble triggering receptor expressed on myeloid cells 2 measurement	3	89
http://www.ebi.ac.uk/efo/EFO_0008578	EFO_0008578	sperm motility measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0004622	EFO_0004622	sphingolipid measurement	5	48
http://www.ebi.ac.uk/efo/EFO_0010393	EFO_0010393	sphingomyelin 18:0 measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0010118	EFO_0010118	sphingomyelin measurement	293	420
http://www.ebi.ac.uk/efo/EFO_0003902	EFO_0003902	spinal fracture	9	4
http://www.ebi.ac.uk/efo/EFO_0007490	EFO_0007490	spinal stenosis	12	31
http://www.ebi.ac.uk/efo/EFO_0007701	EFO_0007701	spine bone mineral density	26	98
http://www.ebi.ac.uk/efo/EFO_0004508	EFO_0004508	spine bone size	3	21
http://www.ebi.ac.uk/efo/EFO_0600047	EFO_0600047	spleen volume	1	109
http://www.ebi.ac.uk/efo/EFO_0008290	EFO_0008290	spondin-1 measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0010820	EFO_0010820	spontaneous coronary artery dissection	3	25
http://www.ebi.ac.uk/efo/EFO_0006917	EFO_0006917	spontaneous preterm birth	16	5
http://www.ebi.ac.uk/efo/EFO_1000656	EFO_1000656	sporadic Creutzfeld Jacob disease	2	17
http://www.ebi.ac.uk/efo/EFO_0001357	EFO_0001357	sporadic amyotrophic lateral sclerosis	6	38
http://www.ebi.ac.uk/efo/EFO_0000707	EFO_0000707	squamous cell carcinoma	11	103
http://www.ebi.ac.uk/efo/EFO_0000708	EFO_0000708	squamous cell lung carcinoma	8	796
http://www.ebi.ac.uk/efo/EFO_0008291	EFO_0008291	stem Cell Factor measurement	3	118
http://www.ebi.ac.uk/efo/EFO_0010822	EFO_0010822	stenosing tenosynovitis	5	1
http://www.ebi.ac.uk/efo/EFO_0010231	EFO_0010231	sterol measurement	6	27
http://www.ebi.ac.uk/efo/EFO_0600076	EFO_0600076	stimulant use measurement	3	1
http://purl.obolibrary.org/obo/MONDO_0008277	MONDO_0008277	stomach polyp	4	43
http://www.ebi.ac.uk/efo/EFO_0010098	EFO_0010098	stress-related disorder	11	1
http://www.ebi.ac.uk/efo/EFO_0007781	EFO_0007781	stressful life event measurement	18	8
http://www.ebi.ac.uk/efo/EFO_0006818	EFO_0006818	stricture	4	1
http://www.ebi.ac.uk/efo/EFO_0000712	EFO_0000712	stroke	53	36
http://www.ebi.ac.uk/efo/EFO_0009603	EFO_0009603	stroke outcome severity measurement	6	2
http://www.ebi.ac.uk/efo/EFO_0000713	EFO_0000713	subarachnoid hemorrhage	7	3
http://www.ebi.ac.uk/efo/EFO_0004766	EFO_0004766	subcutaneous adipose tissue measurement	16	27
http://www.ebi.ac.uk/efo/EFO_0009399	EFO_0009399	subiculum volume	2	9
http://purl.obolibrary.org/obo/MONDO_0002491	MONDO_0002491	substance abuse	7	1145
http://www.ebi.ac.uk/efo/EFO_0004278	EFO_0004278	sudden cardiac arrest	7	15
http://www.ebi.ac.uk/efo/EFO_0010158	EFO_0010158	sugar consumption measurement	5	22
http://www.ebi.ac.uk/efo/EFO_0010097	EFO_0010097	sugar sweetened beverage consumption measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0007624	EFO_0007624	suicide	3	1
http://www.ebi.ac.uk/efo/EFO_0006882	EFO_0006882	suicide behaviour measurement	21	14
http://www.ebi.ac.uk/efo/EFO_0007864	EFO_0007864	sulfate measurement	2	1
http://www.ebi.ac.uk/efo/EFO_0009388	EFO_0009388	sum of basophil and neutrophil counts	1	560
http://www.ebi.ac.uk/efo/EFO_0009389	EFO_0009389	sum of eosinophil and basophil counts	1	707
http://www.ebi.ac.uk/efo/EFO_0009390	EFO_0009390	sum of neutrophil and eosinophil counts	1	552
http://www.ebi.ac.uk/efo/EFO_0010729	EFO_0010729	sun exposure measurement	12	6
http://www.ebi.ac.uk/efo/EFO_0003958	EFO_0003958	sunburn	5	2
http://www.ebi.ac.uk/efo/EFO_0004279	EFO_0004279	suntan	5	154
http://www.ebi.ac.uk/efo/EFO_0006516	EFO_0006516	superior frontal gyrus grey matter volume measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0010331	EFO_0010331	superior temporal gyrus volume measurement	4	8
http://www.ebi.ac.uk/efo/EFO_0008294	EFO_0008294	superoxide dismutase [Mn], mitochondrial measurement	1	11
http://www.ebi.ac.uk/efo/EFO_0005081	EFO_0005081	surfactant protein D measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0000714	EFO_0000714	survival time	60	22
http://www.ebi.ac.uk/efo/EFO_0008407	EFO_0008407	susceptibility to Mycobacterium tuberculosis infection measurement	3	3
http://www.ebi.ac.uk/efo/EFO_0007904	EFO_0007904	susceptibility to childhood ear infection measurement	3	52
http://www.ebi.ac.uk/efo/EFO_0008405	EFO_0008405	susceptibility to hepatitis B infection measurement	2	29
http://www.ebi.ac.uk/efo/EFO_0008408	EFO_0008408	susceptibility to strep throat measurement	1	63
http://www.ebi.ac.uk/efo/EFO_0008413	EFO_0008413	susceptibility to urinary tract infection measurement	1	12
http://www.ebi.ac.uk/efo/EFO_0008412	EFO_0008412	susceptibility to vaginal yeast infection measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0010156	EFO_0010156	sweet liking measurement	1	4
http://www.ebi.ac.uk/efo/EFO_0006523	EFO_0006523	symmetrical dimethylarginine measurement	4	3
http://www.ebi.ac.uk/efo/EFO_0007906	EFO_0007906	synophrys measurement	1	90
http://www.ebi.ac.uk/efo/EFO_1001999	EFO_1001999	systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis	2	114
http://www.ebi.ac.uk/efo/EFO_1002019	EFO_1002019	systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis	2	95
http://www.ebi.ac.uk/efo/EFO_1002020	EFO_1002020	systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis	1	95
http://www.ebi.ac.uk/efo/EFO_0002690	EFO_0002690	systemic lupus erythematosus	60	777
http://www.ebi.ac.uk/efo/EFO_0000717	EFO_0000717	systemic scleroderma	17	365
http://www.ebi.ac.uk/efo/EFO_0006335	EFO_0006335	systolic blood pressure	116	1719
http://www.ebi.ac.uk/efo/EFO_0006944	EFO_0006944	systolic blood pressure change measurement	16	18
http://www.ebi.ac.uk/efo/EFO_0004760	EFO_0004760	t-tau measurement	24	31
http://www.ebi.ac.uk/efo/EFO_0007708	EFO_0007708	t-tau:beta-amyloid 1-42 ratio measurement	5	10
http://www.ebi.ac.uk/efo/EFO_0008458	EFO_0008458	tacrolimus measurement	4	8
http://www.ebi.ac.uk/efo/EFO_0010536	EFO_0010536	taurine measurement	4	4
http://www.ebi.ac.uk/efo/EFO_0010091	EFO_0010091	tea consumption measurement	11	153
http://www.ebi.ac.uk/efo/EFO_0004505	EFO_0004505	telomere length	25	277
http://www.ebi.ac.uk/efo/EFO_1001209	EFO_1001209	temporal arteritis	3	49
http://www.ebi.ac.uk/efo/EFO_0010147	EFO_0010147	temporal lobe volume measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0005279	EFO_0005279	temporomandibular joint disorder	4	3
http://www.ebi.ac.uk/efo/EFO_0008296	EFO_0008296	tenascin measurement	3	63
http://www.ebi.ac.uk/efo/EFO_0005088	EFO_0005088	testicular carcinoma	13	60
http://www.ebi.ac.uk/efo/EFO_0004908	EFO_0004908	testosterone measurement	44	2355
http://www.ebi.ac.uk/efo/EFO_0006935	EFO_0006935	thalamus volume	12	22
http://www.ebi.ac.uk/efo/EFO_0006873	EFO_0006873	theta wave measurement	3	1
http://www.ebi.ac.uk/efo/EFO_0006315	EFO_0006315	thiopurine immunosuppressant-induced pancreatitis	1	25
http://www.ebi.ac.uk/efo/EFO_0007852	EFO_0007852	thiopurine methyltransferase activity measurement	2	4
http://www.ebi.ac.uk/efo/EFO_0004282	EFO_0004282	thoracic aortic aneurysm	5	16
http://www.ebi.ac.uk/efo/EFO_0007769	EFO_0007769	thoracic-to-hip circumference ratio measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0009775	EFO_0009775	threonine measurement	2	34
http://www.ebi.ac.uk/efo/EFO_0008582	EFO_0008582	thrombin activatable fibrinolysis inhibitor activation peptide measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0005538	EFO_0005538	thrombin generation potential measurement	11	4
http://www.ebi.ac.uk/efo/EFO_0007774	EFO_0007774	thrombomodulin measurement	8	39
http://www.ebi.ac.uk/efo/EFO_0008299	EFO_0008299	thrombospondin-2 measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0007615	EFO_0007615	thrombus formation measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0010050	EFO_0010050	thyroglobulin measurement	3	4
http://www.ebi.ac.uk/efo/EFO_0002892	EFO_0002892	thyroid carcinoma	16	24
http://www.ebi.ac.uk/efo/EFO_0004296	EFO_0004296	thyroid function	3	4
http://www.ebi.ac.uk/efo/EFO_1001436	EFO_1001436	thyroid nodule	3	1
http://www.ebi.ac.uk/efo/EFO_0005666	EFO_0005666	thyroid peroxidase antibody measurement	10	17
http://www.ebi.ac.uk/efo/EFO_0004748	EFO_0004748	thyroid stimulating hormone measurement	13	213
http://www.ebi.ac.uk/efo/EFO_0004865	EFO_0004865	thyroid volume	2	5
http://www.ebi.ac.uk/efo/EFO_0005130	EFO_0005130	thyroxine measurement	8	45
http://www.ebi.ac.uk/efo/EFO_0007007	EFO_0007007	ticagrelor measurement	1	37
http://www.ebi.ac.uk/efo/EFO_0010126	EFO_0010126	time to first cigarette measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0600020	EFO_0600020	time to remission of COVID-19 symptoms	2	1
http://www.ebi.ac.uk/efo/EFO_0007510	EFO_0007510	tinea	2	1
http://www.ebi.ac.uk/efo/EFO_0010623	EFO_0010623	tissue factor measurement	2	44
http://www.ebi.ac.uk/efo/EFO_0004791	EFO_0004791	tissue plasminogen activator measurement	3	11
http://www.ebi.ac.uk/efo/EFO_0009115	EFO_0009115	tobacco smoke exposure measurement	5	61
http://www.ebi.ac.uk/efo/EFO_0004738	EFO_0004738	tocopherol measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0020777	EFO_0020777	toll-like receptor 2 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0007924	EFO_0007924	tonsillectomy risk measurement	3	139
http://www.ebi.ac.uk/efo/EFO_0005410	EFO_0005410	tooth agenesis	8	20
http://purl.obolibrary.org/obo/GO_0044691	GO_0044691	tooth eruption	2	25
http://www.ebi.ac.uk/efo/EFO_0004536	EFO_0004536	total blood protein measurement	12	1101
http://www.ebi.ac.uk/efo/EFO_0020962	EFO_0020962	total campesterol measurement	3	18
http://www.ebi.ac.uk/efo/EFO_0007806	EFO_0007806	total cholesterol change measurement	44	10
http://www.ebi.ac.uk/efo/EFO_0004574	EFO_0004574	total cholesterol measurement	118	2472
http://www.ebi.ac.uk/efo/EFO_0008381	EFO_0008381	total cortical area measurement	374	124
http://www.ebi.ac.uk/efo/EFO_0009305	EFO_0009305	total glycated albumin	1	12
http://www.ebi.ac.uk/efo/EFO_0009806	EFO_0009806	total hip arthroplasty	3	1
http://www.ebi.ac.uk/efo/EFO_0006334	EFO_0006334	total iron binding capacity	4	76
http://www.ebi.ac.uk/efo/EFO_0020965	EFO_0020965	total sitosterol measurement	3	13
http://www.ebi.ac.uk/efo/EFO_0004775	EFO_0004775	toxic epidermal necrolysis	12	320
http://www.ebi.ac.uk/efo/EFO_0007908	EFO_0007908	traffic air pollution measurement	6	23
http://www.ebi.ac.uk/efo/EFO_0006821	EFO_0006821	trans fatty acid measurement	4	9
http://www.ebi.ac.uk/efo/EFO_0010707	EFO_0010707	trans-3-hydroxycotinine measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0006341	EFO_0006341	transferrin measurement	4	42
http://www.ebi.ac.uk/efo/EFO_0006333	EFO_0006333	transferrin saturation measurement	4	63
http://www.ebi.ac.uk/efo/EFO_0004818	EFO_0004818	transforming growth factor beta measurement	2	132
http://www.ebi.ac.uk/efo/EFO_0008302	EFO_0008302	transforming growth factor-beta-induced protein ig-h3 measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0008303	EFO_0008303	transmembrane glycoprotein NMB measurement	2	5
http://purl.obolibrary.org/obo/MONDO_0000153	MONDO_0000153	transposition of the great arteries	1	3
http://www.ebi.ac.uk/efo/EFO_0010703	EFO_0010703	trauma exposure measurement	12	12
http://www.ebi.ac.uk/efo/EFO_1002006	EFO_1002006	treatment-resistant hypertension	10	5
http://www.ebi.ac.uk/efo/EFO_0008304	EFO_0008304	trefoil factor 3 measurement	1	19
http://www.ebi.ac.uk/efo/EFO_0009779	EFO_0009779	tri-iodothyronine/thyroxine ratio measurement	1	5
http://www.ebi.ac.uk/efo/EFO_0010406	EFO_0010406	triacylglycerol 48:3 measurement	6	5
http://www.ebi.ac.uk/efo/EFO_0010408	EFO_0010408	triacylglycerol 50:1 measurement	6	280
http://www.ebi.ac.uk/efo/EFO_0010409	EFO_0010409	triacylglycerol 50:2 measurement	9	66
http://www.ebi.ac.uk/efo/EFO_0010410	EFO_0010410	triacylglycerol 50:3 measurement	9	14
http://www.ebi.ac.uk/efo/EFO_0010411	EFO_0010411	triacylglycerol 50:4 measurement	3	8
http://www.ebi.ac.uk/efo/EFO_0010414	EFO_0010414	triacylglycerol 52:2 measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0010415	EFO_0010415	triacylglycerol 52:3 measurement	6	7
http://www.ebi.ac.uk/efo/EFO_0010416	EFO_0010416	triacylglycerol 52:4 measurement	6	7
http://www.ebi.ac.uk/efo/EFO_0010419	EFO_0010419	triacylglycerol 54:1 measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0010420	EFO_0010420	triacylglycerol 54:2 measurement	3	16
http://www.ebi.ac.uk/efo/EFO_0010421	EFO_0010421	triacylglycerol 54:3 measurement	3	7
http://www.ebi.ac.uk/efo/EFO_0010422	EFO_0010422	triacylglycerol 54:4 measurement	6	3
http://www.ebi.ac.uk/efo/EFO_0010423	EFO_0010423	triacylglycerol 54:5 measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0010427	EFO_0010427	triacylglycerol 54:9 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010428	EFO_0010428	triacylglycerol 56:10 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0010433	EFO_0010433	triacylglycerol 56:6 measurement	5	15
http://www.ebi.ac.uk/efo/EFO_0010435	EFO_0010435	triacylglycerol 56:8 measurement	3	10
http://www.ebi.ac.uk/efo/EFO_0010436	EFO_0010436	triacylglycerol 56:9 measurement	2	8
http://www.ebi.ac.uk/efo/EFO_0007685	EFO_0007685	trichloroethylene-induced hypersensitivity	1	16
http://www.ebi.ac.uk/efo/EFO_0007681	EFO_0007681	triglyceride change measurement	45	23
http://www.ebi.ac.uk/efo/EFO_0004530	EFO_0004530	triglyceride measurement	430	2962
http://www.ebi.ac.uk/efo/EFO_0007929	EFO_0007929	triglyceride:HDL cholesterol ratio	1	7
http://www.ebi.ac.uk/efo/EFO_0020947	EFO_0020947	triglycerides:total lipids ratio	14	964
http://www.ebi.ac.uk/efo/EFO_0008392	EFO_0008392	triiodothyronine measurement	4	3
http://www.ebi.ac.uk/efo/EFO_0011003	EFO_0011003	trimethylamine measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0005537	EFO_0005537	triple-negative breast cancer	3	96
http://www.ebi.ac.uk/efo/EFO_0010074	EFO_0010074	trochanter size	1	15
http://www.ebi.ac.uk/efo/EFO_0008305	EFO_0008305	trypsin-2 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0008306	EFO_0008306	tryptase beta-2 measurement	1	7
http://www.ebi.ac.uk/efo/EFO_0008534	EFO_0008534	tryptophan measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0008307	EFO_0008307	tuberculin skin test reactivity measurement	3	6
http://www.ebi.ac.uk/efo/EFO_0600069	EFO_0600069	tumor necrosis factor alpha gene expression measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0008308	EFO_0008308	tumor necrosis factor beta measurement	2	195
http://www.ebi.ac.uk/efo/EFO_0010801	EFO_0010801	tumor necrosis factor ligand superfamily member 12 measurement	2	17
http://www.ebi.ac.uk/efo/EFO_0010613	EFO_0010613	tumor necrosis factor ligand superfamily member 14 measurement	3	7
http://www.ebi.ac.uk/efo/EFO_0010834	EFO_0010834	tumor necrosis factor measurement	4	109
http://www.ebi.ac.uk/efo/EFO_0010931	EFO_0010931	tumor necrosis factor receptor 1 measurement	1	16
http://www.ebi.ac.uk/efo/EFO_0008384	EFO_0008384	tumor necrosis factor receptor II measurement	2	143
http://www.ebi.ac.uk/efo/EFO_0008309	EFO_0008309	tumor necrosis factor receptor superfamily member 19L measurement	1	2
http://www.ebi.ac.uk/efo/EFO_0010610	EFO_0010610	tumor necrosis factor receptor superfamily member 6 measurement	1	15
http://www.ebi.ac.uk/efo/EFO_0008310	EFO_0008310	tumor necrosis factor receptor superfamily member EDAR measurement	1	3
http://www.ebi.ac.uk/efo/EFO_0010607	EFO_0010607	tumor necrosis factor, receptor superfamily, member 5 measurement	1	13
http://www.ebi.ac.uk/efo/EFO_0004684	EFO_0004684	tumor necrosis factor-alpha measurement	6	133
http://www.ebi.ac.uk/efo/EFO_0008311	EFO_0008311	tumor necrosis factor-inducible gene 6 protein measurement	1	4
http://purl.obolibrary.org/obo/MONDO_0005147	MONDO_0005147	type 1 diabetes mellitus	52	656
http://purl.obolibrary.org/obo/MONDO_0005148	MONDO_0005148	type 2 diabetes mellitus	204	2806
http://www.ebi.ac.uk/efo/EFO_0006789	EFO_0006789	typhoid fever	3	25
http://www.ebi.ac.uk/efo/EFO_0020891	EFO_0020891	tyrosine change measurement	2	3
http://www.ebi.ac.uk/efo/EFO_0005058	EFO_0005058	tyrosine measurement	11	121
http://www.ebi.ac.uk/efo/EFO_0020825	EFO_0020825	tyrosine-protein kinase JAK2 measurement	3	9
http://www.ebi.ac.uk/efo/EFO_0020830	EFO_0020830	tyrosine-protein kinase TEC measurement	2	9
http://www.ebi.ac.uk/efo/EFO_0020834	EFO_0020834	tyrosine-protein phosphatase non-receptor type 1 measurement	2	73
http://www.ebi.ac.uk/efo/EFO_0000729	EFO_0000729	ulcerative colitis	56	811
http://www.ebi.ac.uk/efo/EFO_0003761	EFO_0003761	unipolar depression	205	1132
http://www.ebi.ac.uk/efo/EFO_0004284	EFO_0004284	upper aerodigestive tract neoplasm	2	15
http://www.ebi.ac.uk/efo/EFO_0004531	EFO_0004531	urate measurement	39	1456
http://www.ebi.ac.uk/efo/EFO_0004761	EFO_0004761	uric acid measurement	41	411
http://www.ebi.ac.uk/efo/EFO_0007651	EFO_0007651	urinary S-phenylmercapturic acid measurement	1	18
http://www.ebi.ac.uk/efo/EFO_0007778	EFO_0007778	urinary albumin to creatinine ratio	15	370
http://purl.obolibrary.org/obo/MONDO_0001187	MONDO_0001187	urinary bladder cancer	16	2
http://purl.obolibrary.org/obo/MONDO_0004986	MONDO_0004986	urinary bladder carcinoma	36	60
http://www.ebi.ac.uk/efo/EFO_0005116	EFO_0005116	urinary metabolite measurement	9	301
http://www.ebi.ac.uk/efo/EFO_0010967	EFO_0010967	urinary microalbumin measurement	3	8
http://www.ebi.ac.uk/efo/EFO_0010136	EFO_0010136	urinary pH measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0009882	EFO_0009882	urinary potassium to creatinine ratio	1	17
http://www.ebi.ac.uk/efo/EFO_0009883	EFO_0009883	urinary sodium to creatinine ratio	1	9
http://www.ebi.ac.uk/efo/EFO_0009884	EFO_0009884	urinary sodium to potassium ratio	1	13
http://www.ebi.ac.uk/efo/EFO_0005663	EFO_0005663	urinary uromodulin measurement	3	32
http://www.ebi.ac.uk/efo/EFO_0010932	EFO_0010932	urokinase plasminogen activator surface receptor measurement	3	50
http://purl.obolibrary.org/obo/MONDO_0024647	MONDO_0024647	urolithiasis	11	85
http://www.ebi.ac.uk/efo/EFO_0005531	EFO_0005531	urticaria	6	13
http://www.ebi.ac.uk/efo/EFO_0000731	EFO_0000731	uterine fibroid	18	144
http://www.ebi.ac.uk/efo/EFO_1001864	EFO_1001864	uterine prolapse	5	19
http://www.ebi.ac.uk/efo/EFO_0007974	EFO_0007974	vaccenic acid measurement	1	12
http://www.ebi.ac.uk/efo/EFO_0020889	EFO_0020889	valine change measurement	2	2
http://www.ebi.ac.uk/efo/EFO_0009792	EFO_0009792	valine measurement	7	99
http://www.ebi.ac.uk/efo/EFO_0010057	EFO_0010057	vascular cell adhesion molecule-1 measurement	2	6
http://www.ebi.ac.uk/efo/EFO_0004718	EFO_0004718	vascular dementia	4	12
http://www.ebi.ac.uk/efo/EFO_0010804	EFO_0010804	vascular endothelial growth factor A measurement	6	18
http://www.ebi.ac.uk/efo/EFO_0010575	EFO_0010575	vascular endothelial growth factor D measurement	4	30
http://www.ebi.ac.uk/efo/EFO_0004762	EFO_0004762	vascular endothelial growth factor measurement	10	26
http://www.ebi.ac.uk/efo/EFO_0008315	EFO_0008315	vascular endothelial growth factor receptor 3 measurement	1	19
http://www.ebi.ac.uk/efo/EFO_0004915	EFO_0004915	vaspin measurement	3	6
http://www.ebi.ac.uk/efo/EFO_0005654	EFO_0005654	velocity of sound measurement	7	14
http://www.ebi.ac.uk/efo/EFO_0009336	EFO_0009336	velopharyngeal dysfunction	1	21
http://www.ebi.ac.uk/efo/EFO_0004286	EFO_0004286	venous thromboembolism	33	250
http://www.ebi.ac.uk/efo/EFO_0010570	EFO_0010570	ventricular enlargement measurement	1	1
http://www.ebi.ac.uk/efo/EFO_0006796	EFO_0006796	very long-chain saturated fatty acid measurement	3	5
http://www.ebi.ac.uk/efo/EFO_0020857	EFO_0020857	very low density lipoprotein cholesterol change measurement	12	1
http://www.ebi.ac.uk/efo/EFO_0008317	EFO_0008317	very low density lipoprotein cholesterol measurement	265	1511
http://www.ebi.ac.uk/efo/EFO_0008594	EFO_0008594	very low density lipoprotein particle size measurement	4	333
http://www.ebi.ac.uk/efo/EFO_0007536	EFO_0007536	vesicoureteral reflux	3	1
http://www.ebi.ac.uk/efo/EFO_0007537	EFO_0007537	vestibular neuronitis	1	2
http://www.ebi.ac.uk/efo/EFO_0010125	EFO_0010125	viral load	3	354
http://www.ebi.ac.uk/efo/EFO_0005045	EFO_0005045	visceral Leishmaniasis	2	12
http://www.ebi.ac.uk/efo/EFO_0004765	EFO_0004765	visceral adipose tissue measurement	34	736
http://www.ebi.ac.uk/efo/EFO_0004767	EFO_0004767	visceral:subcutaneous adipose tissue ratio	13	3
http://www.ebi.ac.uk/efo/EFO_0004771	EFO_0004771	visual cortical surface area measurement	2	20
http://www.ebi.ac.uk/efo/EFO_0004312	EFO_0004312	vital capacity	35	494
http://www.ebi.ac.uk/efo/EFO_0004857	EFO_0004857	vitamin A measurement	1	8
http://www.ebi.ac.uk/efo/EFO_0004843	EFO_0004843	vitamin B measurement	2	10
http://www.ebi.ac.uk/efo/EFO_0004620	EFO_0004620	vitamin B12 measurement	7	170
http://www.ebi.ac.uk/efo/EFO_0004621	EFO_0004621	vitamin B6 measurement	15	3
http://www.ebi.ac.uk/efo/EFO_0600003	EFO_0600003	vitamin C measurement	1	70
http://www.ebi.ac.uk/efo/EFO_0003762	EFO_0003762	vitamin D deficiency	7	69
http://www.ebi.ac.uk/efo/EFO_0004631	EFO_0004631	vitamin D measurement	57	764
http://www.ebi.ac.uk/efo/EFO_0005675	EFO_0005675	vitamin D-binding protein measurement	3	2
http://www.ebi.ac.uk/efo/EFO_0004867	EFO_0004867	vitamin E measurement	1	14
http://www.ebi.ac.uk/efo/EFO_0008318	EFO_0008318	vitamin K-dependent protein C measurement	2	5
http://www.ebi.ac.uk/efo/EFO_0004729	EFO_0004729	vitamin measurement	2	36
http://www.ebi.ac.uk/efo/EFO_0007620	EFO_0007620	volumetric bone mineral density	6	6
http://www.ebi.ac.uk/efo/EFO_0004629	EFO_0004629	von Willebrand factor measurement	11	138
http://www.ebi.ac.uk/efo/EFO_0004342	EFO_0004342	waist circumference	37	477
http://www.ebi.ac.uk/efo/EFO_0004343	EFO_0004343	waist-hip ratio	50	1048
http://www.ebi.ac.uk/efo/EFO_0007869	EFO_0007869	wellbeing measurement	157	1010
http://www.ebi.ac.uk/efo/EFO_0004683	EFO_0004683	wet macular degeneration	7	321
http://www.ebi.ac.uk/efo/EFO_1001243	EFO_1001243	wheat allergic reaction	2	13
http://www.ebi.ac.uk/efo/EFO_0009715	EFO_0009715	wheezing	5	2
http://www.ebi.ac.uk/efo/EFO_0005665	EFO_0005665	white matter hyperintensity measurement	21	114
http://www.ebi.ac.uk/efo/EFO_0004641	EFO_0004641	white matter integrity	309	467
http://www.ebi.ac.uk/efo/EFO_0005674	EFO_0005674	white matter microstructure measurement	63	65
http://www.ebi.ac.uk/efo/EFO_0006948	EFO_0006948	white wine liking measurement	1	25
http://www.ebi.ac.uk/efo/EFO_0005089	EFO_0005089	whole-brain volume	10	2
http://www.ebi.ac.uk/efo/EFO_0009589	EFO_0009589	worry measurement	39	771